US20090069333A1 - Fungicides - Google Patents

Fungicides Download PDF

Info

Publication number
US20090069333A1
US20090069333A1 US12/187,072 US18707208A US2009069333A1 US 20090069333 A1 US20090069333 A1 US 20090069333A1 US 18707208 A US18707208 A US 18707208A US 2009069333 A1 US2009069333 A1 US 2009069333A1
Authority
US
United States
Prior art keywords
alkyl
compounds
halo
alkoxy
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/187,072
Inventor
Patrick Jelf Crowley
Markus Dobler
Urs Mueller
John Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Crop Protection LLC
Original Assignee
Syngenta Crop Protection LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9950323&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20090069333(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Syngenta Crop Protection LLC filed Critical Syngenta Crop Protection LLC
Priority to US12/187,072 priority Critical patent/US20090069333A1/en
Publication of US20090069333A1 publication Critical patent/US20090069333A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Definitions

  • This invention relates to novel derivatives of pyridopyrazines and pyridopyridazines, to processes for preparing them, to certain intermediate chemicals used in their manufacture, to compositions containing them and to methods of using them to combat fungi, especially fungal infections of plants.
  • Derivatives of the nitrogen-containing 5,6 ring system s-1,2,4-triazolo[1,5-a]pyrimidine are known from the patent literature as being useful for controlling phytopathogenic fungi. Examples of recent patent publications include EP-A-1249452, WO 02/051845, WO 02/083676, WO 02/083677, WO 02/088125, WO 02/088126, WO 02/088127. Condensed nitrogen heterocycles used as antimycotics are known from U.S. Pat. No. 5,821,244. Derivatives of pyridopyrazines are known in the chemical literature, for example from J. Med. Chem . (1968), 11(6), 1216-18 , J. Med. Chem . (1970), 13(5), 853-7 and U.S. Pat. No. 3,984,412, but not for agrochemical purposes.
  • the present invention is concerned with the provision of novel pyridopyrazines and pyridopyridazines for combating phytopathogenic diseases on plants and harvested food crops.
  • W and X, W and Z, X and Y or Y and Z are N and the other two are CR 8 ;
  • R 8 is H, halo, C 1-4 alkyl, C 1-4 alkoxy or halo(C 1-4 )alkyl;
  • R is halo;
  • R 1 is halo, C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl(C 1-6 )alkyl, C 1-8 alkoxy, C 1-8 alkylthio, aryl, aryloxy, arylthio, heteroaryl, heteroaryloxy, heteroarylthio, aryl(C 1-4 )alkyl, aryl(C 1-4 )alkoxy, heteroaryl(C 1-4 )alkyl, heteroaryl(C 1-4 )alkoxy, aryl(C 1-4 )alkylthio, heteroary
  • R 2 is NR 3 R 4 ;
  • R 3 and R 4 are independently H, C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, aryl, aryl(C 1-8 )alkyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl(C 1-6 )alkyl, heteroaryl, heteroaryl(C 1-8 )alkyl, NR 5 R 6 , provided that not both R 3 and R 4 are H or NR 5 R 6 , or R 3 and R 4 together form a C 3-7 alkylene or C 3-7 alkenylene chain optionally substituted with one or more C 1-4 alkyl or C 1-4 alkoxy groups, or, together with the nitrogen atom to which they are attached, R 3 and R 4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C 1-4 )alkyl (especially N-
  • the invention includes a compound of the general formula (1) as defined immediately above except that: C 1-8 alkoxy and C 1-8 alkylthio are excluded as values of R and R 2 ; C 7 alkylene and C 3-7 alkenylene are excluded as chains formed by R 3 and R 4 ; the C 3-6 chain that R 3 and R 4 may form may only be optionally substituted with one or more methyl groups; thiomorpholine, thiomorpholine S-oxide, thiomorpholine S-dioxide and piperazine are excluded as rings that R 3 and R 4 may form; tri(C 1-4 )alkylsilyl is excluded as a substituent of any alkyl, alkenyl, alkynyl or cycloalkyl group or moiety and any morpholine, piperidine or pyrrolidine ring is unsubstituted.
  • the compounds of the invention may contain one or more asymmetric carbon atoms and may exist as enantiomers (or as pairs of diastereoisomers) or as mixtures of such. They may also exist as diastereoisomers by virtue of restricted rotation about a bond. However, mixtures of enantiomers or diastereoisomers may be separated into individual isomers or isomer pairs, and this invention embraces such isomers and mixtures thereof in all proportions. It is to be expected that for any given compound, one isomer may be more fungicidally active than another.
  • alkyl groups and alkyl moieties of alkoxy, alkylthio, etc. contain from 1 to 8, suitably from 1 to 6 and typically from 1 to 4, carbon atoms in the form of straight or branched chains. Examples are methyl, ethyl, n- and iso-propyl, n-, sec-, iso- and tert-butyl, n-pentyl and n-hexyl.
  • Cycloalkyl groups contain from 3 to 8, typically from 3 to 6, carbon atoms and include bicycloalkyl groups such as the bicyclo[2.2.1]heptyl group.
  • Haloalkyl groups or moieties are typically trichloromethyl or trifluoromethyl or contain a trichloromethyl or trifluoromethyl terminal group.
  • alkenyl and alkynyl moieties also contain from 2 to 8, suitably from 2 to 6 and typically from 2 to 4, carbon atoms in the form of straight or branched chains. Examples are allyl, 2-methylallyl and propargyl.
  • Optional substituents include halo, typically fluoro.
  • An example of halo-substituted alkenyl is 3,4,4-trifluoro-n-butenyl.
  • Halo includes fluoro, chloro, bromo and iodo. Most commonly it is fluoro, chloro or bromo and usually fluoro or chloro.
  • Aryl is usually phenyl but also includes naphthyl, anthryl and phenanthryl.
  • Heteroaryl is typically a 5- or 6-membered aromatic ring containing one or more O, N or S heteroatoms, which may be fused to one or more other aromatic or heteroaromatic rings, such as a benzene ring.
  • Examples are thienyl, furyl, pyrrolyl, isoxazolyl, oxazolyl, oxadiazolyl, pyrazolyl, imidazolyl, triazolyl, isothiazolyl, tetrazolyl, thiadiazolyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, benzofuryl, benzothienyl, dibenzofuryl, benzothiazolyl, benzoxazolyl, benzimidazolyl, indolyl, quinolinyl and quinoxalinyl groups and, where appropriate, N-oxides thereof.
  • the 6,6-ring systems embraced by the general formula (1) are pyrido[2,3-c]pyridazines (where W and X are both CR 8 and Y and Z are both N), pyrido[2,3-d]pyridazines (where W and Z are both CR 8 and X and Y are both N), pyrido[3,2-c]pyridazines (where Y and Z are both CR 8 and W and X are both N) and pyrido[2,3-b]pyrazine (where X and Y are both CR 8 and W and Z are both N).
  • pyrido[2,3-b]pyrazines Of particular interest are pyrido[2,3-b]pyrazines.
  • R 8 which may be the same or different for the two CR 8 values of W, X, Y and Z, is H, halo (for example bromo), C 1-4 alkyl (for example methyl), C 1-4 alkoxy (for example methoxy) or halo(C 1-4 )alkyl (for example trifluoromethyl).
  • R 8 will be H.
  • R is halo, especially chloro or fluoro, and R 2 is NR 3 R 4 .
  • R is halo, especially chloro or fluoro
  • R 2 is NR 3 R 4 .
  • the more active compounds are those where R 2 is NR 3 R 4 .
  • R 3 is typically C 1-8 alkyl (for example ethyl, n-propyl, n-butyl, sec-butyl (the S- or R-isomer or the racemate) and tert-butyl), halo(C 1-8 )alkyl (for example 2, 2,2-trifluoroethyl, 2,2,2-trifluoro-1-methylethyl (the S- or R-isomer or the racemate), 3,3,3-trifluoropropyl and 4,4,4-trifluorobutyl), hydroxy(C 1-8 )alkyl (for example hydroxyethyl), C 1-4 alkoxy(C 1-8 )alkyl (for example methoxymethyl and methoxy-iso-butyl), C 1-4 alkoxyhalo(C 1-8 )alkyl (for example 2-methoxy-2-trifluoromethylethyl), tri(C 1-4 )alkylsilyl(C 1-6 )alky
  • R 4 is typically H, C 1-4 alkyl (for example ethyl and n-propyl), halo(C 1-4 )alkyl (for example 2,2,2-trifluoroethyl) or amino.
  • R 3 and R 4 together form a C 4-6 alkylene chain optionally substituted with methyl, for example 3-methylpentylene, or, together with the nitrogen atom to which they are attached,
  • R 3 and R 4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C 1-4 )alkyl (especially N-methyl) ring, in which the morpholine or piperazine rings are optionally substituted with methyl.
  • R 1 is phenyl optionally substituted with from one to five halogen atoms, particularly fluorine and chlorine atoms and especially fluorine atoms or with from one to three substituents selected from halo (for example fluoro and chloro), C 1-4 alkyl (for example methyl), halo(C 1-4 )alkyl (for example trifluoromethyl), C 1-4 alkoxy (for example methoxy) or halo(C 1-4 )alkoxy (for example trifluoromethoxy).
  • halo for example fluoro and chloro
  • C 1-4 alkyl for example methyl
  • halo(C 1-4 )alkyl for example trifluoromethyl
  • C 1-4 alkoxy for example methoxy
  • halo(C 1-4 )alkoxy for example trifluoromethoxy
  • Examples are 2,6-difluorophenyl, 2-fluoro-6-chlorophenyl, 2,5,6-trifluorophenyl, 2,4,6-trifluorophenyl, 2,6-difluoro-4-methoxyphenyl, pentafluorophenyl, 2-fluorophenyl, 2,3,5,6-tetrafluorophenyl, 2-chloro-4,6-difluorophenyl, 2-chlorophenyl, 2,6-dichlorophenyl, 2,4-dichlorophenyl, 2,4,6-trichlorophenyl, 2,3,6-tri-chlorophenyl, pentachlorophenyl, 2-fluoro-4,6-dichlorophenyl, 4-fluoro-2,6-dichlorophenyl, 2-bromophenyl, 2-fluoro-6-bromophenyl, 2-bromo-4,6-difluorophenyl, 2-flu
  • R 1 is pyridyl optionally substituted with from one to four halogen atoms or with from one to three substituents selected from halo (for example fluoro and chloro), C 1-4 alkyl (for example methyl), halo(C 1-4 )alkyl (for example trifluoromethyl), C 1-4 alkoxy (for example methoxy) or halo(C 1-4 )alkoxy (for example trifluoromethoxy).
  • halo for example fluoro and chloro
  • C 1-4 alkyl for example methyl
  • halo(C 1-4 )alkyl for example trifluoromethyl
  • C 1-4 alkoxy for example methoxy
  • halo(C 1-4 )alkoxy for example trifluoromethoxy
  • Examples are 2,4-difluoropyrid-3-yl, 3,5-difluoropyrid-4-yl, tetrafluoropyrid-4-yl, 3-fluoropyrid-2-yl, 4-fluoropyrid-3-yl, 3-fluoropyrid-4-yl, 2-fluoropyrid-3-yl, 2,4,6-trifluoropyrid-3-yl, 3,5-difluoropyrid-2-yl, 2,6-difluoropyrid-3-yl, 2,4-difluoro-6-methoxypyrid-3-yl, 2-fluoro-4-chloropyrid-3-yl, 3-fluoro-5-chloropyrid-4-yl, 2-chloro-4-fluoropyrid-3-yl, 2,4-dichloropyrid-3-yl, 3-chloropyrid-2-yl 1,4-chloropyrid-3-yl, 3-chloropyrid-4-y
  • R 1 is 2- or 3-thienyl optionally substituted with from one to three halogen atoms or with from one to three substituents selected from halo (for example fluoro and chloro), C 1-4 alkyl (for example methyl), halo-(C 1-4 )alkyl (for example trifluoromethyl), C 1-4 alkoxy (for example methoxy) or halo(C 1-4 )alkoxy (for example trifluoromethoxy).
  • halo for example fluoro and chloro
  • C 1-4 alkyl for example methyl
  • halo-(C 1-4 )alkyl for example trifluoromethyl
  • C 1-4 alkoxy for example methoxy
  • halo(C 1-4 )alkoxy for example trifluoromethoxy
  • Examples are 3-fluorothien-2-yl, 3-chlorothien-2-yl, 2,4-difluorothien-3-yl, 2,4-dichlorothien-3-yl and 2,4,5-trichlorothien-3-yl.
  • R 1 of especial interest examples are unsubstituted piperidino and morpholino, 2-methylpiperidino, 2,6-dimethylpiperidino and 2,6-dimethylmorpholino.
  • the invention provides a compound of the general formula (1) wherein W and X, W and Z, X and Y or Y and Z are N and the other two are CR 8 ;
  • R 8 is H, halo, C 1-4 alkyl, C 1-4 alkoxy or halo(C 1-4 )alkyl; R is halo; R 1 is halo, C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl(C 1-6 )alkyl, C 1-8 alkoxy, C 1-8 alkylthio, aryl, aryloxy, arylthio, heteroaryl, heteroaryloxy, heteroarylthio, aryl(C 1-4 )alkyl, aryl(C 1-4 )alkoxy, heteroaryl(C 1-4 )alkyl, heteroaryl(C 1-4 )alkoxy, aryl(C 1-4 )alkylthio, heteroaryl(C 1-4 )alkylthio, morpholino, piperidino or pyrrolidino;
  • R 2 is NR 3 R 4 ;
  • R 3 and R 4 are independently H, C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, aryl, aryl(C 1-8 )alkyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl(C 1-6 )alkyl, heteroaryl, heteroaryl(C 1-8 )alkyl, NR 5 R 6 , provided that not both R 3 and R 4 are H or NR 5 R 6 , or R 3 and R 4 together form a C 3-7 alkylene or C 3-7 alkenylene chain optionally substituted with one or more C 1-4 alkyl or C 1-4 alkoxy groups, or, together with the nitrogen atom to which they are attached, R 3 and R 4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C 1-4 )alkyl (especially N-
  • the invention includes a compound of the general formula (1) as defined immediately above except that: C 7 alkylene and C 3-7 alkenylene are excluded as chains formed by R 3 and R 4 ; the C 3-6 chain that R 3 and R 4 may form may only be optionally substituted with one or more methyl groups; thiomorpholine, thiomorpholine S-oxide, thiomorpholine S-dioxide and piperazine are excluded as rings that R 3 and R 4 may form; tri(C 1-4 )alkylsilyl is excluded as a substituent of any alkyl, alkenyl, alkynyl or cycloalkyl group or moiety, and any morpholine, piperidine or pyrrolidine ring is unsubstituted.
  • the invention provides a compound of the general formula (1) wherein
  • W and X, W and Z, X and Y or Y and Z are N and the other two are CR 8 ;
  • R 3 is H, halo, C 1-4 alkyl, C 1-4 alkoxy or halo(C 1-4 )alkyl;
  • R is halo;
  • R 1 is halo, C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl(C 1-6 )alkyl, C 1-8 alkoxy, C 1-8 alkylthio, aryl, aryloxy, arylthio, heteroaryl, heteroaryloxy, heteroarylthio, aryl(C 1-4 )alkyl, aryl(C 1-4 )alkoxy, heteroaryl(C 1-4 )alkyl, heteroaryl(C 1-4 )alkoxy, aryl(C 1-4 )alkylthio, heteroary
  • R 2 is NR 3 R 4 ;
  • R 3 is C 1-4 alkyl, halo(C 1-4 )alkyl, C 2-4 alkenyl, C 3-6 cycloalkyl, C 3-6 cycloalkyl(C 1-4 )alkyl or phenylamino in which the phenyl ring is optionally substituted with one, two or three substituents selected from halo, C 1-4 alkyl, halo(C 1-4 )alkyl, C 1-4 alkoxy and halo(C 1-4 )alkoxy; and R 4 is H, C 1-4 alkyl or amino, or R 3 and R 4 together form a C 4-6 alkylene chain optionally substituted with C 1-4 alkyl or C 1-4 alkoxy, or, together with the nitrogen atom to which they are attached, R 3 and R 4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperaz
  • the invention includes a compound of the general formula (1) as defined immediately above except that: the C 4-6 chain that R 3 and R 4 may form may only be optionally substituted with methyl; thiomorpholine, thiomorpholine S-oxide, thiomorpholine S-dioxide and piperazine are excluded as rings that R 3 and R 4 may form; tri(C 1-4 )alkylsilyl is excluded as a substituent of any alkyl, alkenyl, alkynyl or cycloalkyl group or moiety, and any morpholine, piperidine or pyrrolidine ring is unsubstituted.
  • the invention provides a compound of the general formula (1) wherein
  • W and X, W and Z, X and Y or Y and Z are N and the other two are CR 3 ;
  • R 3 is H, halo, C 1-4 alkyl, C 1-4 alkoxy or halo(C 1-4 )alkyl;
  • R is halo;
  • R 1 is optionally substituted phenyl;
  • R 2 is NR 3 R 4 ;
  • R 3 and R 4 are independently H, C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, aryl, aryl(C 1-8 )alkyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl(C 1-6 )alkyl, heteroaryl, heteroaryl(C 1-8 )alkyl, NR 5 R 6 , provided that not both R 3 and R 4 are H or NR 5 R 6 , or R 3 and K 4 together form a C 3-7 alkylene or C 3-7 alkenylene chain optionally substituted with one or more C 1-4 alkyl or C 1-4 alkoxy groups, or, together with the nitrogen atom to which they are attached, R 3 and R 4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C 1-4 )alkyl (especially N-
  • the invention includes a compound of the general formula (1) as defined immediately above except that: C 1-8 alkoxy and C 1-8 alkylthio are excluded as values of R and R 2 ; C 7 alkylene and C 3-7 alkenylene are excluded as chains formed by R 3 and R 4 ; the C 3-6 chain that R 3 and R 4 may form may only be optionally substituted with one or more methyl groups; thiomorpholine, thiomorpholine S-oxide, thiomorpholine S-dioxide and piperazine are excluded as rings that R 3 and R 4 may form; tri(C 1-4 )alkylsilyl is excluded as a substituent of any alkyl, alkenyl, alkynyl or cycloalkyl group or moiety, and the morpholine ring that R 3 and R 4 may form is unsubstituted.
  • the invention provides a compound of the general formula (1) wherein W and X, W and Z, X and Y or Y and Z are N and the other two are CR 8 ;
  • R 8 is H, halo(e.g. fluoro, chloro or bromo), C 1-4 alkyl (e.g. methyl), C 1-4 alkoxy (e.g. methoxy) or halo(C 1-4 )alkyl (e.g. trifluoromethyl); R is halo (e.g.
  • R 1 is phenyl optionally substituted with from one to five halogen atoms or with from one to three substituents selected from halo, C 1-4 alkyl, halo(C 1-4 )alkyl, C 1-4 alkoxy or halo(C 1-4 ) alkoxy, pyridyl optionally substituted with from one to four halogen atoms or with from one to three substituents selected from halo, C 1-4 alkyl, halo(C 1-4 )alkyl, C 1-4 alkoxy or halo(C 1-4 )alkoxy, 2- or 3-thienyl optionally substituted with from one to three halogen atoms or with from one to three substituents selected from halo, C 1-4 alkyl, halo(C 1-4 )alkyl, C 1-4 alkoxy or halo(C 1-4 )alkoxy, or piperidino or morpholino both optionally substitute
  • R is NR 3 R 4 ;
  • R 3 is C 1-8 alkyl, halo(C 1-8 )alkyl, hydroxy(C 1-8 )alkyl, C 1-4 alkoxy(C 1-8 )alkyl, C 1-4 alkoxyhalo-(C 1-8 )alkyl, tri(C 1-4 )alkylsilyl(C 1-6 )alkyl, C 1-4 alkylcarbonyl(C 1-8 )alkyl, C 1-4 alkylcarbonylhalo(C 1-8 )alkyl, phenyl(1-4)alkyl, C 2-8 alkenyl, halo(C 2-8 )alkenyl, C 2-8 alkynyl, C 3-8 cycloalkyl optionally substituted with chloro, fluoro or methyl, C 3-8 cycloalkyl(C 1-4 )alkyl, phenylamino, piperidino or morpholino, the phenyl ring of phenylalkyl or pheny
  • the invention provides a compound of the general formula (1) wherein
  • W and X, W and Z, X and Y or Y and Z are N and the other two are CR 8 ;
  • R 8 is H, halo, C 1-4 alkyl, C 1-4 alkoxy or halo(C 1-4 )alkyl;
  • R is halo;
  • R 1 is phenyl optionally substituted with from one to five halogen atoms or with from one to three substituents selected from halo, C 1-4 alkyl, halo(C 1-4 )alkyl, C 1-4 alkoxy or halo(C 1-4 ) alkoxy;
  • R 2 is NR 3 R 4 ;
  • R 3 is C 1-4 alkyl, halo(C 1-4 )alkyl, C 2-4 alkenyl, C 3-6 cycloalkyl, C 3-6 cycloalkyl(C 1-4 )alkyl or phenylamino in which the phenyl ring is optionally substituted with one, two or three substituents selected from halo, C 1-4 alkyl, halo(C 1-4 )alkyl, C 1-4 alkoxy and halo(C 1-4 )alkoxy; and R 4 is H, C 1-4 alkyl or amino, or R 3 and R 4 together form a C 4-6 alkylene chain optionally substituted with methyl, or, together with the nitrogen atom to which they are attached, R 3 and R 4 form a morpholine ring.
  • W and Z are both N and X and Y are both CH.
  • Table 2 consists of 662 compounds of the general formula (1A), where W and Z are N, X and Y are CH, R is Cl, R 1 is 2,5,6-trifluorophenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 2 is the same as compound 1 of Table 1 except that in compound 1 of Table 2, R 1 is 2,5,6-trifluorophenyl.
  • compounds 2 to 662 of Table 2 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 2, R 1 is 2,5,6-trifluorophenyl.
  • Table 3 consists of 662 compounds of the general formula (1A), where W and Z are N, X and Y are CH, R is Cl, R 1 is 2,3,4,5,6-pentafluorophenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 3 is the same as compound 1 of Table 1 except that in compound 1 of Table 3, R 1 is 2,3,4,5,6-pentafluorophenyl.
  • compounds 2 to 662 of Table 3 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 3, R 1 is 2,3,4,5,6-pentafluorophenyl.
  • Table 4 consists of 662 compounds of the general formula (1A), where W and Z are N, X and Y are CH, R is Cl, R 1 is 2,6-difluoro-4-methoxyphenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 4 is the same as compound 1 of Table 1 except that in compound 1 of Table 4, R 1 is 2,6-difluoro-4-methoxyphenyl.
  • compounds 2 to 662 of Table 4 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 4, R 1 is 2,6-difluoro-4-methoxyphenyl.
  • Table 5 consists of 662 compounds of the general formula (1A), where W and Z are N, X and Y are CH, R is Cl, R 1 is 2-fluoro-6-chlorophenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 5 is the same as compound 1 of Table 1 except that in compound 1 of Table 5, R 1 is 2-fluoro-6-chlorophenyl.
  • compounds 2 to 662 of Table 5 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 5, R 1 is 2-fluoro-6-chlorophenyl.
  • Table 11 consists of 662 compounds of the general formula (1A), where W and X are N and Y and Z are CH, R is Cl, R 1 is 2,4,6-trifluorophenyl, and the values of R 3 and K 4 are as listed in Table 1.
  • compound 1 of Table 11 is the same as compound 1 of Table 1 except that in compound 1 of Table 11, the compound has the general formula (1A) where W and X are N and Y and Z are CH.
  • compounds 2 to 662 of Table 11 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 11, the compounds have the general formula (1A) where W and X are N and Y and Z are CH.
  • Table 12 consists of 662 compounds of the general formula (1A), where W and X are N and Y and Z are CH, R is Cl, R 1 is 2,5,6-trifluorophenyl, and the values of R 3 and K 4 are as listed in Table 1.
  • compound 1 of Table 12 is the same as compound 1 of Table 2 except that in compound 1 of Table 12, the compound has the general formula (1A) where W and X are N and Y and Z are CH.
  • compounds 2 to 662 of Table 12 are the same as compounds 2 to 662 of Table 2 except that in the compounds of Table 12, the compounds have the general formula (1A) where W and X are N and Y and Z are CH.
  • Table 13 consists of 662 compounds of the general formula (1A), where W and X are N and Y and Z are CH, R is Cl, R 1 is 2,3,4,5,6-pentafluorophenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 13 is the same as compound 1 of Table 3 except that in compound 1 of Table 13, the compound has the general formula (1A) where W and X are N and Y and Z are CH.
  • compounds 2 to 662 of Table 13 are the same as compounds 2 to 662 of Table 3 except that in the compounds of Table 13, the compounds have the general formula (1A) where W and X are N and Y and Z are CH.
  • Table 14 consists of 662 compounds of the general formula (1A), where W and X are N and Y and Z are CH, R is Cl, R 1 is 2,6-difluoro-4-methoxyphenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 14 is the same as compound 1 of Table 4 except that in compound 1 of Table 14, the compound has the general formula (1A) where W and X are N and Y and Z are CH.
  • compounds 2 to 662 of Table 14 are the same as compounds 2 to 662 of Table 4 except that in the compounds of Table 14, the compounds have the general formula (1A) where W and X are N and Y and Z are CH.
  • Table 15 consists of 662 compounds of the general formula (1A), where W and X are N and Y and Z are CH, R is Cl, R 1 is 2-fluoro-6-chlorophenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 15 is the same as compound 1 of Table 5 except that in compound 1 of Table 15, the compound has the general formula (1A) where W and X are N and Y and Z are CH.
  • compounds 2 to 662 of Table 15 are the same as compounds 2 to 662 of Table 5 except that in the compounds of Table 15, the compounds have the general formula (1A) where W and X are N and Y and Z are CH.
  • Table 21 consists of 662 compounds of the general formula (1A), where W and Z are CH and X and Y are N, R is Cl, R 1 is 2,4,6-trifluorophenyl, and the values of R 3 and K 4 are as listed in Table 1.
  • compound 1 of Table 21 is the same as compound 1 of Table 1 except that in compound 1 of Table 21, the compound has the general formula (1A) where W and Z are CH and X and Y are N.
  • compounds 2 to 662 of Table 21 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 21, the compounds have the general formula (1A) where W and Z are CH and X and Y are N.
  • Table 22 consists of 662 compounds of the general formula (1A), where W and Z are CH and X and Y are N, R is Cl, R 1 is 2,5,6-trifluorophenyl, and the values of R 3 and K 4 are as listed in Table 1.
  • compound 1 of Table 22 is the same as compound 1 of Table 2 except that in compound 1 of Table 22, the compound has the general formula (1A) where W and Z are CH and X and Y are N.
  • compounds 2 to 662 of Table 22 are the same as compounds 2 to 662 of Table 2 except that in the compounds of Table 22, the compounds have the general formula (1A) where W and Z are CH and X and Y are N.
  • Table 23 consists of 662 compounds of the general formula (1A), where W and Z are CH and X and Y are N, R is Cl, R 1 is 2,3,4,5,6-pentafluorophenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 23 is the same as compound 1 of Table 3 except that in compound 1 of Table 23, the compound has the general formula (1A) where W and Z are CH and X and Y are N.
  • compounds 2 to 662 of Table 23 are the same as compounds 2 to 662 of Table 3 except that in the compounds of Table 23, the compounds have the general formula (1A) where W and Z are CH and X and Y are N.
  • Table 24 consists of 662 compounds of the general formula (1A), where W and Z are CH and X and Y are N, R is Cl, R 1 is 2,6-difluoro-4-methoxyphenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 24 is the same as compound 1 of Table 4 except that in compound 1 of Table 24, the compound has the general formula (1A) where W and Z are CH and X and Y are N.
  • compounds 2 to 662 of Table 24 are the same as compounds 2 to 662 of Table 4 except that in the compounds of Table 24, the compounds have the general formula (1A) where W and Z are CH and X and Y are N.
  • Table 25 consists of 662 compounds of the general formula (1A), where W and Z are CH and X and Y are N, R is Cl, R 1 is 2-fluoro-6-chlorophenyl, and the values of R 3 and K 4 are as listed in Table 1.
  • compound 1 of Table 25 is the same as compound 1 of Table 5 except that in compound 1 of Table 25, the compound has the general formula (1A) where W and Z are CH and X and Y are N.
  • compounds 2 to 662 of Table 25 are the same as compounds 2 to 662 of Table 5 except that in the compounds of Table 25, the compounds have the general formula (1A) where W and Z are CH and X and Y are N.
  • Table 26 consists of 662 compounds of the general formula (1A), where W and X are CH and Y and Z are N, R is Cl, R 1 is 2,4,6-trifluorophenyl, and the values of R 3 and K 4 are as listed in Table 1.
  • compound 1 of Table 26 is the same as compound 1 of Table 1 except that in compound 1 of Table 26, the compound has the general formula (1A) where W and X are CH and Y and Z are N.
  • compounds 2 to 662 of Table 26 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 26, the compounds have the general formula (1A) where W and X are CH and Y and Z are N.
  • Table 27 consists of 662 compounds of the general formula (1A), where W and X are CH and Y and Z are N, R is Cl, R 1 is 2,5,6-trifluorophenyl, and the values of R 3 and K 4 are as listed in Table 1.
  • compound 1 of Table 27 is the same as compound 1 of Table 2 except that in compound 1 of Table 27, the compound has the general formula (1A) where W and X are CH and Y and Z are N.
  • compounds 2 to 662 of Table 27 are the same as compounds 2 to 662 of Table 2 except that in the compounds of Table 27, the compounds have the general formula (1A) where W and X are CH and Y and Z are N.
  • Table 28 consists of 662 compounds of the general formula (1A), where W and X are CH and Y and Z are N, R is Cl, R 1 is 2,3,4,5,6-pentafluorophenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 28 is the same as compound 1 of Table 3 except that in compound 1 of Table 28, the compound has the general formula (1A) where W and X are CH and Y and Z are N.
  • compounds 2 to 662 of Table 28 are the same as compounds 2 to 662 of Table 3 except that in the compounds of Table 28, the compounds have the general formula (1A) where W and X are CH and Y and Z are N.
  • Table 29 consists of 662 compounds of the general formula (1A), where W and X are CH and Y and Z are N, R is Cl, R 1 is 2,6-difluoro-4-methoxyphenyl, and the values of R 3 and R 4 are as listed in Table 1.
  • compound 1 of Table 29 is the same as compound 1 of Table 4 except that in compound 1 of Table 29, the compound has the general formula (1A) where W and X are CH and Y and Z are N.
  • compounds 2 to 662 of Table 29 are the same as compounds 2 to 662 of Table 4 except that in the compounds of Table 29, the compounds have the general formula (1A) where W and X are CH and Y and Z are N.
  • Table 30 consists of 662 compounds of the general formula (1A), where W and X are CH and Y and Z are N, R is Cl, R 1 is 2-fluoro-6-chlorophenyl, and the values of R 3 and K 4 are as listed in Table 1.
  • compound 1 of Table 30 is the same as compound 1 of Table 5 except that in compound 1 of Table 30, the compound has the general formula (1A) where W and X are CH and Y and Z are N.
  • compounds 2 to 662 of Table 30 are the same as compounds 2 to 662 of Table 5 except that in the compounds of Table 30, the compounds have the general formula (1A) where W and X are CH and Y and Z are N.
  • Table 31 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 31 R 1 is 2,6-difluorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 32 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 32 R 1 is 2-fluorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 33 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 33 R 1 is 2,3,5,6-tetrafluorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 34 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 34 R 1 is 2-chloro-4,6-difluorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 35 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 35 R 1 is 2-chlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 36 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 36 R 1 is 2,6-dichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 37 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 37 R 1 is 2,4-dichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 38 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 38 R 1 is 2,4,6-trichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 39 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 39 R 1 is 2,3,6-trichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 40 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 40 R 1 is pentachlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 41 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 41 R 1 is 2-fluoro-4,6-dichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 42 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 42 R 1 is 4-fluoro-2,6-dichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 43 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 43 R 1 is 2-bromophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 44 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 44 R 1 is 2-fluoro-6-bromophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 45 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 45 R 1 is 2-bromo-4,6-difluorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 46 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 46 R 1 is 2-fluoro-6-methylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 47 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 47 R 1 is 2-chloro-6-methylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 48 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 48 R 1 is 2-methoxyphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 49 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 49 R 1 is 2,6-dimethoxyphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 50 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 50 R 1 is 2-fluoro-6-methoxyphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 51 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 51 R 1 is 2-trifluoromethylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 52 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 52 R 1 is 2-fluoro-6-trifluoromethylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 53 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 53 R 1 is 2,6-di-(trifluoromethyl)phenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 54 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 54 R 1 is 2-chloro-6-trifluoromethylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 55 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 55 R 1 is 2,4-difluoro-6-trifluoromethylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 56 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 56 R 1 is 2,4-difluoro-6-methoxyphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 57 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 57 R 1 is 2,4-difluoro-6-methylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 58 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 58 R 1 is 2,4-difluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 59 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 59 R 1 is 3,5-difluoropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 60 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 60 R 1 is tetrafluoropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 61 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 61 R 1 is 3-fluoropyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 62 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 62 R 1 is 4-fluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 63 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 63 R 1 is 3-fluoropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 64 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 64 R 1 is 2-fluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 65 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 65 R 1 is 2,4,6-trifluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 66 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 66 R 1 is 3,5-difluoropyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 67 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 67 R 1 is 2,6-difluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 68 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 68 R 1 is 2,4-difluoro-6-methoxypyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 69 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 69 R 1 is 2-fluoro-4-chloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 70 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 70 R 1 is 3-fluoro-5-chloropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 71 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 71 R 1 is 2-chloro-4-fluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 72 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 72 R 1 is 2,4-dichloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 73 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 73 R 1 is 3-chloropyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 74 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 74 R 1 is 4-chloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 75 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 75 R 1 is 3-chloropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 76 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 76 R 1 is 2-chloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 77 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 77 R 1 is 3-trifluoromethylpyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 78 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 78 R 1 is 4-trifluoromethylpyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 79 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 79 R 1 is 3,5-dichloropyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 80 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 80 R 1 is 4,6-dichloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 81 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 81 R 1 is 3-trifluoromethylpyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 82 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 82 R 1 is 2-trifluoromethylpyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 83 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 83 R 1 is 2-fluoro-4-trifluoromethylpyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 84 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 84 R 1 is 3-fluoro-5-trifluoromethylpyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 85 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 85 R 1 is 4-fluoro-2-trifluoromethylpyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 86 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 86 R 1 is 2,6-dichloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 87 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 87 R 1 is 3,5-dichloropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 88 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 88 R 1 is 3-chloro-6-trifluoromethylpyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 89 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 89 R 1 is 3-fluoro-6-trifluoromethylpyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 90 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 90 R 1 is pyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 91 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 91 R 1 is pyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 92 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 92 R 1 is pyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 93 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 93 R 1 is 3-fluorothien-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 94 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 94 R 1 is 3-chlorothien-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 95 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 95 R 1 is 2,4-difluorothien-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 96 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 96 R 1 is 2,4-dichlorothien-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 97 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table R 1 is 2,4,5-trichlorothien-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 98 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 98 R 1 is piperidino instead of 2-fluoro-6-chlorophenyl.
  • Table 99 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 99 R 1 is 2-methylpiperidino instead of 2-fluoro-6-chlorophenyl.
  • Table 100 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 100 R 1 is 2,6-dimethylpiperidino instead of 2-fluoro-6-chlorophenyl.
  • Table 101 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 101 R 1 is morpholino instead of 2-fluoro-6-chlorophenyl.
  • Table 102 consists of 2648 compounds.
  • Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively
  • compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively
  • compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively
  • compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 102 R 1 is 2,6-dimethylmorpholino instead of 2-fluoro-6-chlorophenyl.
  • Table 103 consists of 201, 248 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 102 (thus, for example, compound 1 of Table 103 is the same as compound 1 of Table 1, compound 663 of Table 103 is the same as compound 1 of Table 2, compound 19,861 of Table 103 is the same as compound 1 of Table 31, compound 305,844 of Table 103 is the same as compound 3,972 of Table 102) except that in all of the compounds of Table 103 R is F instead of Cl.
  • Table 104 consists of 201,248 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 102 (thus, for example, compound 1 of Table 104 is the same as compound 1 of Table 1, compound 663 of Table 104 is the same as compound 1 of Table 2, compound 19,861 of Table 104 is the same as compound 1 of Table 31, compound 305,844 of Table 104 is the same as compound 3,972 of Table 102) except that in all of the compounds of Table 104 R is Br instead of Cl.
  • Table 109 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 109 is the same as compound 1 of Table 1, compound 663 of Table 109 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 109 X is CF instead of CH.
  • Table 110 consists of 3310c compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 110 is the same as compound 1 of Table 1, compound 663 of Table 110 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 110 X is CCl instead of CH.
  • Table 111 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 111 is the same as compound 1 of Table 1, compound 663 of Table 111 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 111 X is CBr instead of CH.
  • Table 112 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 112 is the same as compound 1 of Table 1, compound 663 of Table 112 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 112 X is CCH 3 instead of CH.
  • Table 113 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 113 is the same as compound 1 of Table 1, compound 663 of Table 113 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 113 Y is CF instead of CH.
  • Table 114 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 114 is the same as compound 1 of Table 1, compound 663 of Table 114 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 114 Y is CCl instead of CH.
  • Table 115 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 115 is the same as compound 1 of Table 1, compound 663 of Table 115 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 115 Y is CBr instead of CH.
  • Table 116 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 116 is the same as compound 1 of Table 1, compound 663 of Table 116 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 116 Y is CCH 3 instead of CH.
  • Compounds of general formula (4) can be prepared from compounds of general formula (2), which are either commercially available or made by methods known in the literature, by reaction with acids of general formula (3), using standard coupling methods, for example by conversion to the acid chloride using a chlorinating agent such as thionyl chloride, followed by reaction of the resultant acid chloride optionally in the presence of a base such as triethylamine, in a suitable solvent such as dichloromethane or toluene.
  • a chlorinating agent such as thionyl chloride
  • a base such as triethylamine
  • Compounds of general formula (5) can be prepared by treating compounds of general formula (4) with a base such as sodium hydride, optionally in the presence of a Lewis acid such as magnesium oxide, in a suitable solvent such as N,N-dimethylformamide (DMF) or toluene, at between room temperature and 150° C., but preferably at 60-90° C.
  • a base such as sodium hydride
  • a Lewis acid such as magnesium oxide
  • a suitable solvent such as N,N-dimethylformamide (DMF) or toluene
  • Compounds of general formula (6) can be prepared by reaction of compounds of general formula (5) with a chlorination reagent such as phosphorus oxychloride, either neat or in a suitable solvent such as toluene, at between 50 and 150° C., but preferably between 80 and 110° C., or in a microwave reactor at between 150 and 300° C., but preferably between 200 and 250° C.
  • Compounds of formula (7) and (8) can be prepared by reaction of compounds of general formula (6) with an amine R 3 R 4 NH, either neat, or in a suitable solvent such as DMF, between room temperature and 150° C., but preferably between 50 and 80° C. If compounds (7) and (8) are produced as a mixture they can be separated by suitable means such as crystallisation or chromatography under normal or reverse phase conditions.
  • Compounds of general formula (10) can be prepared from compounds of general formula (9), which are either commercially available or made by methods known in the literature, by reaction with acids of general formula (3), using standard coupling methods, for example by conversion to the acid chloride using a chlorinating agent such as thionyl chloride, followed by reaction of the resultant acid chloride optionally in the presence of a base such as triethylamine, in a suitable solvent such as dichloromethane or toluene.
  • a chlorinating agent such as thionyl chloride
  • a base such as triethylamine
  • Compounds of general formula (11) can be prepared by treating compounds of general formula (10) with a base such as sodium hydride, optionally in the presence of a Lewis acid such as magnesium oxide, in a suitable solvent such as N,N-dimethylformamide (DMF) or toluene, at between room temperature and 150° C., but preferably at 60-90° C.
  • a base such as sodium hydride
  • a Lewis acid such as magnesium oxide
  • a suitable solvent such as N,N-dimethylformamide (DMF) or toluene
  • Compounds of general formula (12) can be prepared by reaction of compounds of general formula (11) with a chlorination reagent such as phosphorus oxychloride, either neat or in a suitable solvent such as toluene, at between 50 and 150° C., but preferably between 80 and 110° C., or in a microwave reactor at between 150 and 300° C., but preferably between 200 and 250° C.
  • a chlorination reagent such as phosphorus oxychloride
  • Compounds of formula (7) can be prepared from compounds of formula (12) by reductive amination, for example by reaction with a ketone or aldehyde in a suitable solvent such as ethanol or toluene, at between room temperature and reflux, optionally in the presence of an acid catalyst such as para-toluenesulphonic acid or a drying agent such as molecular sieves, followed by treatment with a suitable reducing agent such as sodium borohydride, at between ⁇ 20° C. and 40° C., but preferably at room temperature.
  • a suitable reducing agent such as sodium borohydride
  • compounds of formula (7) can be formed from compounds of formula (12) by alkylation with a group R 3 LG, by treatment with a suitable base such as sodium hydride in a solvent such as DMF, or a base such as potassium carbonate in a solvent such as acetone or DMF, at between ⁇ 78° C. and 100° C., but preferably between room temperature and 60° C., followed by treatment with R 4 LG in a second step under the same conditions if required.
  • a suitable base such as sodium hydride in a solvent such as DMF, or a base such as potassium carbonate in a solvent such as acetone or DMF
  • Compounds of formula (13) can be prepared as shown in Scheme 3 from compounds of formula (6) by reaction with a source of fluoride ion, such as potassium fluoride, in a suitable solvent such as sulpholane, at a temperature between 50° C. and 200° C., but preferably at 80-150° C.
  • Compounds of formula (14) and/or compounds of formula (15) can be prepared from difluoro compounds of formula (13) by reaction with an amine of formula R 3 R 4 NH in a suitable solvent such as DMF or CH 2 Cl 2 , at a temperature of 0° C.-100° C., but preferably at room temperature.
  • Compounds of general formula (16), where Hal 1 is chlorine or fluorine, can be converted into compounds of formula (17) as shown in Scheme 4.
  • Compounds of general formula (17) where Hal 2 is bromine or iodine can be formed by reacting compounds of general formula (16) with a metal halide, for example cuprous bromide, in a suitable solvent, for example DMF, at between room temperature and 155° C., but preferably between 70° C. and 155° C.
  • W, X, Y, Z, R 1 and R 7 are as define above, other than the compound of formula (6) wherein X and Y are N, W and Z are C—Cl and R 1 is Cl, are believed to be novel compounds and form a further part of this invention.
  • the invention as defined by the general formula (5) embraces all such tautomers.
  • Table 129 consists of 48 compounds of the general formula (5), where W, X, Y, Z and R 1 have the values given in Table 128. Thus, compound 1 of Table 129 has the same W, X, Y, Z and R 1 values as compound 1 of Table 128, etc.
  • Table 130 consists of 48 compounds of the general formula (6), where W, X, Y, Z and R 1 have the values given in Table 128. Thus, compound 1 of Table 130 has the same W, X, Y, Z and R 1 values as compound 1 of Table 128, etc.
  • Table 131 consists of 48 compounds of the general formula (13), where W, X, Y, Z and R 1 have the values given in Table 128. Thus, compound 1 of Table 131 has the same W, X, Y, Z and R 1 values as compound 1 of Table 128, etc.
  • Table 132 consists of 48 compounds of the general formula (4), where W, X, Y, Z and R 1 have the values given in Table 128 and R 7 is ethyl.
  • compound 1 of Table 132 is the same as compound 1 of Table 128 except that in compound 1 of Table 132, K 7 is ethyl instead of methyl.
  • compounds 2 to 48 of Table 132 are the same as compounds 2 to 48 of Table 128 except that in the compounds of Table 132, K 7 is ethyl.
  • the compounds of formula (1) are active fungicides and may be used to control one or more of the following pathogens: Pyricularia oryzae ( Magnaporthe grisea ) on rice and wheat and other Pyricularia spp. on other hosts; Puccinia triticina (or recondita ), Puccinia striiformis and other rusts on wheat, Puccinia hordei, Puccinia striiformis and other rusts on barley, and rusts on other hosts (for example turf, rye, coffee, pears, apples, peanuts, sugar beet, vegetables and ornamental plants); Erysiphe cichoracearum on cucurbits (for example melon); Blumeria (or Erysiphe ) graminis (powdery mildew) on barley, wheat, rye and turf and other powdery mildews on various hosts, such as Sphaerotheca macularis on hops, Sphaero
  • Botrytis cinerea grey mould
  • Botrytis cinerea grey mould
  • Alternaria spp. on vegetables (for example carrots), oil-seed rape, apples, tomatoes, potatoes, cereals (for example wheat) and other hosts
  • Venturia spp. including Venturia inaequalis (scab)) on apples, pears, stone fruit, tree nuts and other hosts
  • Cladosporium spp. on a range of hosts including cereals (for example wheat) and tomatoes
  • Pleospora spp. on apples, pears, onions and other hosts; summer diseases (for example bitter rot ( Glomerella cingulata ), black rot or frogeye leaf spot ( Botryosphaeria obtusa ), Brooks fruit spot ( Mycosphaerella pomi ), Cedar apple rust ( Gymnosporangium juniperi - virginianae ), sooty blotch ( Gloeodes pomigena ), flyspeck ( Schizothyrium pomi ) and white rot ( Botryosphaeria dothidea )) on apples and pears; Plasmopara viticola on vines; other downy mildews, such as Bremia lactucae on lettuce, Peronospora spp.
  • winter diseases for example bitter rot ( Glomerella cingulata ), black rot or frogeye leaf spot ( Botryosphaeria obtusa ), Brooks fruit spot ( Myco
  • a compound of formula (1) may move acropetally, basipetally or locally in plant tissue to be active against one or more fungi. Moreover, a compound of formula (1) may be volatile enough to be active in the vapour phase against one or more fungi on the plant.
  • the invention therefore provides a method of combating or controlling phytopatho-genic fungi which comprises applying a fungicidally effective amount of a compound of formula (1), or a composition containing a compound of formula (1), to a plant, to a seed of a plant, to the locus of the plant or seed or to soil or any other plant growth medium, e.g. nutrient solution.
  • plant as used herein includes seedlings, bushes and trees. Furthermore, the fungicidal method of the invention includes protectant, curative, systemic, eradicant and antisporulant treatments.
  • the compounds of formula (1) are preferably used for agricultural, horticultural and turfgrass purposes in the form of a composition.
  • a compound of formula (1) is usually formulated into a composition which includes, in addition to the compound of formula (1), a suitable inert diluent or carrier and, optionally, a surface active agent (SFA).
  • SFAs are chemicals that are able to modify the properties of an interface (for example, liquid/solid, liquid/air or liquid/liquid interfaces) by lowering the interfacial tension and thereby leading to changes in other properties (for example dispersion, emulsification and wetting).
  • compositions both solid and liquid formulations
  • the composition is generally used for the control of fungi such that a compound of formula (1) is applied at a rate of from 0.1 g to 10 kg per hectare, preferably from 1 g to 6 kg per hectare, more preferably from 1 g to 1 kg per hectare.
  • a compound of formula (1) When used in a seed dressing, a compound of formula (1) is used at a rate of 0.0001 g to 10 g (for example 0.001 g or 0.05 g), preferably 0.005 g to 10 g, more preferably 0.005 g to 4 g, per kilogram of seed.
  • the present invention provides a fungicidal composition
  • a fungicidal composition comprising a fungicidally effective amount of a compound of formula (1) and a suitable carrier or diluent therefor.
  • the invention provides a method of combating and controlling fungi at a locus, which comprises treating the fungi, or the locus of the fungi with a fungicidally effective amount of a composition comprising a compound of formula (1).
  • compositions can be chosen from a number of formulation types, including dustable powders (DP), soluble powders (SP), water soluble granules (SG), water dispersible granules (WG), wettable powders (WP), granules (GR) (slow or fast release), soluble concentrates (SL), oil miscible liquids (OL), ultra low volume liquids (UL), emulsifiable concentrates (EC), dispersible concentrates (DC), emulsions (both oil in water (EW) and water in oil (EO)), micro-emulsions (ME), suspension concentrates (SC), aerosols, fogging/smoke formulations, capsule suspensions (CS) and seed treatment formulations.
  • the formulation type chosen in any instance will depend upon the particular purpose envisaged and the physical, chemical and biological properties of the compound of formula (1).
  • Dustable powders may be prepared by mixing a compound of formula (1) with one or more solid diluents (for example natural clays, kaolin, pyrophillite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earths, calcium phosphates, calcium and magnesium carbonates, sulphur, lime, flours, talc and other organic and inorganic solid carriers) and mechanically grinding the mixture to a fine powder.
  • solid diluents for example natural clays, kaolin, pyrophillite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earths, calcium phosphates, calcium and magnesium carbonates, sulphur, lime, flours, talc and other organic and inorganic solid carriers
  • Soluble powders may be prepared by mixing a compound of formula (1) with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulphate) or one or more water-soluble organic solids (such as a polysaccharide) and, optionally, one or more wetting agents, one or more dispersing agents or a mixture of said agents to improve water dispersibility/solubility. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water soluble granules (SG).
  • water-soluble inorganic salts such as sodium bicarbonate, sodium carbonate or magnesium sulphate
  • water-soluble organic solids such as a polysaccharide
  • wetting agents such as sodium bicarbonate, sodium carbonate or magnesium sulphate
  • dispersing agents such as sodium bicarbonate, sodium carbonate or magnesium sulphate
  • SG water soluble granules
  • WP Wettable powders
  • WG Water dispersible granules
  • Granules may be formed either by granulating a mixture of a compound of formula (1) and one or more powdered solid diluents or carriers, or from pre-formed blank granules by absorbing a compound of formula (1) (or a solution thereof, in a suitable agent) in a porous granular material (such as pumice, attapulgite clays, fuller's earth, kieselguhr, diatomaceous earths or ground corn cobs) or by adsorbing a compound of formula (1) (or a solution thereof, in a suitable agent) on to a hard core material (such as sands, silicates, mineral carbonates, sulphates or phosphates) and drying if necessary.
  • a hard core material such as sands, silicates, mineral carbonates, sulphates or phosphates
  • Agents which are commonly used to aid absorption or adsorption include solvents (such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters) and sticking agents (such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils).
  • solvents such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters
  • sticking agents such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils.
  • One or more other additives may also be included in granules (for example an emulsifying agent, wetting agent or dispersing agent).
  • DC Dispersible Concentrates
  • a compound of formula (1) may be prepared by dissolving a compound of formula (1) in water or an organic solvent, such as a ketone, alcohol or glycol ether.
  • organic solvent such as a ketone, alcohol or glycol ether.
  • surface active agent for example to improve water dilution or prevent crystallisation in a spray tank.
  • Emulsifiable concentrates or oil-in-water emulsions (EW) may be prepared by dissolving a compound of formula (1) in an organic solvent (optionally containing one or more wetting agents, one or more emulsifying agents or a mixture of said agents).
  • Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark), ketones (such as cyclohexanone or methylcyclohexanone), alcohols (such as benzyl alcohol, furfuryl alcohol or butanol), N-alkypyrrolidones (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethyl amides of fatty acids (such as C 8 -C 10 fatty acid dimethylamide) and chlorinated hydrocarbons.
  • aromatic hydrocarbons such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark
  • ketones such as cyclohe
  • An EC product may spontaneously emulsify on addition to water, to produce an emulsion with sufficient stability to allow spray application through appropriate equipment.
  • Preparation of an EW involves obtaining a compound of formula (1) either as a liquid (if it is not a liquid at room temperature, it may be melted at a reasonable temperature, typically below 70° C.) or in solution (by dissolving it in an appropriate solvent) and then emulsifying the resultant liquid or solution into water containing one or more SFAs, under high shear, to produce an emulsion.
  • Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzenes), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other appropriate organic solvents that have a low solubility in water.
  • Microemulsions may be prepared by mixing water with a blend of one or more solvents with one or more SFAs, to produce spontaneously a thermodynamically stable isotropic liquid formulation.
  • a compound of formula (1) is present initially in either the water or the solvent/SFA blend.
  • Suitable solvents for use in MEs include those hereinbefore described for use in ECs or in EWs.
  • An ME may be either an oil-in-water or a water-in-oil system (which system is present may be determined by conductivity measurements) and may be suitable for mixing water-soluble and oil-soluble pesticides in the same formulation.
  • An ME is suitable for dilution into water, either remaining as a microemulsion or forming a conventional oil-in-water emulsion.
  • SC Suspension concentrates
  • SCs may comprise aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of formula (1).
  • SCs may be prepared by ball or bead milling the solid compound of formula (1) in a suitable medium, optionally with one or more dispersing agents, to produce a fine particle suspension of the compound.
  • One or more wetting agents may be included in the composition and a suspending agent may be included to reduce the rate at which the particles settle.
  • a compound of formula (1) may be dry milled and added to water, containing agents hereinbefore described, to produce the desired end product.
  • Aerosol formulations comprise a compound of formula (1) and a suitable propellant (for example n-butane).
  • a compound of formula (1) may also be dissolved or dispersed in a suitable medium (for example water or a water miscible liquid, such as n-propanol) to provide compositions for use in non-pressurised, hand-actuated spray pumps.
  • a compound of formula (1) may be mixed in the dry state with a pyrotechnic mixture to form a composition suitable for generating, in an enclosed space, a smoke containing the compound.
  • Capsule suspensions may be prepared in a manner similar to the preparation of EW formulations but with an additional polymerisation stage such that an aqueous dispersion of oil droplets is obtained, in which each oil droplet is encapsulated by a polymeric shell and contains a compound of formula (1) and, optionally, a carrier or diluent therefor.
  • the polymeric shell may be produced by either an interfacial polycondensation reaction or by a coacervation procedure.
  • the compositions may provide for controlled release of the compound of formula (1) and they may be used for seed treatment.
  • a compound of formula (1) may also be formulated in a biodegradable polymeric matrix to provide a slow, controlled release of the compound.
  • a composition may include one or more additives to improve the biological performance of the composition (for example by improving wetting, retention or distribution on surfaces; resistance to rain on treated surfaces; or uptake or mobility of a compound of formula (1)).
  • additives include surface active agents, spray additives based on oils, for example certain mineral oils or natural plant oils (such as soy bean and rape seed oil), and blends of these with other bio-enhancing adjuvants (ingredients which may aid or modify the action of a compound of formula (1)).
  • a compound of formula (1) may also be formulated for use as a seed treatment, for example as a powder composition, including a powder for dry seed treatment (DS), a water soluble powder (SS) or a water dispersible powder for slurry treatment (WS), or as a liquid composition, including a flowable concentrate (FS), a solution (LS) or a capsule suspension (CS).
  • DS powder for dry seed treatment
  • SS water soluble powder
  • WS water dispersible powder for slurry treatment
  • CS capsule suspension
  • the preparations of DS, SS, WS, FS and LS compositions are very similar to those of, respectively, DP, SP, WP, SC and DC compositions described above.
  • Compositions for treating seed may include an agent for assisting the adhesion of the composition to the seed (for example a mineral oil or a film-forming barrier).
  • Wetting agents, dispersing agents and emulsifying agents may be SFAs of the cationic, anionic, amphoteric or non-ionic type.
  • Suitable SFAs of the cationic type include quaternary ammonium compounds (for example cetyltrimethyl ammonium bromide), imidazolines and amine salts.
  • Suitable anionic SFAs include alkali metals salts of fatty acids, salts of aliphatic monoesters of sulphuric acid (for example sodium lauryl sulphate), salts of sulphonated aromatic compounds (for example sodium dodecylbenzenesulphonate, calcium dodecyl-benzenesulphonate, butylnaphthalene sulphonate and mixtures of sodium di-isopropyl- and tri-isopropyl-naphthalene sulphonates), ether sulphates, alcohol ether sulphates (for example sodium laureth-3-sulphate), ether carboxylates (for example sodium laureth-3-carboxylate), phosphate esters (products from the reaction between one or more fatty alcohols and phosphoric acid (predominately mono-esters) or phosphorus pentoxide (predominately di-esters), for example the reaction between lauryl alcohol and tetraphosphoric acid;
  • Suitable SFAs of the amphoteric type include betaines, propionates and glycinates.
  • Suitable SFAs of the non-ionic type include condensation products of alkylene oxides, such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long chain fatty acids or hexitol anhydrides; condensation products of said partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; simple esters (for example fatty acid polyethylene glycol esters); amine oxides (for example lauryl dimethyl amine oxide); and lecithins.
  • alkylene oxides such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof
  • fatty alcohols such as oleyl alcohol or cetyl alcohol
  • alkylphenols such as octylphenol, nonyl
  • Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and swelling clays (such as bentonite or attapulgite).
  • hydrophilic colloids such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose
  • swelling clays such as bentonite or attapulgite
  • a compound of formula (1) may be applied by any of the known means of applying fungicidal compounds. For example, it may be applied, formulated or unformulated, to any part of the plant, including the foliage, stems, branches or roots, to the seed before it is planted or to other media in which plants are growing or are to be planted (such as soil surrounding the roots, the soil generally, paddy water or hydroponic culture systems), directly or it may be sprayed on, dusted on, applied by dipping, applied as a cream or paste formulation, applied as a vapour or applied through distribution or incorporation of a composition (such as a granular composition or a composition packed in a water-soluble bag) in soil or an aqueous environment.
  • a composition such as a granular composition or a composition packed in a water-soluble bag
  • a compound of formula (1) may also be injected into plants or sprayed onto vegetation using electrodynamic spraying techniques or other low volume methods, or applied by land or aerial irrigation systems.
  • compositions for use as aqueous preparations are generally supplied in the form of a concentrate containing a high proportion of the active ingredient, the concentrate being added to water before use.
  • These concentrates which may include DCs, SCs, ECs, EWs, MEs SGs, SPs, WPs, WGs and CSs, are often required to withstand storage for prolonged periods and, after such storage, to be capable of addition to water to form aqueous preparations which remain homogeneous for a sufficient time to enable them to be applied by conventional spray equipment.
  • Such aqueous preparations may contain varying amounts of a compound of formula (1) (for example 0.0001 to 10%, by weight) depending upon the purpose for which they are to be used.
  • a compound of formula (1) may be used in mixtures with fertilisers (for example nitrogen-, potassium- or phosphorus-containing fertilisers).
  • fertilisers for example nitrogen-, potassium- or phosphorus-containing fertilisers.
  • Suitable formulation types include granules of fertiliser.
  • the mixtures suitably contain up to 25% by weight of the compound of formula (1).
  • the invention therefore also provides a fertiliser composition comprising a fertiliser and a compound of formula (1).
  • compositions of this invention may contain other compounds having biological activity, for example micronutrients or compounds having similar or complementary fungicidal activity or which possess plant growth regulating, herbicidal, insecticidal, nematicidal or acaricidal activity.
  • the resulting composition may have a broader spectrum of activity or a greater level of intrinsic activity than the compound of formula (1) alone. Further the other fungicide may have a synergistic effect on the fungicidal activity of the compound of formula (1).
  • the compound of formula (1) may be the sole active ingredient of the composition or it may be admixed with one or more additional active ingredients such as a pesticide, fungicide, synergist, herbicide or plant growth regulator where appropriate.
  • An additional active ingredient may: provide a composition having a broader spectrum of activity or increased persistence at a locus; synergise the activity or complement the activity (for example by increasing the speed of effect or overcoming repellency) of the compound of formula (1); or help to overcome or prevent the development of resistance to individual components.
  • the particular additional active ingredient will depend upon the intended utility of the composition.
  • the compounds of formula (1) may be mixed with soil, peat or other rooting media for the protection of plants against seed-borne, soil-borne or foliar fungal diseases.
  • Some mixtures may comprise active ingredients, which have significantly different physical, chemical or biological properties such that they do not easily lend themselves to the same conventional formulation type.
  • other formulation types may be prepared.
  • one active ingredient is a water insoluble solid and the other a water insoluble liquid
  • the resultant composition is a suspoemulsion (SE) formulation.
  • Step 1 The product of Step 1 (3.25 g) was dissolved in DMF (10 ml) and added dropwise to a stirred suspension of sodium hydride (0.60 g of an 80% dispersion in mineral oil) in DMF (80 ml). There was an immediate reaction, and the mixture was stirred at room temperature for 2 hours, and at 80° C. for 8 hours. The reaction mixture was cooled and evaporated to give a yellow solid (3 g), which was then acidified with dilute hydrochloric acid. The resultant white suspension was filtered and collected, washed with ether and dried to give 6,8-dihydroxy-7-(2,4,6-trifluorophenyl)pyrido[2,3-b]pyrazine (1.8 g).
  • Phosphorus oxychloride (20.90 g) was added over 15 minutes to a suspension of the product from Step 2 (10.0 g), in 1,2-dichloroethane (80 ml) containing DMF (5.0 g) maintained at a temperature between 79°-81° C. Stirring was continued at this temperature for 3 hours, and the reaction was then cooled. The mixture was poured carefully into saturated sodium bicarbonate solution (500 ml) keeping the temperature below 30° C. After stirring for 20 minutes the product was extracted with ethyl acetate, washed with water and brine and dried over sodium sulphate.
  • Step 1 The product from Step 1 (0.30 g) was added to a suspension of isopropylamine (0.090 g), potassium carbonate (0.21 g) and a catalytic amount of DMAP in DMF (3 ml), and the mixture was stirred at room temperature for 19 hours. After addition of ethyl acetate, the mixture was washed with water and brine, dried over sodium sulphate, filtered and the solvent evaporated.
  • Phosphorus oxychloride (0.048 ml) was added to the product from Step 3 (0.05 g) in 1,2-dichloroethane (2 ml) containing a catalytic amount of DMF. The suspension was stirred and refluxed for 1 hour and then stood for 18 hours, and then refluxed for a further hour and then allowed to cool. The excess phosphorus oxychloride was evaporated to give a brown oil, which was dissolved in DCM and washed with cold water.
  • Isopropylamine (0.5 ml) was added to the product from Step 4 (0.015 g) dissolved in DCM (1 ml) containing dimethylacetamide (0.3 ml) in a sealed tube. The yellow solution became yellow/greenish. The vessel was then sealed and stirred at room temperature. The solvents were evaporated and the crude residue was purified using preparative thin layer chromatography silica gel plates eluting with ethyl acetate:hexane 1:1 to give [6-Chloro-7-(2,4,6-trifluorophenyl)-pyrido[3,2-c]pyridazin-8-yl]-isopropylamine (0.003 g).
  • 3-Aminopyridazine-4-carboxylic acid (1.68 g, prepared as in JOC, (1985), 50, 346) was refluxed in ethanol (170 ml) with concentrated hydrochloric acid (2 ml) and p-toluene-sulphonyl chloride (0.1 g) for 55 hours. The solvent was evaporated and ice water added to the residue, which was then neutralised with solid sodium bicarbonate. The mixture was extracted with chloroform, insoluble material filtered, the organic extract dried over magnesium sulphate and evaporated to give 3-aminopyridazine-4-carboxylic acid ethyl ester (1.02 g) as a white solid.
  • 3 21 1.27 (d, 6 H), 4.05 (m, 1 H), 4.90 (bs, 1 H),6.92 (m, 2 H), 9.55 (s, 1 H), 9.90 (s, 1 H).
  • 3 26 1.20 (d, 6 H), 3.71 (m, 1 H), 4.45 (bs, 1 H),6.87-6.92 (m, 2 H), 7.97 (d, 1 H), 9.37 (d, 1 H).
  • 3 31 1.25 (d, 6 H), 4.5 (bd, 1 H), 4.6 (m, 1 H),7.15 (t, 2 H), 7.6 (m, 1 H), 8.625 (fd, 1 H),8.85 (fd, 1 H).
  • 2660 103 1.3 (d, 3 H), 1.4 (d, 3 H), 3.9 (m, 1 H), 6.95-7.6(m, 4 H), 8.75 (m, 1 H), 9.05 (m, 1 H).
  • 2706 103 0.8 (m, 6 H), 1.72 (m, 1 H), 2.6 (m, 2 H), 7.02-7.47 (m, 4 H), 8.6 (d, 1 H), 8.92 (d, 1 H).
  • 43704 103 133-135° C.(diastereoisomer 1) 43704 103 137-139° C.(diastereoisomer 2) 43715 103 118-119° C.
  • This Example illustrates the fungicidal properties of the compounds of the general formula (1).
  • Test compounds were tested in a leaf disk assay, with methods described below. Test compounds were dissolved in DMSO, and diluted into water to 200 ppm.
  • Plasmopara viticola downy mildew of grapevine: grapevine leaf disks were placed on agar in a 24-well plate and sprayed a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed seven days after inoculation as preventive fungicidal activity.
  • Phytophthora infestans (late blight of potato on tomato): tomato leaf disks were placed on water agar in a 24-well plate and sprayed with a solution of the test compound.
  • Pyrenophora teres barley leaf segments were placed on agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed four days after inoculation as preventive fungicidal activity.
  • Pyricularia oryzae rice blast: rice leaf segments were placed on agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus.
  • Botrytis cinerea grey mould: bean leaf disks were placed on agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed four days after inoculation as preventive fungicidal activity.
  • Puccinia recondita f.sp. tritici Compounds 3 (1), 14 (1), 15 (1), 16 (1), 17 (1), 23 (1), 58 (1), 108 (1), 161 (1), 162 (1), 4 (5), 17 (5), 23 (5), 28 (5), 58 (5), 108 (5), 3 (31), 16 (37), 665 (37), 678 (37), 3 (103), 12 (103), 23 (103), 58 (103), 92 (103), 2651 (103), 2660 (103), 2671 (103), 23844 (103) diastereoisomer 1, 23855 (103), 23890 (103); Septoria nodorum , Compounds 391), 15 (1), 16 (1), 17 (1), 23 (1), 58 (1), 5895), 161 (5), 22 (6), 665 (37), 685 (43), 12 (103), 23 (103), 58 (103), 2660 (103), 2671 (103), 23844 (103) diastereoisomer 1, 23855

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Health & Medical Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

This invention relates to novel derivatives of pyridopyrazines and pyridopyridazines, to processes for preparing them, to intermediate chemicals used in their manufacture, to compositions containing them and to methods of using them to combat fungi, especially fungal infections of plants. The fungicidal compounds have the general formula (1) wherein R, R1, R2, W, X Y and Z are defined in the specification
Figure US20090069333A1-20090312-C00001

Description

  • This application is a division of application Ser. No. 10/540,035 filed Jun. 22, 2006, still pending, which is the National Stage of International Application No. PCT/GB2003/005250, filed Dec. 3, 2003, which claims the benefit of Great Britain Application No. 0230020.0, filed Dec. 23, 2002, all of which are incorporated herein by reference.
  • This invention relates to novel derivatives of pyridopyrazines and pyridopyridazines, to processes for preparing them, to certain intermediate chemicals used in their manufacture, to compositions containing them and to methods of using them to combat fungi, especially fungal infections of plants.
  • Derivatives of the nitrogen-containing 5,6 ring system s-1,2,4-triazolo[1,5-a]pyrimidine are known from the patent literature as being useful for controlling phytopathogenic fungi. Examples of recent patent publications include EP-A-1249452, WO 02/051845, WO 02/083676, WO 02/083677, WO 02/088125, WO 02/088126, WO 02/088127. Condensed nitrogen heterocycles used as antimycotics are known from U.S. Pat. No. 5,821,244. Derivatives of pyridopyrazines are known in the chemical literature, for example from J. Med. Chem. (1968), 11(6), 1216-18, J. Med. Chem. (1970), 13(5), 853-7 and U.S. Pat. No. 3,984,412, but not for agrochemical purposes.
  • The present invention is concerned with the provision of novel pyridopyrazines and pyridopyridazines for combating phytopathogenic diseases on plants and harvested food crops.
  • Thus, according to the present invention, there is provided a compound of the general formula (1):
  • Figure US20090069333A1-20090312-C00002
  • wherein
    W and X, W and Z, X and Y or Y and Z are N and the other two are CR8;
    R8 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
    R is halo;
    R1 is halo, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, C1-8 alkoxy, C1-8 alkylthio, aryl, aryloxy, arylthio, heteroaryl, heteroaryloxy, heteroarylthio, aryl(C1-4)alkyl, aryl(C1-4)alkoxy, heteroaryl(C1-4)alkyl, heteroaryl(C1-4)alkoxy, aryl(C1-4)alkylthio, heteroaryl(C1-4)alkylthio, morpholino, piperidino or pyrrolidino;
  • R2 is NR3R4;
  • R3 and R4 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl, heteroaryl(C1-8)alkyl, NR5R6, provided that not both R3 and R4 are H or NR5R6, or
    R3 and R4 together form a C3-7 alkylene or C3-7 alkenylene chain optionally substituted with one or more C1-4 alkyl or C1-4 alkoxy groups, or,
    together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl (especially N-methyl) ring; and
    R5 and R6 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl or heteroaryl(C1-8)alkyl;
    any of the foregoing alkyl, alkenyl, alkynyl or cycloalkyl groups or moieties (other than for R8) being optionally substituted with halogen, cyano, C1-6 alkoxy, C1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 haloalkoxy, C1-6 alkylthio, tri(C1-4)alkylsilyl, C1-6 alkylamino or C1-6 dialkylamino,
    any of the foregoing morpholine, thiomorpholine, piperidine, piperazine and pyrrolidine rings being optionally substituted with C1-4 alkyl (especially methyl), and
    any of the foregoing aryl or heteroaryl groups or moieties being optionally substituted with one or more substituents selected from halo, hydroxy, mercapto, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C2-6 alkenyloxy, C2-6 alkynyloxy, halo(C1-6)alkyl, halo(C1-6)alkoxy, C1-6 alkylthio, halo(C1-6)alkylthio, hydroxy(C1-6)alkyl, C1-4 alkoxy(C1-6)alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenoxy, benzyloxy, benzoyloxy, cyano, isocyano, thiocyanato, isothiocyanato, nitro, —NR′″R″″, —NHCOR′″, —NHCONR′″R″″, —CONR′″R″″, —SO2R′″, —OSO2R′″, —COR′″, —CR′″═NR″″ or —N═CR′″R″″, in which R′″ and R″″ are independently hydrogen, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy, halo(C1-4)alkoxy, C1-4 alkylthio, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenyl or benzyl, the phenyl and benzyl groups being optionally substituted with halogen, C1-4 alkyl or C1-4 alkoxy.
  • The invention includes a compound of the general formula (1) as defined immediately above except that: C1-8 alkoxy and C1-8 alkylthio are excluded as values of R and R2; C7 alkylene and C3-7 alkenylene are excluded as chains formed by R3 and R4; the C3-6 chain that R3 and R4 may form may only be optionally substituted with one or more methyl groups; thiomorpholine, thiomorpholine S-oxide, thiomorpholine S-dioxide and piperazine are excluded as rings that R3 and R4 may form; tri(C1-4)alkylsilyl is excluded as a substituent of any alkyl, alkenyl, alkynyl or cycloalkyl group or moiety and any morpholine, piperidine or pyrrolidine ring is unsubstituted.
  • The compounds of the invention may contain one or more asymmetric carbon atoms and may exist as enantiomers (or as pairs of diastereoisomers) or as mixtures of such. They may also exist as diastereoisomers by virtue of restricted rotation about a bond. However, mixtures of enantiomers or diastereoisomers may be separated into individual isomers or isomer pairs, and this invention embraces such isomers and mixtures thereof in all proportions. It is to be expected that for any given compound, one isomer may be more fungicidally active than another.
  • Except where otherwise stated, alkyl groups and alkyl moieties of alkoxy, alkylthio, etc., contain from 1 to 8, suitably from 1 to 6 and typically from 1 to 4, carbon atoms in the form of straight or branched chains. Examples are methyl, ethyl, n- and iso-propyl, n-, sec-, iso- and tert-butyl, n-pentyl and n-hexyl. Cycloalkyl groups contain from 3 to 8, typically from 3 to 6, carbon atoms and include bicycloalkyl groups such as the bicyclo[2.2.1]heptyl group. Haloalkyl groups or moieties are typically trichloromethyl or trifluoromethyl or contain a trichloromethyl or trifluoromethyl terminal group.
  • Except where otherwise stated, alkenyl and alkynyl moieties also contain from 2 to 8, suitably from 2 to 6 and typically from 2 to 4, carbon atoms in the form of straight or branched chains. Examples are allyl, 2-methylallyl and propargyl. Optional substituents include halo, typically fluoro. An example of halo-substituted alkenyl is 3,4,4-trifluoro-n-butenyl.
  • Halo includes fluoro, chloro, bromo and iodo. Most commonly it is fluoro, chloro or bromo and usually fluoro or chloro.
  • Aryl is usually phenyl but also includes naphthyl, anthryl and phenanthryl.
  • Heteroaryl is typically a 5- or 6-membered aromatic ring containing one or more O, N or S heteroatoms, which may be fused to one or more other aromatic or heteroaromatic rings, such as a benzene ring. Examples are thienyl, furyl, pyrrolyl, isoxazolyl, oxazolyl, oxadiazolyl, pyrazolyl, imidazolyl, triazolyl, isothiazolyl, tetrazolyl, thiadiazolyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, benzofuryl, benzothienyl, dibenzofuryl, benzothiazolyl, benzoxazolyl, benzimidazolyl, indolyl, quinolinyl and quinoxalinyl groups and, where appropriate, N-oxides thereof.
  • The 6,6-ring systems embraced by the general formula (1) are pyrido[2,3-c]pyridazines (where W and X are both CR8 and Y and Z are both N), pyrido[2,3-d]pyridazines (where W and Z are both CR8 and X and Y are both N), pyrido[3,2-c]pyridazines (where Y and Z are both CR8 and W and X are both N) and pyrido[2,3-b]pyrazine (where X and Y are both CR8 and W and Z are both N). Of particular interest are pyrido[2,3-b]pyrazines.
  • R8, which may be the same or different for the two CR8 values of W, X, Y and Z, is H, halo (for example bromo), C1-4 alkyl (for example methyl), C1-4 alkoxy (for example methoxy) or halo(C1-4)alkyl (for example trifluoromethyl). Usually R8 will be H.
  • R is halo, especially chloro or fluoro, and R2 is NR3R4. In the case of pyrido[2,3-b]pyrazine ring systems, the more active compounds are those where R2 is NR3R4. R3 is typically C1-8 alkyl (for example ethyl, n-propyl, n-butyl, sec-butyl (the S- or R-isomer or the racemate) and tert-butyl), halo(C1-8)alkyl (for example 2, 2,2-trifluoroethyl, 2,2,2-trifluoro-1-methylethyl (the S- or R-isomer or the racemate), 3,3,3-trifluoropropyl and 4,4,4-trifluorobutyl), hydroxy(C1-8)alkyl (for example hydroxyethyl), C1-4 alkoxy(C1-8)alkyl (for example methoxymethyl and methoxy-iso-butyl), C1-4 alkoxyhalo(C1-8)alkyl (for example 2-methoxy-2-trifluoromethylethyl), tri(C1-4)alkylsilyl(C1-6)alkyl (for example trimethylsilylmethyl), C1-4 alkylcarbonyl(C1-8)alkyl (for example 1-acetylethyl and 1-tert-butylcarbonylethyl), C1-4 alkylcarbonylhalo(C1-8)alkyl (for example 1-acetyl-2,2,2-trifluoroethyl), phenyl(1-4)alkyl (for example benzyl), C2-8 alkenyl (for example allyl and methylallyl), halo(C2-8)alkenyl (for example 3-methyl-4,4-difluorobut-3-enyl), C2-8 alkynyl (for example propargyl), C3-8 cycloalkyl (for example cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl) optionally substituted with chloro, fluoro or methyl, C3-8 cycloalkyl(C1-4)alkyl (for example cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl and cyclohexylmethyl), phenylamino, piperidino or morpholino, the phenyl ring of phenylalkyl or phenylamino being optionally substituted with one, two or three substituents selected from halo (typically fluoro, chloro or bromo), C1-4 alkyl (typically methyl), halo(C1-4)alkyl (typically trifluoromethyl), C1-4 alkoxy (typically methoxy) and halo(C1-4)alkoxy (typically trifluoromethoxy). R4 is typically H, C1-4 alkyl (for example ethyl and n-propyl), halo(C1-4)alkyl (for example 2,2,2-trifluoroethyl) or amino. Alternatively R3 and R4 together form a C4-6 alkylene chain optionally substituted with methyl, for example 3-methylpentylene, or, together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl (especially N-methyl) ring, in which the morpholine or piperazine rings are optionally substituted with methyl.
  • Typically R1 is phenyl optionally substituted with from one to five halogen atoms, particularly fluorine and chlorine atoms and especially fluorine atoms or with from one to three substituents selected from halo (for example fluoro and chloro), C1-4 alkyl (for example methyl), halo(C1-4)alkyl (for example trifluoromethyl), C1-4 alkoxy (for example methoxy) or halo(C1-4)alkoxy (for example trifluoromethoxy). Examples are 2,6-difluorophenyl, 2-fluoro-6-chlorophenyl, 2,5,6-trifluorophenyl, 2,4,6-trifluorophenyl, 2,6-difluoro-4-methoxyphenyl, pentafluorophenyl, 2-fluorophenyl, 2,3,5,6-tetrafluorophenyl, 2-chloro-4,6-difluorophenyl, 2-chlorophenyl, 2,6-dichlorophenyl, 2,4-dichlorophenyl, 2,4,6-trichlorophenyl, 2,3,6-tri-chlorophenyl, pentachlorophenyl, 2-fluoro-4,6-dichlorophenyl, 4-fluoro-2,6-dichlorophenyl, 2-bromophenyl, 2-fluoro-6-bromophenyl, 2-bromo-4,6-difluorophenyl, 2-fluoro-6-methylphenyl, 2-chloro-6-methylphenyl, 2-methoxyphenyl, 2,6-dimethoxyphenyl, 2-fluoro-6-methoxyphenyl, 2-trifluoromethylphenyl, 2-fluoro-6-trifluoromethylphenyl, 2,6-di-(trifluoromethyl)phenyl, 2-chloro-6-trifluoromethylphenyl, 2,4-difluoro-6-trifluoromethylphenyl, 2,4-difluoro-6-methoxyphenyl and 2,4-difluoro-6-methylphenyl.
  • Also of particular interest are compounds where R1 is pyridyl optionally substituted with from one to four halogen atoms or with from one to three substituents selected from halo (for example fluoro and chloro), C1-4 alkyl (for example methyl), halo(C1-4)alkyl (for example trifluoromethyl), C1-4 alkoxy (for example methoxy) or halo(C1-4)alkoxy (for example trifluoromethoxy). Examples are 2,4-difluoropyrid-3-yl, 3,5-difluoropyrid-4-yl, tetrafluoropyrid-4-yl, 3-fluoropyrid-2-yl, 4-fluoropyrid-3-yl, 3-fluoropyrid-4-yl, 2-fluoropyrid-3-yl, 2,4,6-trifluoropyrid-3-yl, 3,5-difluoropyrid-2-yl, 2,6-difluoropyrid-3-yl, 2,4-difluoro-6-methoxypyrid-3-yl, 2-fluoro-4-chloropyrid-3-yl, 3-fluoro-5-chloropyrid-4-yl, 2-chloro-4-fluoropyrid-3-yl, 2,4-dichloropyrid-3-yl, 3-chloropyrid-2-yl 1,4-chloropyrid-3-yl, 3-chloropyrid-4-yl, 2-chloropyrid-3-yl, 3-trifluoromethylpyrid-2-yl, 4-trifluoromethylpyrid-3-yl, 3,5-dichloropyrid-2-yl, 4,6-dichloropyrid-3-yl, 3-trifluoromethylpyrid-4-yl, 2-trifluoromethylpyrid-3-yl, 2-fluoro-4-trifluoromethylpyrid-3-yl, 3-fluoro-5-trifluoromethylpyrid-4-yl, 4-fluoro-2-trifluoromethylpyrid-3-yl, 2,6-dichloropyrid-3-yl, 3,5-dichloropyrid-4-yl, 3-chloro-6-trifluoromethylpyrid-2-yl, 3-fluoro-6-trifluoromethylpyrid-2-yl, pyrid-2-yl, pyrid-3-yl and pyrid-4-yl.
  • Also of particular interest are compounds where R1 is 2- or 3-thienyl optionally substituted with from one to three halogen atoms or with from one to three substituents selected from halo (for example fluoro and chloro), C1-4 alkyl (for example methyl), halo-(C1-4)alkyl (for example trifluoromethyl), C1-4 alkoxy (for example methoxy) or halo(C1-4)alkoxy (for example trifluoromethoxy). Examples are 3-fluorothien-2-yl, 3-chlorothien-2-yl, 2,4-difluorothien-3-yl, 2,4-dichlorothien-3-yl and 2,4,5-trichlorothien-3-yl.
  • Examples of other values of R1 of especial interest are unsubstituted piperidino and morpholino, 2-methylpiperidino, 2,6-dimethylpiperidino and 2,6-dimethylmorpholino.
  • In one aspect the invention provides a compound of the general formula (1) wherein W and X, W and Z, X and Y or Y and Z are N and the other two are CR8;
  • R8 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
    R is halo;
    R1 is halo, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, C1-8 alkoxy, C1-8 alkylthio, aryl, aryloxy, arylthio, heteroaryl, heteroaryloxy, heteroarylthio, aryl(C1-4)alkyl, aryl(C1-4)alkoxy, heteroaryl(C1-4)alkyl, heteroaryl(C1-4)alkoxy, aryl(C1-4)alkylthio, heteroaryl(C1-4)alkylthio, morpholino, piperidino or pyrrolidino;
  • R2 is NR3R4;
  • R3 and R4 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl, heteroaryl(C1-8)alkyl, NR5R6, provided that not both R3 and R4 are H or NR5R6, or
    R3 and R4 together form a C3-7 alkylene or C3-7 alkenylene chain optionally substituted with one or more C1-4 alkyl or C1-4 alkoxy groups, or,
    together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl (especially N-methyl) ring; and
    R5 and R6 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl or heteroaryl(C1-8)alkyl;
    any of the foregoing alkyl, alkenyl, alkynyl or cycloalkyl groups or moieties (other than for R8) being optionally substituted with halogen, cyano, C1-6 alkoxy, C1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 haloalkoxy, C1-6 alkylthio, tri(C1-4)alkylsilyl, C1-6 alkylamino or C1-6 dialkylamino,
    any of the foregoing morpholine, thiomorpholine, piperidine, piperazine and pyrrolidine rings being optionally substituted with C1-4 alkyl (especially methyl), and any of the foregoing aryl, heteroaryl, aryloxy or heteroaryl groups being optionally substituted with one or more substituents selected from halo, hydroxy, mercapto, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C2-6 alkenyloxy, C2-6 alkynyloxy, halo(C1-6)alkyl, halo(C1-6)alkoxy, C1-6 alkylthio, halo(C1-6)alkylthio, hydroxy(C1-6)alkyl, C1-4 alkoxy(C1-6)alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenoxy, benzyloxy, benzoyloxy, cyano, isocyano, thiocyanato, isothiocyanato, nitro, —NR′″R″″, —NHCOR′″, —NHCONR′″R″″, —CONR′″R″″, —SO2R′″, —OSO2R′″, —COR′″, —CR′″═NR″″ or —N═CR′″R″″, in which R′″ and R″″ are independently hydrogen, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy, halo-(C1-4)alkoxy, C1-4 alkylthio, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenyl or benzyl, the phenyl and benzyl groups being optionally substituted with halogen, C1-4 alkyl or C1-4 alkoxy.
    Of particular interest are compounds where W and Z are both N and X and Y are both CH.
  • The invention includes a compound of the general formula (1) as defined immediately above except that: C7 alkylene and C3-7 alkenylene are excluded as chains formed by R3 and R4; the C3-6 chain that R3 and R4 may form may only be optionally substituted with one or more methyl groups; thiomorpholine, thiomorpholine S-oxide, thiomorpholine S-dioxide and piperazine are excluded as rings that R3 and R4 may form; tri(C1-4)alkylsilyl is excluded as a substituent of any alkyl, alkenyl, alkynyl or cycloalkyl group or moiety, and any morpholine, piperidine or pyrrolidine ring is unsubstituted.
  • In another aspect the invention provides a compound of the general formula (1) wherein
  • W and X, W and Z, X and Y or Y and Z are N and the other two are CR8;
    R3 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
    R is halo;
    R1 is halo, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, C1-8 alkoxy, C1-8 alkylthio, aryl, aryloxy, arylthio, heteroaryl, heteroaryloxy, heteroarylthio, aryl(C1-4)alkyl, aryl(C1-4)alkoxy, heteroaryl(C1-4)alkyl, heteroaryl(C1-4)alkoxy, aryl(C1-4)alkylthio, heteroaryl(C1-4)alkylthio, morpholino, piperidino or pyrrolidino;
  • R2 is NR3R4;
  • R3 is C1-4 alkyl, halo(C1-4)alkyl, C2-4 alkenyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl or phenylamino in which the phenyl ring is optionally substituted with one, two or three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy and halo(C1-4)alkoxy; and
    R4 is H, C1-4 alkyl or amino, or
    R3 and R4 together form a C4-6 alkylene chain optionally substituted with C1-4 alkyl or
    C1-4 alkoxy, or,
    together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl (especially N-methyl) ring;
    any of the foregoing alkyl, alkenyl, alkynyl or cycloalkyl groups or moieties (other than for R8) being optionally substituted with halogen, cyano, C1-6 alkoxy, C1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 haloalkoxy, C1-6 alkylthio, tri(C1-4)alkylsilyl, C1-6 alkylamino or C1-6 dialkylamino,
    any of the foregoing morpholine, thiomorpholine, piperidine, piperazine and pyrrolidine rings being optionally substituted with C1-4 alkyl (especially methyl), and
    any of the foregoing aryl or heteroaryl groups or moieties being optionally substituted with one or more substituents selected from halo, hydroxy, mercapto, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C2-6 alkenyloxy, C2-6 alkynyloxy, halo(C1-6)alkyl, halo(C1-6)alkoxy, C1-6 alkylthio, halo(C1-6)alkylthio, hydroxy(C1-6)alkyl, C1-4 alkoxy(C1-6)alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenoxy, benzyloxy, benzoyloxy, cyano, isocyano, thiocyanato, isothiocyanato, nitro, —NR′″R″″, —NHCOR′″, —NHCONR′″R″″, —CONR′″R″″, —SO2R′″, —OSO2R′″, —COR′″, —CR′″═NR″″ or —N═CR′″R″″, in which R′″ and R″″ are independently hydrogen, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy, halo(C1-4)alkoxy, C1-4 alkylthio, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenyl or benzyl, the phenyl and benzyl groups being optionally substituted with halogen, C1-4 alkyl or C1-4 alkoxy.
    Of particular interest are compounds where W and Z are both N and X and Y are both CH.
  • The invention includes a compound of the general formula (1) as defined immediately above except that: the C4-6 chain that R3 and R4 may form may only be optionally substituted with methyl; thiomorpholine, thiomorpholine S-oxide, thiomorpholine S-dioxide and piperazine are excluded as rings that R3 and R4 may form; tri(C1-4)alkylsilyl is excluded as a substituent of any alkyl, alkenyl, alkynyl or cycloalkyl group or moiety, and any morpholine, piperidine or pyrrolidine ring is unsubstituted.
  • In yet another aspect the invention provides a compound of the general formula (1) wherein
  • W and X, W and Z, X and Y or Y and Z are N and the other two are CR3;
    R3 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
    R is halo;
    R1 is optionally substituted phenyl;
  • R2 is NR3R4;
  • R3 and R4 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl, heteroaryl(C1-8)alkyl, NR5R6, provided that not both R3 and R4 are H or NR5R6, or
    R3 and K4 together form a C3-7 alkylene or C3-7 alkenylene chain optionally substituted with one or more C1-4 alkyl or C1-4 alkoxy groups, or,
    together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl (especially N-methyl) ring; and
    R5 and R6 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl or heteroaryl(C1-8)alkyl;
    any of the foregoing alkyl, alkenyl, alkynyl or cycloalkyl groups or moieties (other than for R8) being optionally substituted with halogen, cyano, C1-6 alkoxy, C1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 haloalkoxy, C1-6 alkylthio, tri(C1-4)alkylsilyl, C1-6 alkylamino or C1-6 dialkylamino,
    any of the foregoing morpholine, thiomorpholine, piperidine, piperazine and pyrrolidine rings being optionally substituted with C1-4 alkyl (especially methyl), and
    any of the foregoing aryl or heteroaryl groups or moieties, including the phenyl group of R1, being optionally substituted with one or more substituents selected from halo, hydroxy, mercapto, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C2-6 alkenyloxy, C2-6 alkynyloxy, halo(C1-6)alkyl, halo(C1-6)alkoxy, C1-6 alkylthio, halo(C1-6)alkylthio, hydroxy(C1-6)alkyl, C1-4 alkoxy(C1-6)alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenoxy, benzyloxy, benzoyloxy, cyano, isocyano, thiocyanato, isothiocyanato, nitro, —NR′″R″″, —NHCOR′″, —NHCONR′″R″″, —CONR′″R″″, —SO2R′″, —OS2R′″, —COR′″, —CR′″═NR″″ or —N═CR′″R″″, in which R′″ and R″″ are independently hydrogen, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy, halo(C1-4)alkoxy, C1-4 alkylthio, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenyl or benzyl, the phenyl and benzyl groups being optionally substituted with halogen, C1-4 alkyl or C1-4 alkoxy. Of particular interest are compounds where W and Z are both N and X and Y are both CH.
  • The invention includes a compound of the general formula (1) as defined immediately above except that: C1-8 alkoxy and C1-8 alkylthio are excluded as values of R and R2; C7 alkylene and C3-7 alkenylene are excluded as chains formed by R3 and R4; the C3-6 chain that R3 and R4 may form may only be optionally substituted with one or more methyl groups; thiomorpholine, thiomorpholine S-oxide, thiomorpholine S-dioxide and piperazine are excluded as rings that R3 and R4 may form; tri(C1-4)alkylsilyl is excluded as a substituent of any alkyl, alkenyl, alkynyl or cycloalkyl group or moiety, and the morpholine ring that R3 and R4 may form is unsubstituted.
  • In still yet another aspect the invention provides a compound of the general formula (1) wherein W and X, W and Z, X and Y or Y and Z are N and the other two are CR8;
  • R8 is H, halo(e.g. fluoro, chloro or bromo), C1-4 alkyl (e.g. methyl), C1-4 alkoxy (e.g. methoxy) or halo(C1-4)alkyl (e.g. trifluoromethyl);
    R is halo (e.g. fluoro, chloro or bromo);
    R1 is phenyl optionally substituted with from one to five halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy or halo(C1-4) alkoxy, pyridyl optionally substituted with from one to four halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy or halo(C1-4)alkoxy, 2- or 3-thienyl optionally substituted with from one to three halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy or halo(C1-4)alkoxy, or piperidino or morpholino both optionally substituted with one or two methyl groups;
  • R is NR3R4;
  • R3 is C1-8 alkyl, halo(C1-8)alkyl, hydroxy(C1-8)alkyl, C1-4 alkoxy(C1-8)alkyl, C1-4 alkoxyhalo-(C1-8)alkyl, tri(C1-4)alkylsilyl(C1-6)alkyl, C1-4 alkylcarbonyl(C1-8)alkyl, C1-4 alkylcarbonylhalo(C1-8)alkyl, phenyl(1-4)alkyl, C2-8 alkenyl, halo(C2-8)alkenyl, C2-8 alkynyl, C3-8 cycloalkyl optionally substituted with chloro, fluoro or methyl, C3-8 cycloalkyl(C1-4)alkyl, phenylamino, piperidino or morpholino, the phenyl ring of phenylalkyl or phenylamino being optionally substituted with one, two or three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy and halo(C1-4)alkoxy; and
    R4 is H, C1-4 alkyl, halo(C1-4)alkyl or amino, or
    R3 and R4 together form a C3-7 alkylene or C3-7 alkenylene chain optionally substituted with methyl, or,
    together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl (especially N-methyl) ring, in which the morpholine or piperazine rings are optionally substituted with methyl.
    Of particular interest are compounds where W and Z are both N and X and Y are both CH.
  • In still yet another aspect the invention provides a compound of the general formula (1) wherein
  • W and X, W and Z, X and Y or Y and Z are N and the other two are CR8;
    R8 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
    R is halo;
    R1 is phenyl optionally substituted with from one to five halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy or halo(C1-4) alkoxy;
  • R2 is NR3R4;
  • R3 is C1-4 alkyl, halo(C1-4)alkyl, C2-4 alkenyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl or phenylamino in which the phenyl ring is optionally substituted with one, two or three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy and halo(C1-4)alkoxy; and
    R4 is H, C1-4 alkyl or amino, or R3 and R4 together form a C4-6 alkylene chain optionally substituted with methyl, or, together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine ring.
    Of particular interest are compounds where W and Z are both N and X and Y are both CH.
  • Compounds that form part of the invention are illustrated in Tables 1 to 127 below. Characterising data are given later in the Examples and in Table 133.
  • In Table 1 the compounds have the general formula (1A), where W and Z are N, X and Y are CH, R is Cl, R1 is 2,4,6-trifluorophenyl and R3 and R4 are as shown in the table.
  • TABLE 1
    Figure US20090069333A1-20090312-C00003
    Cmpd
    No R3 R4
     1 C2H5 H
     2 n-C3H7 H
     3 i-C3H7 H
     4 n-C4H9 H
     5 t-C4H9 H
     6 CH2═CHCH2 H
     7 CH2═C(CH3)CH2 H
     8 CF3CH2 H
     9 CF3CH2CH2 H
     10 CF3CH2CH2CH2 H
     11 CF3(CH3)CH H
     12 (S)-CF3(CH3)CH H
     13 (R)-CF3(CH3)CH H
     14 cyclo-C3H5 H
     15 cyclo-C4H7 H
     16 cyclo-C5H9 H
     17 cyclo-C6H11 H
     18 cyclo-C3H5CH2 H
     19 cyclo-C4H7CH2 H
     20 —(CH2)2O(CH2)2
     21 cyclo-C6H11CH2 H
     22 —(CH2)2CH(CH3)(CH2)2
     23 CH3CH2(CH3)CH H
     24 (S)-CH3CH2(CH3)CH H
     25 (R)-CH3CH2(CH3)CH H
     26 C2H5 C2H5
     27 n-C3H7 n-C3H7
     28 CH2═C(CH3)CH2 C2H5
     29 CF3CH2 C2H5
     30 C2H5 NH2
     31 n-C3H7 NH2
     32 i-C3H7 NH2
     33 n-C4H9 NH2
     34 CH2═CHCH2 NH2
     35 CH2═C(CH3)CH2 NH2
     36 CF2═CFCH2CH2 NH2
     37 CF3CH2 NH2
     38 CF3CH2CH2 NH2
     39 CF3CH2CH2CH2 NH2
     40 4-t-C4H9-C6H4NH H
     41 4-F—C6H4NH H
     42 C6H5NH H
     43 4-CH3—C6H4NH H
     44 4-Br—C6H4NH H
     45 2-F—C6H4NH H
     46 3,4-Cl2—C6H3NH H
     47 3-CF3—C6H4NH H
     48 3,5-Cl2—C6H3NH H
     49 4-CF3O—C6H5NH H
     50 2-CF3—C6H4NH H
     51 4-CF3—C6H4NH H
     52 2-Br—C6H4NH H
     53 2-Cl—C6H4NH H
     54 2-CH3-4-Cl—C6H3NH H
     55 2-CH3-5-F—C6H3NH H
     56 3-Cl—C6H4NH H
     57 CH3 H
     58 (CH3)2CHCH2 H
     59 (CH3)3CCH2 H
     60 (CH3)3C(CH3)CH H
     61 CH3CH2(CH3)2C H
     62 CH3CH2(CF3)CH H
     63 (S)-CH3CH2(CF3)CH H
     64 (R)-CH3CH2(CF3)CH H
     65 CH3CH2(CH3CH2)CH H
     66 (CH3)2CH(CH3CH2)CH H
     67 (CH3)2CH(CH3)CH H
     68 (CH3)2CH(CF3)CH H
     69 (S)-(CH3)2CH(CF3)CH H
     70 (R)-(CH3)2CH(CF3)CH H
     71 HC═C(CH3)CH2 H
     72 CH2═CH(CH3CH2)CH H
     73 CH3CH2CH2(CH3)CH H
     74 CH3CH2CH2(CF3)CH H
     75 (S)-CH3CH2CH2(CF3)CH H
     76 (R)-CH3CH2CH2(CF3)CH H
     77 CH3CH2CH2(CH3)2C H
     78 CH3CH2(CH3)CHCH2 H
     79 (CH3)2CHCH2CH2 H
     80 (CH3)3CCH2CH2 H
     81 CH3CH2(CH3)CH(CH3)—CH H
     82 CH3CH2(CH3)CH(CF3)—CH H
     83 (S)-CH3CH2(CH3)CH—(CF3)CH H
     84 (R)-CH3CH2(CH3)CH—(CF3)CH H
     85 CH3(CH3)CHCH2(CH3)—CH H
     86 CH3(CH3)CHCH2(CF3)—CH H
     87 (S)-CH3(CH3)CHCH2—(CF3)CH H
     88 (R)-CH3(CH3)CHCH2—(CF3)CH H
     89 (CH3)2CH(CH3)CH—(CH3)CH2 H
     90 (CH3)3CCH2(CH3)CH H
     91 E-CH3CH═CH(CH3)CH H
     92 E-CH3CH═CH(CH3CH2)—CH H
     93 CH3CH2CH2(CH3CH2)—CH H
     94 CH3CH2(CH3CH2)—CHCH2 H
     95 CF2═CFCH2CH2 H
     96 CF3CH2(CH3)CHCH2 H
     97 CF3CF2CH2CH2 H
     98 CF3CF2CF2CH2 H
     99 CF2═C(CH3)CH2CH2 H
    100 CH3CH2CH2CH2CH2 H
    101 CH3CH2CH2CH2—(CH3)CH H
    102 CH3CH2CH2(CH3)—CHCH2 H
    103 CH3CH2(CH3)CHCH2-CH2 H
    104 CH3CH2CH2(CH3)CH—(CH3)CH H
    105 CH3CH2(CH3)CHCH2-(CH3)CH H
    106 HOCH2CH2 H
    107 CH3OCH2CH2 H
    108 CH3OCH2(CH3)CH H
    109 CH3OCH2(CF3)CH H
    110 CH3OCH2(CH3)2C H
    111 CH3O(CH3)CHCH2 H
    112 CH3O(CH3)CH(CH3)CH H
    113 HC≡CCH2 H
    114 CH3C≡CCH2 H
    115 HC≡CCH2CH2 H
    116 HOCH2CH2CH2 H
    117 CH3OCH2CH2CH2 H
    118 (CH3)3SiCH2 H
    119 C6H5CH2 H
    120 C6H5(CH3)CH H
    121 4-F—C6H4CH2 H
    122 4-Cl—C6H4CH2 H
    123 4-F—C6H5(CH3)CH H
    124 4-Cl—C6H5(CH3)CH H
    125 C6H5CH2CH2 H
    126 4-F—C6H5CH2CH2 H
    127 1-piperidino H
    128 1-pyrrolidino H
    129 cyclo-C5H9CH2 H
    130 Bicyclo[2.2.1]hept-2-yl H
    131 1-CH3-cyclopropyl H
    132 cis-2-CH3-cyclopropyl H
    133 trans-2-CH3-cyclopropyl H
    134 2,2-(CH3)2-cyclopropyl H
    135 1-CH3-cyclobutyl H
    136 cis-2-CH3-cyclobutyl H
    137 trans-2-CH3-cyclobutyl H
    138 cis-3-CH3-cyclobutyl H
    139 trans-3-CH3-cyclobutyl H
    140 2,2-(CH3)2-cyclobutyl H
    141 3,3-(CH3)2-cyclobutyl H
    142 1-CH3-cyclopentyl H
    143 cis-2-CH3-cyclopentyl H
    144 trans-2-CH3-cyclopentyl H
    145 cis-3-CH3-cyclopentyl H
    146 trans-3-CH3-cyclopentyl H
    147 2,2-(CH3)2-cyclopentyl H
    148 3,3-(CH3)2-cyclopentyl H
    149 1-CH3-cyclohexyl H
    150 cis-2-CH3-cyclohexyl H
    151 trans-2-CH3-cyclohexyl H
    152 cis-3-CH3-cyclohexyl H
    153 trans-3-CH3-cyclohexyl H
    154 2,2-(CH3)2-cyclohexyl H
    155 3,3-(CH3)2-cyclohexyl H
    156 cis-4-CH3-cyclohexyl H
    157 trans-4-CH3-cyclohexyl H
    158 4,4-(CH3)2-cyclohexyl H
    159 4-(CH3)3C-cyclohexyl H
    160 —(CH2)3
    161 —(CH2)4
    162 —(CH2)5
    163 —(CH2)6
    164 —(CH2)2(CH3)2C(CH2)2
    165 —(CH3)CH(CH2)2
    166 —(CH3)CH(CH2)3
    167 —(CH3)CH(CH2)4
    168 —(CH3)CH(CH2)5
    169 —CH2CH═CH(CH2)2
    170 —(CH2)2NH(CH2)2
    171 —(CH2)2NCH3(CH2)2
    172 —(CH2)2S(CH2)2
    173 —(CH2)2SO(CH2)2
    174 —(CH2)2SO2(CH2)2
    175 —CH2(CH3)CHO(CH3)CHCH2
    176 C2H5 CH3
    177 n-C3H7 CH3
    178 i-C3H7 CH3
    179 n-C4H9 CH3
    180 t-C4H9 CH3
    181 CH2═CHCH2 CH3
    182 CH2═C(CH3)CH2 CH3
    183 CF3CH2 CH3
    184 CF3CH2CH2 CH3
    185 CF3CH2CH2CH2 CH3
    186 CF3(CH3)CH CH3
    187 (S)-CF3(CH3)CH CH3
    188 (R)-CF3(CH3)CH CH3
    189 cyclo-C3H5 CH3
    190 cyclo-C4H7 CH3
    191 cyclo-C5H9 CH3
    192 cyclo-C6H11 CH3
    193 cyclo-C3H5CH2 CH3
    194 cyclo-C4H7CH2 CH3
    195 cyclo-C6H11CH2 CH3
    196 CH3CH2(CH3)CH CH3
    197 (S)-CH3CH2(CH3)CH CH3
    198 (R)-CH3CH2(CH3)CH CH3
    199 cyclo-C7H13 CH3
    200 CH2═C(CH3)CH2 CH3
    201 CF3CH2 CH3
    202 4-t-C4H9—C6H4NH CH3
    203 4-F-C6H4NH CH3
    204 C6H5NH CH3
    205 4-CH3—C6H4NH CH3
    206 4-Br—C6H4NH CH3
    207 2-F-C6H4NH CH3
    208 3,4-Cl2—C6H3NH CH3
    209 3-CF3—C6H4NH CH3
    210 3,5-Cl2—C6H3NH CH3
    211 4-CF3O—C6H5NH CH3
    212 2-CF3—C6H4NH CH3
    213 4-CF3—C6H4NH CH3
    214 2-Br—C6H4NH CH3
    215 2-Cl—C6H4NH CH3
    216 2-CH3-4-Cl—C6H3NH CH3
    217 2-CH3-5-F—C6H3NH CH3
    218 3-Cl—C6H4NH CH3
    219 CH3 CH3
    220 (CH3)2CHCH2 CH3
    221 (CH3)3CCH2 CH3
    222 (CH3)3C(CH3)CH CH3
    223 CH3CH2(CH3)2C CH3
    224 CH3CH2(CF3)CH CH3
    225 (S)-CH3CH2(CF3)CH CH3
    226 (R)-CH3CH2(CF3)CH CH3
    227 CH3CH2(CH3CH2)CH CH3
    228 (CH3)2CH(CH3CH2)CH CH3
    229 (CH3)2CH(CH3)CH CH3
    230 (CH3)2CH(CF3)CH CH3
    231 (S)-(CH3)2CH(CF3)CH CH3
    232 (R)-(CH3)2CH(CF3)CH CH3
    233 HC═C(CH3)CH2 CH3
    234 CH2═CH(CH3CH2)CH CH3
    235 CH3CH2CH2(CH3)CH CH3
    236 CH3CH2CH2(CF3)CH CH3
    237 (S)-CH3CH2CH2(CF3)CH CH3
    238 (R)-CH3CH2CH2(CF3)CH CH3
    239 CH3CH2CH2(CF3)2C CH3
    240 CH3CH2(CH3)CHCH2 CH3
    241 (CH3)2CHCH2CH2 CH3
    242 (CH3)3CCH2CH2 CH3
    243 CH3CH2(CH3)CH(CH3)—CH CH3
    244 CH3CH2(CH3)CH(CF3)—CH CH3
    245 (S)-CH3CH2(CH3)CH—(CF3)CH CH3
    246 (R)-CH3CH2(CH3)CH—(CF3)CH CH3
    247 CH3(CH3)CHCH2—(CH3)CH CH3
    248 CH3(CH3)CHCH2—(CF3)CH CH3
    249 (S)-CH3(CH3)CHCH2—(CF3)CH CH3
    250 (R)-CH3(CH3)HCH2—(CF3)CH CH3
    251 (CH3)2CH(CH3)CH(CH3)—CH2 CH3
    252 (CH3)3CCH2(CH3)CH CH3
    253 E-CH3CH═CH(CH3)CH CH3
    254 E-CH3CH═CH(CH3CH2)—CH CH3
    255 CH3CH2CH2(CH3CH2)—CH CH3
    256 CH3CH2(CH3CH2)—CHCH2 CH3
    257 CF2═CFCH2CH2 CH3
    258 CF3CH2(CH3)CHCH2 CH3
    259 CF3CF2CH2CH2 CH3
    260 CF3CF2CF2CH2 CH3
    261 CF2═C(CH3)CH2CH2 CH3
    262 CH3CH2CH2CH2CH2 CH3
    263 CH3CH2CH2CH2(CH3)—CH CH3
    264 CH3CH2CH2(CH3)—CHCH2 CH3
    265 CH3CH2(CH3)CHCH2—CH2 CH3
    266 CH3CH2CH2(CH3)CH—(CH3)CH CH3
    267 CH3CH2(CH3)CHCH2—(CH3)CH CH3
    268 HOCH2CH2 CH3
    269 CH3OCH2CH2 CH3
    270 CH3OCH2(CH3)CH CH3
    271 CH3OCH2(CF3)CH CH3
    272 CH3OCH2(CH3)2C CH3
    273 CH3O(CH3)CHCH2 CH3
    274 CH3O(CH3)CH(CH3)CH CH3
    275 HC≡CCH2 CH3
    276 CH3C≡CCH2 CH3
    277 HC≡CCH2CH2 CH3
    278 HOCH2CH2CH2 CH3
    279 CH3OCH2CH2CH2 CH3
    280 (CH3)3SiCH2 CH3
    281 C6H5CH2 CH3
    282 C6H5(CH3)CH CH3
    283 4-F—C6H4CH2 H
    284 4-Cl—C6H4CH2 CH3
    285 4-F—C6H5(CH3)CH CH3
    286 4-Cl—C6H5(CH3)CH CH3
    287 C6H5CH2CH2 CH3
    288 4-F—C6H5CH2CH2 CH3
    289 1-piperidino CH3
    290 1-pyrrolidino CH3
    291 cyclo-C5H9CH2 CH3
    292 bicyclo[2.2.1]hept-2-yl CH3
    293 1-CH3-cyclopropyl CH3
    294 cis-2-CH3-cyclopropyl CH3
    295 trans-2-CH3-cyclopropyl CH3
    296 2,2-(CH3)2-cyclopropyl CH3
    297 1-CH3-cyclobutyl CH3
    298 cis-2-CH3-cyclobutyl CH3
    299 trans-2-CH3-cyclobutyl CH3
    300 cis-3-CH3-cyclobutyl CH3
    301 trans-3-CH3-cyclobutyl CH3
    302 2,2-(CH3)2-cyclobutyl CH3
    303 3,3-(CH3)2-cyclobutyl CH3
    304 1-CH3-cyclopentyl CH3
    305 cis-2-CH3-cyclopentyl CH3
    306 trans-2-CH3-cyclopentyl CH3
    307 cis-3-CH3-cyclopentyl CH3
    308 trans-3-CH3-cyclopentyl CH3
    309 2,2-(CH3)2-cyclopentyl CH3
    310 3,3-(CH3)2-cyclopentyl CH3
    311 1-CH3-cyclohexyl CH3
    312 cis-2-CH3-cyclohexyl CH3
    313 trans-2-CH3-cyclohexyl CH3
    314 cis-3-CH3-cyclohexyl CH3
    315 trans-3-CH3-cyclohexyl CH3
    316 2,2-(CH3)2-cyclohexyl CH3
    317 3,3-(CH3)2-cyclohexyl CH3
    318 cis-4-CH3-cyclohexyl CH3
    319 trans-4-CH3-cyclohexyl CH3
    320 4,4-(CH3)2-cyclohexyl CH3
    321 4-(CH3)3C-cyclohexyl CH3
    322 n-C3H7 C2H5
    323 i-C3H7 C2H5
    324 n-C4H9 C2H5
    325 t-C4H9 C2H5
    326 CH2═CHCH2 C2H5
    327 CF3CH2CH2 C2H5
    328 CF3CH2CH2CH2 C2H5
    329 CF3(CH3)CH C2H5
    330 (S)-CF3(CH3)CH C2H5
    331 (R)-CF3(CH3)CH C2H5
    332 cyclo-C3H5 C2H5
    333 cyclo-C4H7 C2H5
    334 cyclo-C5H9 C2H5
    335 cyclo-C6H11 C2H5
    336 cyclo-C3H5CH2 C2H5
    337 cyclo-C4H7CH2 C2H5
    338 cyclo-C6H11CH2 C2H5
    339 CH3CH2(CH3)CH C2H5
    340 (S)-CH3CH2(CH3)CH C2H5
    341 (R)-CH3CH2(CH3)CH C2H5
    342 cyclo-C7H13 C2H5
    343 4-t-C4H9—C6H4NH C2H5
    344 4-F—C6H4NH C2H5
    345 C6H5NH C2H5
    346 4-CH3—C6H4NH C2H5
    347 4-Br—C6H4NH C2H5
    348 2-F—C6H4NH C2H5
    349 3,4-Cl2—C6H3NH C2H5
    350 3-CF3—C6H4NH C2H5
    351 3,5-Cl2—C6H3NH C2H5
    352 4-CF3O—C6H5NH C2H5
    353 2-CF3—C6H4NH C2H5
    354 4-CF3—C6H4NH C2H5
    355 2-Br—C6H4NH C2H5
    356 2-Cl—C6H4NH C2H5
    357 2-CH3-4-Cl—C6H3NH C2H5
    358 2-CH3-5-F—C6H3NH C2H5
    359 3-Cl—C6H4NH C2H5
    360 (CH3)2CHCH2 C2H5
    361 (CH3)3CCH2 C2H5
    362 (CH3)3C(CH3)CH C2H5
    363 CH3CH2(CH3)2C C2H5
    364 CH3CH2(CF3)CH C2H5
    365 (S)-CH3CH2(CF3)CH C2H5
    366 (R)-CH3CH2(CF3)CH C2H5
    367 CH3CH2(CH3CH2)CH C2H5
    368 (CH3)2CH(CH3CH2)CH C2H5
    369 (CH3)2CH(CH3)CH C2H5
    370 (CH3)2CH(CF3)CH C2H5
    371 (S)-(CH3)2CH(CF3)CH C2H5
    372 (R)-(CH3)2CH(CF3)CH C2H5
    373 HC═C(CH3)CH2 C2H5
    374 CH2═CH(CH3CH2)CH C2H5
    375 CH3CH2CH2(CH3)CH C2H5
    376 CH3CH2CH2(CF3)CH C2H5
    377 (S)-CH3CH2CH2(CF3)CH C2H5
    378 (R)-CH3CH2CH2(CF3)CH C2H5
    379 CH3CH2CH2(CH3)2C C2H5
    380 CH3CH2(CH3)CHCH2 C2H5
    381 (CH3)2CHCH2CH2 C2H5
    382 (CH3)3CCH2CH2 C2H5
    383 CH3CH2(CH3)CH(CH3)—CH C2H5
    384 CH3CH2(CH3)CH(CF3)—CH C2H5
    385 (S)-CH3CH2(CH3)CH—(CF3)CH C2H5
    386 (R)-CH3CH2(CH3)CH—(CF3)CH C2H5
    387 CH3(CH3)CHCH2(CH3)—CH C2H5
    388 CH3(CH3)CHCH2(CF3)—CH C2H5
    389 (S)-CH3(CH3)CHCH2-(CF3)CH C2H5
    390 (R)-CH3(CH3)CHCH2-(CF3)CH C2H5
    391 (CH3)2CH(CH3)CH—(CH3)CH2 C2H5
    392 (CH3)3CCH2(CH3)CH C2H5
    393 E-CH3CH═CH(CH3)CH C2H5
    394 E-C H3CH═CH—(CH3CH2)CH C2H5
    395 CH3CH2CH2(CH3CH2)—CH C2H5
    396 CH3CH2(CH3CH2)CH—CH2 C2H5
    397 CF2═CFCH2CH2 C2H5
    398 CF3CH2(CH3)CHCH2 C2H5
    399 CF3CF2CH2CH2 C2H5
    400 CF3CF2CF2CH2 C2H5
    401 CF2═C(CH3)CH2CH2 C2H5
    402 CH3CH2CH2CH2CH2 C2H5
    403 CH3CH2CH2CH2(CH3)—CH C2H5
    404 CH3CH2CH2(CH3)CH—CH2 C2H5
    405 CH3CH2(CH3)CHCH2—CH2 C2H5
    406 CH3CH2CH2(CH3)CH—(CH3)CH C2H5
    407 CH3CH2(CH3)CHCH2—(CH3)CH C2H5
    408 HOCH2CH2 C2H5
    409 CH3OCH2CH2 C2H5
    410 CH3OCH2(CH3)CH C2H5
    411 CH3OCH2(CF3)CH C2H5
    412 CH3OCH2(CH3)2C C2H5
    413 CH3O(CH3)CHCH2 C2H5
    414 CH3O(CH3)CH(CH3)CH C2H5
    415 HC≡CCH2 C2H5
    416 CH3C≡CCH2 C2H5
    417 HC≡CCH2CH2 C2H5
    418 HOCH2CH2CH2 C2H5
    419 CH3OCH2CH2CH2 C2H5
    420 (CH3)3SiCH2 C2H5
    421 C6H5CH2 C2H5
    422 C6H5(CH3)CH C2H5
    423 4-F—C6H4CH2 C2H5
    424 4-Cl—C6H4CH2 C2H5
    425 4-F—C6H5(CH3)CH C2H5
    426 4-Cl—C6H5(CH3)CH C2H5
    427 C6H5CH2CH2 C2H5
    428 4-F—C6H5CH2CH2 C2H5
    429 1-piperidino C2H5
    430 1-pyrrolidino C2H5
    431 cyclo-C5H9CH2 C2H5
    432 Bicyclo[2.2.1]hept-2-yl C2H5
    433 1-CH3-cyclopropyl C2H5
    434 cis-2-CH3-cyclopropyl C2H5
    435 trans-2-CH3-cyclopropyl C2H5
    436 2,2-(CH3)2-cyclopropyl C2H5
    437 1-CH3-cyclobutyl C2H5
    438 cis-2-CH3-cyclobutyl C2H5
    439 trans-2-CH3-cyclobutyl C2H5
    440 cis-3-CH3-cyclobutyl C2H5
    441 trans-3-CH3-cyclobutyl C2H5
    442 2,2-(CH3)2-cyclobutyl C2H5
    443 3,3-(CH3)2-cyclobutyl C2H5
    444 1-CH3-cyclopentyl C2H5
    445 cis-2-CH3-cyclopentyl C2H5
    446 trans-2-CH3-cyclopentyl C2H5
    447 cis-3-CH3-cyclopentyl C2H5
    448 trans-3-CH3-cyclopentyl C2H5
    449 2,2-(CH3)2-cyclopentyl C2H5
    450 3,3-(CH3)2-cyclopentyl C2H5
    451 1-CH3-cyclohexyl C2H5
    452 cis-2-CH3-cyclohexyl C2H5
    453 trans-2-CH3-cyclohexyl C2H5
    454 cis-3-CH3-cyclohexyl C2H5
    355 trans-3-CH3-cyclohexyl C2H5
    456 2,2-(CH3)2-cyclohexyl C2H5
    457 3,3-(CH3)2-cyclohexyl C2H5
    458 cis-4-CH3-cyclohexyl C2H5
    459 trans-4-CH3-cyclohexyl C2H5
    460 4,4-(CH3)2-cyclohexyl C2H5
    461 4-(CH3)3C-cyclohexyl C2H5
    462 n-C3H7 CF3CH2
    463 i-C3H7 CF3CH2
    464 n-C4H9 CF3CH2
    465 t-C4H9 CF3CH2
    466 CH2═CHCH2 CF3CH2
    467 CH2═C(CH3)CH2 CF3CH2
    468 CF3CH2 CF3CH2
    469 CF3CH2CH2 CF3CH2
    470 CF3CH2CH2CH2 CF3CH2
    471 CF3(CH3)CH CF3CH2
    472 (S)-CF3(CH3)CH CF3CH2
    473 (R)-CF3(CH3)CH CF3CH2
    474 cyclo-C3H5 CF3CH2
    475 cyclo-C4H7 CF3CH2
    476 cyclo-C5H9 CF3CH2
    477 cyclo-C6H11 CF3CH2
    478 cyclo-C3H5CH2 CF3CH2
    479 cyclo-C4H7CH2 CF3CH2
    480 cyclo-C6H11CH2 CF3CH2
    481 CH3CH2(CH3)CH CF3CH2
    482 (S)-CH3CH2(CH3)CH CF3CH2
    483 (R)-CH3CH2(CH3)CH CF3CH2
    484 cyclo-C7H13 CF3CH2
    485 CH2═C(CH3)CH2 CF3CH2
    486 CF3CH2 CF3CH2
    487 4-t-C4H9—C6H4NH CF3CH2
    488 4-F—C6H4NH CF3CH2
    489 C6H5NH CF3CH2
    490 4-CH3—C6H4NH CF3CH2
    491 4-Br—C6H4NH CF3CH2
    492 2-F—C6H4NH CF3CH2
    493 3,4-Cl2—C6H3NH CF3CH2
    494 3-CF3—C6H4NH CF3CH2
    495 3,5-Cl2—C6H3NH CF3CH2
    496 4-CF3O—C6H5NH CF3CH2
    497 2-CF3—C6H4NH CF3CH2
    498 4-CF3—C6H4NH CF3CH2
    499 2-Br—C6H4NH CF3CH2
    500 2-Cl—C6H4NH CF3CH2
    501 2-CH3-4-Cl—C6H3NH CF3CH2
    502 2-CH3-5-F—C6H3NH CF3CH2
    503 3-Cl—C6H4NH CF3CH2
    504 (CH3)2CHCH2 CF3CH2
    505 (CH3)3CCH2 CF3CH2
    506 (CH3)3C(CH3)CH CF3CH2
    507 CH3CH2(CH3)2C CF3CH2
    508 CH3CH2(CF3)CH CF3CH2
    509 (S)-CH3CH2(CF3)CH CF3CH2
    510 (R)-CH3CH2(CF3)CH CF3CH2
    511 CH3CH2(CH3CH2)CH CF3CH2
    512 (CH3)2CH(CH3CH2)CH CF3CH2
    513 (CH3)2CH(CH3)CH CF3CH2
    514 (CH3)2CH(CF3)CH CF3CH2
    515 (S)-(CH3)2CH(CF3)CH CF3CH2
    516 (R)-(CH3)2CH(CF3)CH CF3CH2
    517 HC═C(CH3)CH2 CF3CH2
    518 CH2═CH(CH3CH2)CH CF3CH2
    520 CH3CH2CH2(CH3)CH CF3CH2
    521 CH3CH2CH2(CF3)CH CF3CH2
    522 (S)-CH3CH2CH2(CF3)CH CF3CH2
    523 (R)-CH3CH2CH2(CF3)CH CF3CH2
    524 CH3CH2CH2(CH3)2C CF3CH2
    525 CH3CH2(CH3)CHCH2 CF3CH2
    526 (CH3)2CHCH2CH2 CF3CH2
    527 (CH3)3CCH2CH2 CF3CH2
    528 CH3CH2(CH3)CH(CH3)—CH CF3CH2
    529 CH3CH2(CH3)CH(CF3)—CH CF3CH2
    530 (S)-CH3CH2(CH3)CH—(CF3)CH CF3CH2
    531 (R)-CH3CH2(CH3)CH—(CF3)CH CF3CH2
    532 CH3(CH3)CHCH2(CH3)—CH CF3CH2
    533 CH3(CH3)CHCH2(CF3)—CH CF3CH2
    534 (S)-CH3(CH3)CHCH2(CF3)CH CF3CH2
    535 (R)-CH3(CH3)CHCH2—(CF3)CH CF3CH2
    536 (CH3)2CH(CH3)CH—(CH3)CH2 CF3CH2
    537 (CH3)3CCH2(CH3)CH CF3CH2
    538 E-CH3CH═CH(CH3)CH CF3CH2
    539 E-CH3CH═CH(CH3CH2)—CH CF3CH2
    540 CH3CH2CH2(CH3CH2)—CH CF3CH2
    541 CH3CH2(CH3CH2)CH—CH2 CF3CH2
    542 CF2═CFCH2CH2 CF3CH2
    543 CF3CH2(CH3)CHCH2 CF3CH2
    544 CF3CF2CH2CH2 CF3CH2
    545 CF3CF2CF2CH2 CF3CH2
    546 CF2═C(CH3)CH2CH2 CF3CH2
    547 CH3CH2CH2CH2CH2 CF3CH2
    548 CH3CH2CH2CH2(CH3)—CH CF3CH2
    549 CH3CH2CH2(CH3)CH—CH2 CF3CH2
    550 CH3CH2(CH3)CHCH2—CH2 CF3CH2
    551 CH3CH2CH2(CH3)CH—(CH3)CH CF3CH2
    552 CH3CH2(CH3)CHCH2—(CH3)CH CF3CH2
    553 HOCH2CH2 CF3CH2
    554 CH3OCH2CH2 CF3CH2
    555 CH3OCH2(CH3)CH CF3CH2
    556 CH3OCH2(CF3)CH CF3CH2
    557 CH3OCH2(CH3)2C CF3CH2
    558 CH3O(CH3)CHCH2 CF3CH2
    559 CH3O(CH3)CH(CH3)CH CF3CH2
    560 HC≡CCH2 CF3CH2
    561 CH3C≡CCH2 CF3CH2
    562 HC≡CCH2CH2 CF3CH2
    563 HOCH2CH2CH2 CF3CH2
    564 CH3OCH2CH2CH2 CF3CH2
    565 (CH3)3SiCH2 CF3CH2
    566 C6H5CH2 CF3CH2
    567 C6H5(CH3)CH CF3CH2
    568 4-F—C6H4CH2 CF3CH2
    569 4-Cl—C6H4CH2 CF3CH2
    570 4-F—C6H5(CH3)CH CF3CH2
    571 4-Cl—C6H5(CH3)CH CF3CH2
    572 C6H5CH2CH2 CF3CH2
    573 4-F—C6H5CH2CH2 CF3CH2
    574 1-piperidino CF3CH2
    575 1-pyrrolidino CF3CH2
    576 cyclo-C5H9CH2 CF3CH2
    577 bicyclo[2.2.1]hept-2-yl CF3CH2
    578 1-CH3-cyclopropyl CF3CH2
    579 cis-2-CH3-cyclopropyl CF3CH2
    580 trans-2-CH3-cyclopropyl CF3CH2
    581 2,2-(CH3)2-cyclopropyl CF3CH2
    582 1-CH3-cyclobutyl CF3CH2
    583 cis-2-CH3-cyclobutyl CF3CH2
    584 trans-2-CH3-cyclobutyl CF3CH2
    585 cis-3-CH3-cyclobutyl CF3CH2
    586 trans-3-CH3-cyclobutyl CF3CH2
    587 2,2-(CH3)2-cyclobutyl CF3CH2
    588 3,3-(CH3)2-cyclobutyl CF3CH2
    589 1-CH3-cyclopentyl CF3CH2
    590 cis-2-CH3-cyclopentyl CF3CH2
    591 trans-2-CH3-cyclopentyl CF3CH2
    592 cis-3-CH3-cyclopentyl CF3CH2
    593 trans-3-CH3-cyclopentyl CF3CH2
    594 2,2-(CH3)2-cyclopentyl CF3CH2
    595 3,3-(CH3)2-cyclopentyl CF3CH2
    596 1-CH3-cyclohexyl CF3CH2
    597 cis-2-CH3-cyclohexyl CF3CH2
    598 trans-2-CH3-cyclohexyl CF3CH2
    599 cis-3-CH3-cyclohexyl CF3CH2
    600 trans-3-CH3-cyclohexyl CF3CH2
    601 2,2-(CH3)2-cyclohexyl CF3CH2
    602 3,3-(CH3)2-cyclohexyl CF3CH2
    603 cis-4-CH3-cyclohexyl CF3CH2
    604 trans-4-CH3-cyclohexyl CF3CH2
    605 4,4-(CH3)2-cyclohexyl CF3CH2
    606 4-(CH3)3C-cyclohexyl CF3CH2
    607 cis-1-CH3-2-fluoro-cyclopropyl H
    608 trans-1-CH3-2-fluoro-cyclopropyl H
    609 1-CH3-2,2-difluoro-cyclopropyl H
    610 cis-1-CH3-2-chloro-2-fluorocyclopropyl H
    611 trans-1-CH3-2-chloro-2-fluorocyclopropyl H
    612 CH3CO(CH3)CH H
    613 CH3CH2CO(CH3)CH H
    614 (CH3)2CHCO(CH3)CH H
    615 (CH3)3CCO(CH3)CH H
    616 CH3CH2CH2CO(CH3)CH H
    617 CH3CO(CF3)CH H
    618 CH3CH2CO(CF3)CH H
    619 CH3CO(CH3)2C H
    620 CH3CH2CO(CH3)2C H
    621 cis-1-CH3-2-fluoro-cyclopropyl CH3
    622 trans-1-CH3-2-fluoro-cyclopropyl CH3
    623 1-CH3-2,2-difluoro-cyclopropyl CH3
    624 cis-1-CH3-2-chloro-2-fluorocyclopropyl CH3
    625 trans-1-CH3-2-chloro-2-fluorocyclopropyl CH3
    626 CH3CO(CH3)CH CH3
    627 CH3CH2CO(CH3)CH CH3
    628 (CH3)2CHCO(CH3)CH CH3
    629 (CH3)3CCO(CH3)CH CH3
    630 CH3CH2CH2CO(CH3)CH CH3
    631 CH3CO(CF3)CH CH3
    632 CH3CH2CO(CF3)CH CH3
    633 CH3CO(CH3)2C CH3
    634 CH3CH2CO(CH3)2C CH3
    635 cis-1-CH3-2-fluoro-cyclopropyl C2H5
    636 trans-1-CH3-2-fluoro-cyclopropyl C2H5
    637 1-CH3-2,2-difluoro-cyclopropyl C2H5
    638 cis-1-CH3-2-chloro-2-fluorocyclopropyl C2H5
    639 trans-1-CH3-2-chloro-2-fluorocyclopropyl C2H5
    640 CH3CO(CH3)CH C2H5
    641 CH3CH2CO(CH3)CH C2H5
    642 (CH3)2CHCO(CH3)CH C2H5
    643 (CH3)3CCO(CH3)CH C2H5
    644 CH3CH2CH2CO(CH3)CH C2H5
    645 CH3CO(CF3)CH C2H5
    646 CH3CH2CO(CF3)CH C2H5
    647 CH3CO(CH3)2C C2H5
    648 CH3CH2CO(CH3)2C C2H5
    649 cis-1-CH3-2-fluoro-cyclopropyl CF3CH2
    650 trans-1-CH3-2-fluoro-cyclopropyl CF3CH2
    651 1-CH3-2,2-difluoro-cyclopropyl CF3CH2
    652 cis-1-CH3-2-chloro-2-fluorocyclopropyl CF3CH2
    653 trans-1-CH3-2-chloro-2-fluorocyclopropyl CF3CH2
    654 CH3CO(CH3)CH CF3CH2
    655 CH3CH2CO(CH3)CH CF3CH2
    656 (CH3)2CHCO(CH3)CH CF3CH2
    657 (CH3)3CCO(CH3)CH CF3CH2
    658 CH3CH2CH2CO(CH3)CH CF3CH2
    659 CH3CO(CF3)CH CF3CH2
    660 CH3CH2CO(CF3)CH CF3CH2
    661 CH3CO(CH3)2C CF3CH2
    662 CH3CH2CO(CH3)2C CF3CH2
  • Table 2
  • Table 2 consists of 662 compounds of the general formula (1A), where W and Z are N, X and Y are CH, R is Cl, R1 is 2,5,6-trifluorophenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 2 is the same as compound 1 of Table 1 except that in compound 1 of Table 2, R1 is 2,5,6-trifluorophenyl. Similarly, compounds 2 to 662 of Table 2 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 2, R1 is 2,5,6-trifluorophenyl.
  • Table 3
  • Table 3 consists of 662 compounds of the general formula (1A), where W and Z are N, X and Y are CH, R is Cl, R1 is 2,3,4,5,6-pentafluorophenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 3 is the same as compound 1 of Table 1 except that in compound 1 of Table 3, R1 is 2,3,4,5,6-pentafluorophenyl. Similarly, compounds 2 to 662 of Table 3 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 3, R1 is 2,3,4,5,6-pentafluorophenyl.
  • Table 4
  • Table 4 consists of 662 compounds of the general formula (1A), where W and Z are N, X and Y are CH, R is Cl, R1 is 2,6-difluoro-4-methoxyphenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 4 is the same as compound 1 of Table 1 except that in compound 1 of Table 4, R1 is 2,6-difluoro-4-methoxyphenyl. Similarly, compounds 2 to 662 of Table 4 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 4, R1 is 2,6-difluoro-4-methoxyphenyl.
  • Table 5
  • Table 5 consists of 662 compounds of the general formula (1A), where W and Z are N, X and Y are CH, R is Cl, R1 is 2-fluoro-6-chlorophenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 5 is the same as compound 1 of Table 1 except that in compound 1 of Table 5, R1 is 2-fluoro-6-chlorophenyl. Similarly, compounds 2 to 662 of Table 5 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 5, R1 is 2-fluoro-6-chlorophenyl.
  • Table 11
  • Table 11 consists of 662 compounds of the general formula (1A), where W and X are N and Y and Z are CH, R is Cl, R1 is 2,4,6-trifluorophenyl, and the values of R3 and K4 are as listed in Table 1. Thus, compound 1 of Table 11 is the same as compound 1 of Table 1 except that in compound 1 of Table 11, the compound has the general formula (1A) where W and X are N and Y and Z are CH. Similarly, compounds 2 to 662 of Table 11 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 11, the compounds have the general formula (1A) where W and X are N and Y and Z are CH.
  • Table 12
  • Table 12 consists of 662 compounds of the general formula (1A), where W and X are N and Y and Z are CH, R is Cl, R1 is 2,5,6-trifluorophenyl, and the values of R3 and K4 are as listed in Table 1. Thus, compound 1 of Table 12 is the same as compound 1 of Table 2 except that in compound 1 of Table 12, the compound has the general formula (1A) where W and X are N and Y and Z are CH. Similarly, compounds 2 to 662 of Table 12 are the same as compounds 2 to 662 of Table 2 except that in the compounds of Table 12, the compounds have the general formula (1A) where W and X are N and Y and Z are CH.
  • Table 13
  • Table 13 consists of 662 compounds of the general formula (1A), where W and X are N and Y and Z are CH, R is Cl, R1 is 2,3,4,5,6-pentafluorophenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 13 is the same as compound 1 of Table 3 except that in compound 1 of Table 13, the compound has the general formula (1A) where W and X are N and Y and Z are CH. Similarly, compounds 2 to 662 of Table 13 are the same as compounds 2 to 662 of Table 3 except that in the compounds of Table 13, the compounds have the general formula (1A) where W and X are N and Y and Z are CH.
  • Table 14
  • Table 14 consists of 662 compounds of the general formula (1A), where W and X are N and Y and Z are CH, R is Cl, R1 is 2,6-difluoro-4-methoxyphenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 14 is the same as compound 1 of Table 4 except that in compound 1 of Table 14, the compound has the general formula (1A) where W and X are N and Y and Z are CH. Similarly, compounds 2 to 662 of Table 14 are the same as compounds 2 to 662 of Table 4 except that in the compounds of Table 14, the compounds have the general formula (1A) where W and X are N and Y and Z are CH.
  • Table 15
  • Table 15 consists of 662 compounds of the general formula (1A), where W and X are N and Y and Z are CH, R is Cl, R1 is 2-fluoro-6-chlorophenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 15 is the same as compound 1 of Table 5 except that in compound 1 of Table 15, the compound has the general formula (1A) where W and X are N and Y and Z are CH. Similarly, compounds 2 to 662 of Table 15 are the same as compounds 2 to 662 of Table 5 except that in the compounds of Table 15, the compounds have the general formula (1A) where W and X are N and Y and Z are CH.
  • Table 21
  • Table 21 consists of 662 compounds of the general formula (1A), where W and Z are CH and X and Y are N, R is Cl, R1 is 2,4,6-trifluorophenyl, and the values of R3 and K4 are as listed in Table 1. Thus, compound 1 of Table 21 is the same as compound 1 of Table 1 except that in compound 1 of Table 21, the compound has the general formula (1A) where W and Z are CH and X and Y are N. Similarly, compounds 2 to 662 of Table 21 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 21, the compounds have the general formula (1A) where W and Z are CH and X and Y are N.
  • Table 22
  • Table 22 consists of 662 compounds of the general formula (1A), where W and Z are CH and X and Y are N, R is Cl, R1 is 2,5,6-trifluorophenyl, and the values of R3 and K4 are as listed in Table 1. Thus, compound 1 of Table 22 is the same as compound 1 of Table 2 except that in compound 1 of Table 22, the compound has the general formula (1A) where W and Z are CH and X and Y are N. Similarly, compounds 2 to 662 of Table 22 are the same as compounds 2 to 662 of Table 2 except that in the compounds of Table 22, the compounds have the general formula (1A) where W and Z are CH and X and Y are N.
  • Table 23
  • Table 23 consists of 662 compounds of the general formula (1A), where W and Z are CH and X and Y are N, R is Cl, R1 is 2,3,4,5,6-pentafluorophenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 23 is the same as compound 1 of Table 3 except that in compound 1 of Table 23, the compound has the general formula (1A) where W and Z are CH and X and Y are N. Similarly, compounds 2 to 662 of Table 23 are the same as compounds 2 to 662 of Table 3 except that in the compounds of Table 23, the compounds have the general formula (1A) where W and Z are CH and X and Y are N.
  • Table 24
  • Table 24 consists of 662 compounds of the general formula (1A), where W and Z are CH and X and Y are N, R is Cl, R1 is 2,6-difluoro-4-methoxyphenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 24 is the same as compound 1 of Table 4 except that in compound 1 of Table 24, the compound has the general formula (1A) where W and Z are CH and X and Y are N. Similarly, compounds 2 to 662 of Table 24 are the same as compounds 2 to 662 of Table 4 except that in the compounds of Table 24, the compounds have the general formula (1A) where W and Z are CH and X and Y are N.
  • Table 25
  • Table 25 consists of 662 compounds of the general formula (1A), where W and Z are CH and X and Y are N, R is Cl, R1 is 2-fluoro-6-chlorophenyl, and the values of R3 and K4 are as listed in Table 1. Thus, compound 1 of Table 25 is the same as compound 1 of Table 5 except that in compound 1 of Table 25, the compound has the general formula (1A) where W and Z are CH and X and Y are N. Similarly, compounds 2 to 662 of Table 25 are the same as compounds 2 to 662 of Table 5 except that in the compounds of Table 25, the compounds have the general formula (1A) where W and Z are CH and X and Y are N.
  • Table 26
  • Table 26 consists of 662 compounds of the general formula (1A), where W and X are CH and Y and Z are N, R is Cl, R1 is 2,4,6-trifluorophenyl, and the values of R3 and K4 are as listed in Table 1. Thus, compound 1 of Table 26 is the same as compound 1 of Table 1 except that in compound 1 of Table 26, the compound has the general formula (1A) where W and X are CH and Y and Z are N. Similarly, compounds 2 to 662 of Table 26 are the same as compounds 2 to 662 of Table 1 except that in the compounds of Table 26, the compounds have the general formula (1A) where W and X are CH and Y and Z are N.
  • Table 27
  • Table 27 consists of 662 compounds of the general formula (1A), where W and X are CH and Y and Z are N, R is Cl, R1 is 2,5,6-trifluorophenyl, and the values of R3 and K4 are as listed in Table 1. Thus, compound 1 of Table 27 is the same as compound 1 of Table 2 except that in compound 1 of Table 27, the compound has the general formula (1A) where W and X are CH and Y and Z are N. Similarly, compounds 2 to 662 of Table 27 are the same as compounds 2 to 662 of Table 2 except that in the compounds of Table 27, the compounds have the general formula (1A) where W and X are CH and Y and Z are N.
  • Table 28
  • Table 28 consists of 662 compounds of the general formula (1A), where W and X are CH and Y and Z are N, R is Cl, R1 is 2,3,4,5,6-pentafluorophenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 28 is the same as compound 1 of Table 3 except that in compound 1 of Table 28, the compound has the general formula (1A) where W and X are CH and Y and Z are N. Similarly, compounds 2 to 662 of Table 28 are the same as compounds 2 to 662 of Table 3 except that in the compounds of Table 28, the compounds have the general formula (1A) where W and X are CH and Y and Z are N.
  • Table 29
  • Table 29 consists of 662 compounds of the general formula (1A), where W and X are CH and Y and Z are N, R is Cl, R1 is 2,6-difluoro-4-methoxyphenyl, and the values of R3 and R4 are as listed in Table 1. Thus, compound 1 of Table 29 is the same as compound 1 of Table 4 except that in compound 1 of Table 29, the compound has the general formula (1A) where W and X are CH and Y and Z are N. Similarly, compounds 2 to 662 of Table 29 are the same as compounds 2 to 662 of Table 4 except that in the compounds of Table 29, the compounds have the general formula (1A) where W and X are CH and Y and Z are N.
  • Table 30
  • Table 30 consists of 662 compounds of the general formula (1A), where W and X are CH and Y and Z are N, R is Cl, R1 is 2-fluoro-6-chlorophenyl, and the values of R3 and K4 are as listed in Table 1. Thus, compound 1 of Table 30 is the same as compound 1 of Table 5 except that in compound 1 of Table 30, the compound has the general formula (1A) where W and X are CH and Y and Z are N. Similarly, compounds 2 to 662 of Table 30 are the same as compounds 2 to 662 of Table 5 except that in the compounds of Table 30, the compounds have the general formula (1A) where W and X are CH and Y and Z are N.
  • Table 31
  • Table 31 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 31 R1 is 2,6-difluorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 32
  • Table 32 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 32 R1 is 2-fluorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 33
  • Table 33 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 33 R1 is 2,3,5,6-tetrafluorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 34
  • Table 34 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 34 R1 is 2-chloro-4,6-difluorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 35
  • Table 35 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 35 R1 is 2-chlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 36
  • Table 36 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 36 R1 is 2,6-dichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 37
  • Table 37 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 37 R1 is 2,4-dichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 38
  • Table 38 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 38 R1 is 2,4,6-trichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 39
  • Table 39 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 39 R1 is 2,3,6-trichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 40
  • Table 40 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 40 R1 is pentachlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 41
  • Table 41 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 41 R1 is 2-fluoro-4,6-dichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 42
  • Table 42 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 42 R1 is 4-fluoro-2,6-dichlorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 43
  • Table 43 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 43 R1 is 2-bromophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 44
  • Table 44 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 44 R1 is 2-fluoro-6-bromophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 45
  • Table 45 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 45 R1 is 2-bromo-4,6-difluorophenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 46
  • Table 46 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 46 R1 is 2-fluoro-6-methylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 47
  • Table 47 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 47 R1 is 2-chloro-6-methylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 48
  • Table 48 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 48 R1 is 2-methoxyphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 49
  • Table 49 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 49 R1 is 2,6-dimethoxyphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 50
  • Table 50 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 50 R1 is 2-fluoro-6-methoxyphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 51
  • Table 51 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 51 R1 is 2-trifluoromethylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 52
  • Table 52 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 52 R1 is 2-fluoro-6-trifluoromethylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 53
  • Table 53 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 53 R1 is 2,6-di-(trifluoromethyl)phenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 54
  • Table 54 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 54 R1 is 2-chloro-6-trifluoromethylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 55
  • Table 55 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 55 R1 is 2,4-difluoro-6-trifluoromethylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 56
  • Table 56 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 56 R1 is 2,4-difluoro-6-methoxyphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 57
  • Table 57 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 57 R1 is 2,4-difluoro-6-methylphenyl instead of 2-fluoro-6-chlorophenyl.
  • Table 58
  • Table 58 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 58 R1 is 2,4-difluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 59
  • Table 59 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 59 R1 is 3,5-difluoropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 60
  • Table 60 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 60 R1 is tetrafluoropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 61
  • Table 61 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 61 R1 is 3-fluoropyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 62
  • Table 62 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 62 R1 is 4-fluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 63
  • Table 63 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 63 R1 is 3-fluoropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 64
  • Table 64 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 64 R1 is 2-fluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 65
  • Table 65 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 65 R1 is 2,4,6-trifluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 66
  • Table 66 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 66 R1 is 3,5-difluoropyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 67
  • Table 67 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 67 R1 is 2,6-difluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 68
  • Table 68 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 68 R1 is 2,4-difluoro-6-methoxypyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 69
  • Table 69 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 69 R1 is 2-fluoro-4-chloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 70
  • Table 70 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 70 R1 is 3-fluoro-5-chloropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 71
  • Table 71 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 71 R1 is 2-chloro-4-fluoropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 72
  • Table 72 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 72 R1 is 2,4-dichloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 73
  • Table 73 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 73 R1 is 3-chloropyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 74
  • Table 74 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 74 R1 is 4-chloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 75
  • Table 75 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 75 R1 is 3-chloropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 76
  • Table 76 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 76 R1 is 2-chloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 77
  • Table 77 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 77 R1 is 3-trifluoromethylpyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 78
  • Table 78 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 78 R1 is 4-trifluoromethylpyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 79
  • Table 79 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 79 R1 is 3,5-dichloropyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 80
  • Table 80 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 80 R1 is 4,6-dichloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 81
  • Table 81 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 81 R1 is 3-trifluoromethylpyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 82
  • Table 82 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 82 R1 is 2-trifluoromethylpyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 83
  • Table 83 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 83 R1 is 2-fluoro-4-trifluoromethylpyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 84
  • Table 84 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 84 R1 is 3-fluoro-5-trifluoromethylpyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 85
  • Table 85 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 85 R1 is 4-fluoro-2-trifluoromethylpyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 86
  • Table 86 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 86 R1 is 2,6-dichloropyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 87
  • Table 87 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 87 R1 is 3,5-dichloropyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 88
  • Table 88 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 88 R1 is 3-chloro-6-trifluoromethylpyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 89
  • Table 89 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 89 R1 is 3-fluoro-6-trifluoromethylpyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 90
  • Table 90 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 90 R1 is pyrid-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 91
  • Table 91 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 91 R1 is pyrid-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 92
  • Table 92 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 92 R1 is pyrid-4-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 93
  • Table 93 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 93 R1 is 3-fluorothien-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 94
  • Table 94 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 94 R1 is 3-chlorothien-2-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 95
  • Table 95 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 95 R1 is 2,4-difluorothien-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 96
  • Table 96 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 96 R1 is 2,4-dichlorothien-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 97
  • Table 97 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table R1 is 2,4,5-trichlorothien-3-yl instead of 2-fluoro-6-chlorophenyl.
  • Table 98
  • Table 98 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 98 R1 is piperidino instead of 2-fluoro-6-chlorophenyl.
  • Table 99
  • Table 99 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 99 R1 is 2-methylpiperidino instead of 2-fluoro-6-chlorophenyl.
  • Table 100
  • Table 100 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 100 R1 is 2,6-dimethylpiperidino instead of 2-fluoro-6-chlorophenyl.
  • Table 101
  • Table 101 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 101 R1 is morpholino instead of 2-fluoro-6-chlorophenyl.
  • Table 102
  • Table 102 consists of 2648 compounds. Compounds 1 to 662 are exactly the same as compounds 1 to 662 of Table 5 respectively, compounds 1325 to 1986 are exactly the same as compounds 1 to 662 of Table 15 respectively, compounds 2649 to 3310 are exactly the same as compounds 1 to 662 of Table 25 respectively, and compounds 3311 to 3972 are exactly the same as compounds 1 to 662 of Table 30 respectively, except that in all of the compounds of Table 102 R1 is 2,6-dimethylmorpholino instead of 2-fluoro-6-chlorophenyl.
  • Table 103
  • Table 103 consists of 201, 248 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 102 (thus, for example, compound 1 of Table 103 is the same as compound 1 of Table 1, compound 663 of Table 103 is the same as compound 1 of Table 2, compound 19,861 of Table 103 is the same as compound 1 of Table 31, compound 305,844 of Table 103 is the same as compound 3,972 of Table 102) except that in all of the compounds of Table 103 R is F instead of Cl.
  • Table 104
  • Table 104 consists of 201,248 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 102 (thus, for example, compound 1 of Table 104 is the same as compound 1 of Table 1, compound 663 of Table 104 is the same as compound 1 of Table 2, compound 19,861 of Table 104 is the same as compound 1 of Table 31, compound 305,844 of Table 104 is the same as compound 3,972 of Table 102) except that in all of the compounds of Table 104 R is Br instead of Cl.
  • Table 109
  • Table 109 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 109 is the same as compound 1 of Table 1, compound 663 of Table 109 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 109 X is CF instead of CH.
  • Table 110
  • Table 110 consists of 3310c compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 110 is the same as compound 1 of Table 1, compound 663 of Table 110 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 110 X is CCl instead of CH.
  • Table 111
  • Table 111 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 111 is the same as compound 1 of Table 1, compound 663 of Table 111 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 111 X is CBr instead of CH.
  • Table 112
  • Table 112 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 112 is the same as compound 1 of Table 1, compound 663 of Table 112 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 112 X is CCH3 instead of CH.
  • Table 113
  • Table 113 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 113 is the same as compound 1 of Table 1, compound 663 of Table 113 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 113 Y is CF instead of CH.
  • Table 114
  • Table 114 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 114 is the same as compound 1 of Table 1, compound 663 of Table 114 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 114 Y is CCl instead of CH.
  • Table 115
  • Table 115 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 115 is the same as compound 1 of Table 1, compound 663 of Table 115 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 115 Y is CBr instead of CH.
  • Table 116
  • Table 116 consists of 3310 compounds. Each of these compounds is exactly the same as the corresponding compound in Tables 1 to 5 (thus, for example, compound 1 of Table 116 is the same as compound 1 of Table 1, compound 663 of Table 116 is the same as compound 1 of Table 2, etc.) except that in all of the compounds of Table 116 Y is CCH3 instead of CH.
  • Compounds of formula (7) or (8), which are examples of compounds of general formula (1) where one of R and R2 is NR3R4, can be made as shown in Scheme 1, in which W, X, Y, Z, R1, R3 and R4 have the meanings given above and R7 is C1-4 alkyl.
  • Figure US20090069333A1-20090312-C00004
  • Compounds of general formula (4) can be prepared from compounds of general formula (2), which are either commercially available or made by methods known in the literature, by reaction with acids of general formula (3), using standard coupling methods, for example by conversion to the acid chloride using a chlorinating agent such as thionyl chloride, followed by reaction of the resultant acid chloride optionally in the presence of a base such as triethylamine, in a suitable solvent such as dichloromethane or toluene. Compounds of general formula (5) can be prepared by treating compounds of general formula (4) with a base such as sodium hydride, optionally in the presence of a Lewis acid such as magnesium oxide, in a suitable solvent such as N,N-dimethylformamide (DMF) or toluene, at between room temperature and 150° C., but preferably at 60-90° C. Compounds of general formula (6) can be prepared by reaction of compounds of general formula (5) with a chlorination reagent such as phosphorus oxychloride, either neat or in a suitable solvent such as toluene, at between 50 and 150° C., but preferably between 80 and 110° C., or in a microwave reactor at between 150 and 300° C., but preferably between 200 and 250° C. Compounds of formula (7) and (8) can be prepared by reaction of compounds of general formula (6) with an amine R3R4NH, either neat, or in a suitable solvent such as DMF, between room temperature and 150° C., but preferably between 50 and 80° C. If compounds (7) and (8) are produced as a mixture they can be separated by suitable means such as crystallisation or chromatography under normal or reverse phase conditions.
  • Compounds of the general formulae (5), (6), (7) and (8) may be derivatised, via the chloro or hydroxy substituents, using routine chemical techniques to form other compounds of the general formula (1). Alternatively, other compounds of the general formula (1) may be prepared using a similar methodology to that described for preparing the compounds (5) to (8) and employing preparative techniques known from the chemical literature.
  • Compounds of formula (7) can also be made as shown in Scheme 2.
  • Figure US20090069333A1-20090312-C00005
  • Compounds of general formula (10) can be prepared from compounds of general formula (9), which are either commercially available or made by methods known in the literature, by reaction with acids of general formula (3), using standard coupling methods, for example by conversion to the acid chloride using a chlorinating agent such as thionyl chloride, followed by reaction of the resultant acid chloride optionally in the presence of a base such as triethylamine, in a suitable solvent such as dichloromethane or toluene. Compounds of general formula (11) can be prepared by treating compounds of general formula (10) with a base such as sodium hydride, optionally in the presence of a Lewis acid such as magnesium oxide, in a suitable solvent such as N,N-dimethylformamide (DMF) or toluene, at between room temperature and 150° C., but preferably at 60-90° C. Compounds of general formula (12) can be prepared by reaction of compounds of general formula (11) with a chlorination reagent such as phosphorus oxychloride, either neat or in a suitable solvent such as toluene, at between 50 and 150° C., but preferably between 80 and 110° C., or in a microwave reactor at between 150 and 300° C., but preferably between 200 and 250° C. Compounds of formula (7) can be prepared from compounds of formula (12) by reductive amination, for example by reaction with a ketone or aldehyde in a suitable solvent such as ethanol or toluene, at between room temperature and reflux, optionally in the presence of an acid catalyst such as para-toluenesulphonic acid or a drying agent such as molecular sieves, followed by treatment with a suitable reducing agent such as sodium borohydride, at between −20° C. and 40° C., but preferably at room temperature. The aldehyde or ketone is chosen so that the desired groups R3 and R4 are formed after reduction of the product of reaction with the amine (12). For example if compounds of formula (12) are reacted with one equivalent of propionaldehyde and then sodium borohydride, compounds of formula (7) where R3 is npropyl, and R4 is hydrogen are formed. If required, the reaction can be repeated with a different aldehyde or ketone. For example, if acetone is used for the second reaction, then compounds of formula (7) where R3 is n-propyl and R4 is iso-propyl, are formed. Alternatively compounds of formula (7) can be formed from compounds of formula (12) by alkylation with a group R3LG, by treatment with a suitable base such as sodium hydride in a solvent such as DMF, or a base such as potassium carbonate in a solvent such as acetone or DMF, at between −78° C. and 100° C., but preferably between room temperature and 60° C., followed by treatment with R4LG in a second step under the same conditions if required.
  • Figure US20090069333A1-20090312-C00006
  • Compounds of formula (13) can be prepared as shown in Scheme 3 from compounds of formula (6) by reaction with a source of fluoride ion, such as potassium fluoride, in a suitable solvent such as sulpholane, at a temperature between 50° C. and 200° C., but preferably at 80-150° C. Compounds of formula (14) and/or compounds of formula (15) can be prepared from difluoro compounds of formula (13) by reaction with an amine of formula R3R4NH in a suitable solvent such as DMF or CH2Cl2, at a temperature of 0° C.-100° C., but preferably at room temperature.
  • Figure US20090069333A1-20090312-C00007
  • Compounds of general formula (16), where Hal1 is chlorine or fluorine, can be converted into compounds of formula (17) as shown in Scheme 4. Compounds of general formula (17) where Hal2 is bromine or iodine can be formed by reacting compounds of general formula (16) with a metal halide, for example cuprous bromide, in a suitable solvent, for example DMF, at between room temperature and 155° C., but preferably between 70° C. and 155° C.
  • Further assistance in the preparation of the compounds of formula (1) may be derived from the following publications: Emilio, Toja, et. al., J. Heterocyclic Chem., 23, 1955 (1986), H. Schafer, et. al., J. f. prakt. Chemie, 321(4), 695 (1970) and H. Bredereck et. al., Chem. Ber. 96, 1868-1872 (1993).
  • The intermediate chemicals having the general formulae (4), (5), (6) and (13):
  • Figure US20090069333A1-20090312-C00008
  • wherein W, X, Y, Z, R1 and R7 are as define above, other than the compound of formula (6) wherein X and Y are N, W and Z are C—Cl and R1 is Cl, are believed to be novel compounds and form a further part of this invention.
  • It should be noted that the intermediate of general formula (5) may exist in the tautomeric forms (a), (b) and (c) as well as in the form shown in formula (5):
  • Figure US20090069333A1-20090312-C00009
  • The invention as defined by the general formula (5) embraces all such tautomers.
  • Of particular interest are the intermediates listed in Tables 128 to 132 below. In Table 128 the compounds have the general formula (4) where R7 is methyl and W, X, Y, Z and R1 have the values shown in the table.
  • TABLE 128
    Cmpd
    No. R1 W X Y Z
    1 2,4,6-trifluorophenyl N CH CH N
    2 2,5,6-trifluorophenyl N CH CH N
    3 2,3,4,5,6-pentafluorophenyl N CH CH N
    4 2,3,5,6-tetrafluorophenyl N CH CH N
    5 2,6-difluoro-4-methoxyphenyl N CH CH N
    6 2-fluoro-6-chlorophenyl N CH CH N
    7 2,6-difluorophenyl N CH CH N
    8 2,3,5,6-tetrafluorophenyl N CH CH N
    9 2-fluorophenyl N CH CH N
    10 2-chlorophenyl N CH CH N
    11 2-bromophenyl N CH CH N
    12 2,4-dichlorophenyl N CH CH N
    13 2,4,6-trifluorophenyl N N CH CH
    14 2,5,6-trifluorophenyl N N CH CH
    15 2,3,4,5,6-pentafluorophenyl N N CH CH
    16 2,3,5,6-tetrafluorophenyl N N CH CH
    17 2,6-difluoro-4-methoxyphenyl N N CH CH
    18 2-fluoro-6-chlorophenyl N N CH CH
    19 2,6-difluorophenyl N N CH CH
    20 2,3,5,6-tetrafluorophenyl N N CH CH
    21 2-fluorophenyl N N CH CH
    22 2-chlorophenyl N N CH CH
    23 2-bromophenyl N N CH CH
    24 2,4-dichlorophenyl N N CH CH
    25 2,4,6-trifluorophenyl CH N N CH
    26 2,5,6-trifluorophenyl CH N N CH
    27 2,3,4,5,6-pentafluorophenyl CH N N CH
    28 2,3,5,6-tetrafluorophenyl CH N N CH
    29 2,6-difluoro-4-methoxyphenyl CH N N CH
    30 2-fluoro-6-chlorophenyl CH N N CH
    31 2,6-difluorophenyl CH N N CH
    32 2,3,5,6-tetrafluorophenyl CH N N CH
    33 2-fluorophenyl CH N N CH
    34 2-chlorophenyl CH N N CH
    35 2-bromophenyl CH N N CH
    36 2,4-dichlorophenyl CH N N CH
    37 2,4,6-trifluorophenyl CH CH N N
    38 2,5,6-trifluorophenyl CH CH N N
    39 2,3,4,5,6-pentafluorophenyl CH CH N N
    40 2,3,5,6-tetrafluorophenyl CH CH N N
    41 2,6-difluoro-4-methoxyphenyl CH CH N N
    42 2-fluoro-6-chlorophenyl CH CH N N
    43 2,6-difluorophenyl CH CH N N
    44 2,3,5,6-tetrafluorophenyl CH CH N N
    45 2-fluorophenyl CH CH N N
    46 2-chlorophenyl CH CH N N
    47 2-bromophenyl CH CH N N
    48 2,4-dichlorophenyl CH CH N N
  • Table 129
  • Table 129 consists of 48 compounds of the general formula (5), where W, X, Y, Z and R1 have the values given in Table 128. Thus, compound 1 of Table 129 has the same W, X, Y, Z and R1 values as compound 1 of Table 128, etc.
  • Table 130
  • Table 130 consists of 48 compounds of the general formula (6), where W, X, Y, Z and R1 have the values given in Table 128. Thus, compound 1 of Table 130 has the same W, X, Y, Z and R1 values as compound 1 of Table 128, etc.
  • Table 131
  • Table 131 consists of 48 compounds of the general formula (13), where W, X, Y, Z and R1 have the values given in Table 128. Thus, compound 1 of Table 131 has the same W, X, Y, Z and R1 values as compound 1 of Table 128, etc.
  • Table 132
  • Table 132 consists of 48 compounds of the general formula (4), where W, X, Y, Z and R1 have the values given in Table 128 and R7 is ethyl. Thus, compound 1 of Table 132 is the same as compound 1 of Table 128 except that in compound 1 of Table 132, K7 is ethyl instead of methyl. Similarly, compounds 2 to 48 of Table 132 are the same as compounds 2 to 48 of Table 128 except that in the compounds of Table 132, K7 is ethyl.
  • The compounds of formula (1) are active fungicides and may be used to control one or more of the following pathogens: Pyricularia oryzae (Magnaporthe grisea) on rice and wheat and other Pyricularia spp. on other hosts; Puccinia triticina (or recondita), Puccinia striiformis and other rusts on wheat, Puccinia hordei, Puccinia striiformis and other rusts on barley, and rusts on other hosts (for example turf, rye, coffee, pears, apples, peanuts, sugar beet, vegetables and ornamental plants); Erysiphe cichoracearum on cucurbits (for example melon); Blumeria (or Erysiphe) graminis (powdery mildew) on barley, wheat, rye and turf and other powdery mildews on various hosts, such as Sphaerotheca macularis on hops, Sphaerotheca fusca (Sphaerotheca fuliginea) on cucurbits (for example cucumber), Leveillula taurica on tomatoes, aubergine and green pepper, Podosphaera leucotricha on apples and Uncinula necator on vines; Cochliobolus spp., Helminthosporium spp., Drechslera spp. (Pyrenophora spp.), Rhynchosporium spp., Mycosphaerella graminicola (Septoria tritici) and Phaeosphaeria nodorum (Stagonospora nodorum or Septoria nodorum), Pseudocercosporella herpotrichoides and Gaeumannomyces graminis on cereals (for example wheat, barley, rye), turf and other hosts; Cercospora arachidicola and Cercosporidium personatum on peanuts and other Cercospora spp. on other hosts, for example sugar beet, bananas, soya beans and rice; Botrytis cinerea (grey mould) on tomatoes, strawberries, vegetables, vines and other hosts and other Botrytis spp. on other hosts; Alternaria spp. on vegetables (for example carrots), oil-seed rape, apples, tomatoes, potatoes, cereals (for example wheat) and other hosts; Venturia spp. (including Venturia inaequalis (scab)) on apples, pears, stone fruit, tree nuts and other hosts; Cladosporium spp. on a range of hosts including cereals (for example wheat) and tomatoes; Monilinia spp. on stone fruit, tree nuts and other hosts; Didymella spp. on tomatoes, turf, wheat, cucurbits and other hosts; Phoma spp. on oil-seed rape, turf, rice, potatoes, wheat and other hosts; Aspergillus spp. and Aureobasidium spp. on wheat, lumber and other hosts; Ascochyta spp. on peas, wheat, barley and other hosts; Stemphylium spp. (Pleospora spp.) on apples, pears, onions and other hosts; summer diseases (for example bitter rot (Glomerella cingulata), black rot or frogeye leaf spot (Botryosphaeria obtusa), Brooks fruit spot (Mycosphaerella pomi), Cedar apple rust (Gymnosporangium juniperi-virginianae), sooty blotch (Gloeodes pomigena), flyspeck (Schizothyrium pomi) and white rot (Botryosphaeria dothidea)) on apples and pears; Plasmopara viticola on vines; other downy mildews, such as Bremia lactucae on lettuce, Peronospora spp. on soybeans, tobacco, onions and other hosts, Pseudoperonospora humuli on hops and Pseudoperonospora cubensis on cucurbits; Pythium spp. (including Pythium ultimum) on turf and other hosts; Phytophthora infestans on potatoes and tomatoes and other Phytophthora spp. on vegetables, strawberries, avocado, pepper, ornamentals, tobacco, cocoa and other hosts; Thanatephorus cucumeris on rice and turf and other Rhizoctonia spp. on various hosts such as wheat and barley, peanuts, vegetables, cotton and turf, Sclerotinia spp. on turf, peanuts, potatoes, oil-seed rape and other hosts; Sclerotium spp. on turf, peanuts and other hosts; Gibberella fujikuroi on rice; Colletotrichum spp. on a range of hosts including turf, coffee and vegetables; Laetisaria fuciformis on turf, Mycosphaerella spp. on bananas, peanuts, citrus, pecans, papaya and other hosts; Diaporthe spp. on citrus, soybean, melon, pears, lupin and other hosts; Elsinoe spp. on citrus, vines, olives, pecans, roses and other hosts; Verticillium spp. on a range of hosts including hops, potatoes and tomatoes; Pyrenopeziza spp. on oil-seed rape and other hosts; Oncobasidium theobromae on cocoa causing vascular streak dieback; Fusarium spp., Typhula spp., Microdochium nivale, Ustilago spp., Urocystis spp., Tilletia spp. and Claviceps purpurea on a variety of hosts but particularly wheat, barley, turf and maize; Ramularia spp. on sugar beet, barley and other hosts; post-harvest diseases particularly of fruit (for example Penicillium digitatum, Penicillium italicum and Trichoderma viride on oranges, Colletotrichum musae and Gloeosporium musarum on bananas and Botrytis cinerea on grapes); other pathogens on vines, notably Eutypa lata, Guignardia bidwellii, Phellinus igniarus, Phomopsis viticola, Pseudopeziza tracheiphila and Stereum hirsutum; other pathogens on trees (for example Lophodermium seditiosum) or lumber, notably Cephaloascus fragrans, Ceratocystis spp., Ophiostomapiceae, Penicillium spp., Trichoderma pseudokoningii, Trichoderma viride, Trichoderma harzianum, Aspergillus niger, Leptographium lindbergi and Aureobasidium pullulans; and fungal vectors of viral diseases (for example Polymyxa graminis on cereals as the vector of barley yellow mosaic virus (BYMV) and Polymyxa betae on sugar beet as the vector of rhizomania).
  • A compound of formula (1) may move acropetally, basipetally or locally in plant tissue to be active against one or more fungi. Moreover, a compound of formula (1) may be volatile enough to be active in the vapour phase against one or more fungi on the plant.
  • The invention therefore provides a method of combating or controlling phytopatho-genic fungi which comprises applying a fungicidally effective amount of a compound of formula (1), or a composition containing a compound of formula (1), to a plant, to a seed of a plant, to the locus of the plant or seed or to soil or any other plant growth medium, e.g. nutrient solution.
  • The term “plant” as used herein includes seedlings, bushes and trees. Furthermore, the fungicidal method of the invention includes protectant, curative, systemic, eradicant and antisporulant treatments.
  • The compounds of formula (1) are preferably used for agricultural, horticultural and turfgrass purposes in the form of a composition.
  • In order to apply a compound of formula (1) to a plant, to a seed of a plant, to the locus of the plant or seed or to soil or any other growth medium, a compound of formula (1) is usually formulated into a composition which includes, in addition to the compound of formula (1), a suitable inert diluent or carrier and, optionally, a surface active agent (SFA). SFAs are chemicals that are able to modify the properties of an interface (for example, liquid/solid, liquid/air or liquid/liquid interfaces) by lowering the interfacial tension and thereby leading to changes in other properties (for example dispersion, emulsification and wetting). It is preferred that all compositions (both solid and liquid formulations) comprise, by weight, 0.0001 to 95%, more preferably 1 to 85%, for example 5 to 60%, of a compound of formula (1). The composition is generally used for the control of fungi such that a compound of formula (1) is applied at a rate of from 0.1 g to 10 kg per hectare, preferably from 1 g to 6 kg per hectare, more preferably from 1 g to 1 kg per hectare.
  • When used in a seed dressing, a compound of formula (1) is used at a rate of 0.0001 g to 10 g (for example 0.001 g or 0.05 g), preferably 0.005 g to 10 g, more preferably 0.005 g to 4 g, per kilogram of seed.
  • In another aspect the present invention provides a fungicidal composition comprising a fungicidally effective amount of a compound of formula (1) and a suitable carrier or diluent therefor.
  • In a still further aspect the invention provides a method of combating and controlling fungi at a locus, which comprises treating the fungi, or the locus of the fungi with a fungicidally effective amount of a composition comprising a compound of formula (1).
  • The compositions can be chosen from a number of formulation types, including dustable powders (DP), soluble powders (SP), water soluble granules (SG), water dispersible granules (WG), wettable powders (WP), granules (GR) (slow or fast release), soluble concentrates (SL), oil miscible liquids (OL), ultra low volume liquids (UL), emulsifiable concentrates (EC), dispersible concentrates (DC), emulsions (both oil in water (EW) and water in oil (EO)), micro-emulsions (ME), suspension concentrates (SC), aerosols, fogging/smoke formulations, capsule suspensions (CS) and seed treatment formulations. The formulation type chosen in any instance will depend upon the particular purpose envisaged and the physical, chemical and biological properties of the compound of formula (1).
  • Dustable powders (DP) may be prepared by mixing a compound of formula (1) with one or more solid diluents (for example natural clays, kaolin, pyrophillite, bentonite, alumina, montmorillonite, kieselguhr, chalk, diatomaceous earths, calcium phosphates, calcium and magnesium carbonates, sulphur, lime, flours, talc and other organic and inorganic solid carriers) and mechanically grinding the mixture to a fine powder.
  • Soluble powders (SP) may be prepared by mixing a compound of formula (1) with one or more water-soluble inorganic salts (such as sodium bicarbonate, sodium carbonate or magnesium sulphate) or one or more water-soluble organic solids (such as a polysaccharide) and, optionally, one or more wetting agents, one or more dispersing agents or a mixture of said agents to improve water dispersibility/solubility. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water soluble granules (SG).
  • Wettable powders (WP) may be prepared by mixing a compound of formula (1) with one or more solid diluents or carriers, one or more wetting agents and, preferably, one or more dispersing agents and, optionally, one or more suspending agents to facilitate the dispersion in liquids. The mixture is then ground to a fine powder. Similar compositions may also be granulated to form water dispersible granules (WG).
  • Granules (GR) may be formed either by granulating a mixture of a compound of formula (1) and one or more powdered solid diluents or carriers, or from pre-formed blank granules by absorbing a compound of formula (1) (or a solution thereof, in a suitable agent) in a porous granular material (such as pumice, attapulgite clays, fuller's earth, kieselguhr, diatomaceous earths or ground corn cobs) or by adsorbing a compound of formula (1) (or a solution thereof, in a suitable agent) on to a hard core material (such as sands, silicates, mineral carbonates, sulphates or phosphates) and drying if necessary. Agents which are commonly used to aid absorption or adsorption include solvents (such as aliphatic and aromatic petroleum solvents, alcohols, ethers, ketones and esters) and sticking agents (such as polyvinyl acetates, polyvinyl alcohols, dextrins, sugars and vegetable oils). One or more other additives may also be included in granules (for example an emulsifying agent, wetting agent or dispersing agent).
  • Dispersible Concentrates (DC) may be prepared by dissolving a compound of formula (1) in water or an organic solvent, such as a ketone, alcohol or glycol ether. These solutions may contain a surface active agent (for example to improve water dilution or prevent crystallisation in a spray tank).
  • Emulsifiable concentrates (EC) or oil-in-water emulsions (EW) may be prepared by dissolving a compound of formula (1) in an organic solvent (optionally containing one or more wetting agents, one or more emulsifying agents or a mixture of said agents). Suitable organic solvents for use in ECs include aromatic hydrocarbons (such as alkylbenzenes or alkylnaphthalenes, exemplified by SOLVESSO 100, SOLVESSO 150 and SOLVESSO 200; SOLVESSO is a Registered Trade Mark), ketones (such as cyclohexanone or methylcyclohexanone), alcohols (such as benzyl alcohol, furfuryl alcohol or butanol), N-alkypyrrolidones (such as N-methylpyrrolidone or N-octylpyrrolidone), dimethyl amides of fatty acids (such as C8-C10 fatty acid dimethylamide) and chlorinated hydrocarbons. An EC product may spontaneously emulsify on addition to water, to produce an emulsion with sufficient stability to allow spray application through appropriate equipment. Preparation of an EW involves obtaining a compound of formula (1) either as a liquid (if it is not a liquid at room temperature, it may be melted at a reasonable temperature, typically below 70° C.) or in solution (by dissolving it in an appropriate solvent) and then emulsifying the resultant liquid or solution into water containing one or more SFAs, under high shear, to produce an emulsion. Suitable solvents for use in EWs include vegetable oils, chlorinated hydrocarbons (such as chlorobenzenes), aromatic solvents (such as alkylbenzenes or alkylnaphthalenes) and other appropriate organic solvents that have a low solubility in water.
  • Microemulsions (ME) may be prepared by mixing water with a blend of one or more solvents with one or more SFAs, to produce spontaneously a thermodynamically stable isotropic liquid formulation. A compound of formula (1) is present initially in either the water or the solvent/SFA blend. Suitable solvents for use in MEs include those hereinbefore described for use in ECs or in EWs. An ME may be either an oil-in-water or a water-in-oil system (which system is present may be determined by conductivity measurements) and may be suitable for mixing water-soluble and oil-soluble pesticides in the same formulation. An ME is suitable for dilution into water, either remaining as a microemulsion or forming a conventional oil-in-water emulsion.
  • Suspension concentrates (SC) may comprise aqueous or non-aqueous suspensions of finely divided insoluble solid particles of a compound of formula (1). SCs may be prepared by ball or bead milling the solid compound of formula (1) in a suitable medium, optionally with one or more dispersing agents, to produce a fine particle suspension of the compound. One or more wetting agents may be included in the composition and a suspending agent may be included to reduce the rate at which the particles settle. Alternatively, a compound of formula (1) may be dry milled and added to water, containing agents hereinbefore described, to produce the desired end product.
  • Aerosol formulations comprise a compound of formula (1) and a suitable propellant (for example n-butane). A compound of formula (1) may also be dissolved or dispersed in a suitable medium (for example water or a water miscible liquid, such as n-propanol) to provide compositions for use in non-pressurised, hand-actuated spray pumps.
  • A compound of formula (1) may be mixed in the dry state with a pyrotechnic mixture to form a composition suitable for generating, in an enclosed space, a smoke containing the compound.
  • Capsule suspensions (CS) may be prepared in a manner similar to the preparation of EW formulations but with an additional polymerisation stage such that an aqueous dispersion of oil droplets is obtained, in which each oil droplet is encapsulated by a polymeric shell and contains a compound of formula (1) and, optionally, a carrier or diluent therefor. The polymeric shell may be produced by either an interfacial polycondensation reaction or by a coacervation procedure. The compositions may provide for controlled release of the compound of formula (1) and they may be used for seed treatment. A compound of formula (1) may also be formulated in a biodegradable polymeric matrix to provide a slow, controlled release of the compound.
  • A composition may include one or more additives to improve the biological performance of the composition (for example by improving wetting, retention or distribution on surfaces; resistance to rain on treated surfaces; or uptake or mobility of a compound of formula (1)). Such additives include surface active agents, spray additives based on oils, for example certain mineral oils or natural plant oils (such as soy bean and rape seed oil), and blends of these with other bio-enhancing adjuvants (ingredients which may aid or modify the action of a compound of formula (1)).
  • A compound of formula (1) may also be formulated for use as a seed treatment, for example as a powder composition, including a powder for dry seed treatment (DS), a water soluble powder (SS) or a water dispersible powder for slurry treatment (WS), or as a liquid composition, including a flowable concentrate (FS), a solution (LS) or a capsule suspension (CS). The preparations of DS, SS, WS, FS and LS compositions are very similar to those of, respectively, DP, SP, WP, SC and DC compositions described above. Compositions for treating seed may include an agent for assisting the adhesion of the composition to the seed (for example a mineral oil or a film-forming barrier).
  • Wetting agents, dispersing agents and emulsifying agents may be SFAs of the cationic, anionic, amphoteric or non-ionic type.
  • Suitable SFAs of the cationic type include quaternary ammonium compounds (for example cetyltrimethyl ammonium bromide), imidazolines and amine salts.
  • Suitable anionic SFAs include alkali metals salts of fatty acids, salts of aliphatic monoesters of sulphuric acid (for example sodium lauryl sulphate), salts of sulphonated aromatic compounds (for example sodium dodecylbenzenesulphonate, calcium dodecyl-benzenesulphonate, butylnaphthalene sulphonate and mixtures of sodium di-isopropyl- and tri-isopropyl-naphthalene sulphonates), ether sulphates, alcohol ether sulphates (for example sodium laureth-3-sulphate), ether carboxylates (for example sodium laureth-3-carboxylate), phosphate esters (products from the reaction between one or more fatty alcohols and phosphoric acid (predominately mono-esters) or phosphorus pentoxide (predominately di-esters), for example the reaction between lauryl alcohol and tetraphosphoric acid; additionally these products may be ethoxylated), sulphosuccinamates, paraffin or olefine sulphonates, taurates and lignosulphonates.
  • Suitable SFAs of the amphoteric type include betaines, propionates and glycinates.
  • Suitable SFAs of the non-ionic type include condensation products of alkylene oxides, such as ethylene oxide, propylene oxide, butylene oxide or mixtures thereof, with fatty alcohols (such as oleyl alcohol or cetyl alcohol) or with alkylphenols (such as octylphenol, nonylphenol or octylcresol); partial esters derived from long chain fatty acids or hexitol anhydrides; condensation products of said partial esters with ethylene oxide; block polymers (comprising ethylene oxide and propylene oxide); alkanolamides; simple esters (for example fatty acid polyethylene glycol esters); amine oxides (for example lauryl dimethyl amine oxide); and lecithins.
  • Suitable suspending agents include hydrophilic colloids (such as polysaccharides, polyvinylpyrrolidone or sodium carboxymethylcellulose) and swelling clays (such as bentonite or attapulgite).
  • A compound of formula (1) may be applied by any of the known means of applying fungicidal compounds. For example, it may be applied, formulated or unformulated, to any part of the plant, including the foliage, stems, branches or roots, to the seed before it is planted or to other media in which plants are growing or are to be planted (such as soil surrounding the roots, the soil generally, paddy water or hydroponic culture systems), directly or it may be sprayed on, dusted on, applied by dipping, applied as a cream or paste formulation, applied as a vapour or applied through distribution or incorporation of a composition (such as a granular composition or a composition packed in a water-soluble bag) in soil or an aqueous environment.
  • A compound of formula (1) may also be injected into plants or sprayed onto vegetation using electrodynamic spraying techniques or other low volume methods, or applied by land or aerial irrigation systems.
  • Compositions for use as aqueous preparations (aqueous solutions or dispersions) are generally supplied in the form of a concentrate containing a high proportion of the active ingredient, the concentrate being added to water before use. These concentrates, which may include DCs, SCs, ECs, EWs, MEs SGs, SPs, WPs, WGs and CSs, are often required to withstand storage for prolonged periods and, after such storage, to be capable of addition to water to form aqueous preparations which remain homogeneous for a sufficient time to enable them to be applied by conventional spray equipment. Such aqueous preparations may contain varying amounts of a compound of formula (1) (for example 0.0001 to 10%, by weight) depending upon the purpose for which they are to be used.
  • A compound of formula (1) may be used in mixtures with fertilisers (for example nitrogen-, potassium- or phosphorus-containing fertilisers). Suitable formulation types include granules of fertiliser. The mixtures suitably contain up to 25% by weight of the compound of formula (1).
  • The invention therefore also provides a fertiliser composition comprising a fertiliser and a compound of formula (1).
  • The compositions of this invention may contain other compounds having biological activity, for example micronutrients or compounds having similar or complementary fungicidal activity or which possess plant growth regulating, herbicidal, insecticidal, nematicidal or acaricidal activity.
  • By including another fungicide, the resulting composition may have a broader spectrum of activity or a greater level of intrinsic activity than the compound of formula (1) alone. Further the other fungicide may have a synergistic effect on the fungicidal activity of the compound of formula (1).
  • The compound of formula (1) may be the sole active ingredient of the composition or it may be admixed with one or more additional active ingredients such as a pesticide, fungicide, synergist, herbicide or plant growth regulator where appropriate. An additional active ingredient may: provide a composition having a broader spectrum of activity or increased persistence at a locus; synergise the activity or complement the activity (for example by increasing the speed of effect or overcoming repellency) of the compound of formula (1); or help to overcome or prevent the development of resistance to individual components. The particular additional active ingredient will depend upon the intended utility of the composition.
  • Examples of fungicidal compounds which may be included in the composition of the invention are AC 382042 (N-(1-cyano-1,2-dimethylpropyl)-2-(2,4-dichlorophenoxy) propionamide), acibenzolar-S-methyl, alanycarb, aldimorph, anilazine, azaconazole, azafenidin, azoxystrobin, benalaxyl, benomyl, benthiavalicarb, biloxazol, bitertanol, blasticidin S, boscalid (new name for nicobifen), bromuconazole, bupirimate, captafol, captan, carbendazim, carbendazim chlorhydrate, carboxin, carpropamid, carvone, CGA 41396, CGA 41397, chinomethionate, chlorbenzthiazone, chlorothalonil, chlorozolinate, clozylacon, copper containing compounds such as copper oxychloride, copper oxyquinolate, copper sulphate, copper tallate, and Bordeaux mixture, cyamidazosulfamid, cyazofamid (IKF-916), cyflufenamid, cymoxanil, cyproconazole, cyprodinil, debacarb, di-2-pyridyl disulphide 1,1′-dioxide, dichlofluanid, diclocymet, diclomezine, dicloran, diethofencarb, difenoconazole, difenzoquat, diflumetorim, O,O-di-iso-propyl-S-benzyl thiophosphate, dimefluazole, dimetconazole, dimethirimol, dimethomorph, dimoxystrobin, diniconazole, dinocap, dithianon, dodecyl dimethyl ammonium chloride, dodemorph, dodine, doguadine, edifenphos, epoxiconazole, ethaboxam, ethirimol, ethyl (Z)-N-benzyl-N([methyl(methyl-thioethylideneaminooxycarbonyl)amino]thio)-β-alaninate, etridiazole, famoxadone, fenamidone, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenoxanil (AC 382042), fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, ferbam, ferimzone, fluazinam, fludioxonil, flumetover, flumorph, fluoroimide, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutolanil, flutriafol, folpet, fosetyl-aluminium, fuberidazole, furalaxyl, furametpyr, guazatine, hexaconazole, hydroxyisoxazole, hymexazole, imazalil, imibenconazole, iminoctadine, iminoctadine triacetate, ipconazole, iprobenfos, iprodione, iprovalicarb, isopropanyl butyl carbamate, isoprothiolane, kasugamycin, kresoxim-methyl, LY186054, LY211795, LY 248908, mancozeb, maneb, mefenoxam, mepanipyrim, mepronil, metalaxyl, metalaxyl M, metconazole, metiram, metiram-zinc, metominostrobin, metrafenone, MON65500 (N-allyl-4,5-dimethyl-2-trimethylsilylthiophene-3-carboxamide), myclobutanil, NTN0301, neoasozin, nickel dimethyldithiocarbamate, nitrothale-isopropyl, nuarimol, ofurace, organomercury compounds, orysastrobin, oxadixyl, oxasulfuron, oxolinic acid, oxpoconazole, oxycarboxin, pefurazoate, penconazole, pencycuron, phenazin oxide, phosphorus acids, phthalide, picoxystrobin, polyoxin D, polyram, probenazole, prochloraz, procymidone, propamocarb, propamocarb hydrochloride, propiconazole, propineb, propionic acid, proquinazid, prothioconazole, pyraclostrobin, pyrazophos, pyrifenox, pyrimethanil, pyroquilon, pyroxyfur, pyrrolnitrin, quaternary ammonium compounds, quinomethionate, quinoxyfen, quintozene, silthiofam (MON 65500), S-imazalil, simeconazole, sipconazole, sodium pentachlorophenate, spiroxamine, streptomycin, sulphur, tebuconazole, tecloftalam, tecnazene, tetraconazole, thiabendazole, thifluzamide, 2-(thiocyanomethylthio)-benzothiazole, thiophanate-methyl, thiram, tiadinil, timibenconazole, tolclofos-methyl, tolylfluanid, triadimefon, triadimenol, triazbutil, triazoxide, tricyclazole, tridemorph, trifloxystrobin, triflumizole, triforine, triticonazole, validamycin A, vapam, vinclozolin, XRD-563, zineb, ziram, zoxamide and compounds of the formulae:
  • Figure US20090069333A1-20090312-C00010
  • The compounds of formula (1) may be mixed with soil, peat or other rooting media for the protection of plants against seed-borne, soil-borne or foliar fungal diseases.
  • Some mixtures may comprise active ingredients, which have significantly different physical, chemical or biological properties such that they do not easily lend themselves to the same conventional formulation type. In these circumstances other formulation types may be prepared. For example, where one active ingredient is a water insoluble solid and the other a water insoluble liquid, it may nevertheless be possible to disperse each active ingredient in the same continuous aqueous phase by dispersing the solid active ingredient as a suspension (using a preparation analogous to that of an SC) but dispersing the liquid active ingredient as an emulsion (using a preparation analogous to that of an EW). The resultant composition is a suspoemulsion (SE) formulation.
  • The invention is illustrated by the following Examples in which the following abbreviations are used:
  • ml=millilitres f=fine
    g=grammes THF=tetrahydrofuran
    ppm=parts per million DCM=dichloromethane
    s=singlet DMF═N,N-dimethylformamide
    d=doublet DMSO=dimethylsulphoxide
    t=triplet DMAP=4-dimethylaminopyridine
    q=quartet NMR=nuclear magnetic resonance
    m=multiplet HPLC=high performance liquid
    b=broad chromatography
  • EXAMPLE 1
  • This Example illustrates the preparation of [6-chloro-7-(2,4,6-trifluorophenyl)-pyrido[2,3-b]pyrazin-8-yl]-isopropylamine (Compound No. 3, Table 1).
  • Figure US20090069333A1-20090312-C00011
  • Step 1 Methyl 2-amino-3-pyrazine carboxylate (2.2 g) was dissolved in dry DCM (20 ml) to give a cloudy pale yellow solution, and pyridine (2 ml) in dry DCM (12 ml) was added. The stirred suspension was cooled in an ice bath, and 2,4,6-trifluorophenylacetyl chloride (3.0 g) in dry DCM (13 ml) was added dropwise. The reaction gradually became a deep orange, and then went clear. It was stirred for 6 hours and stood overnight. The reaction mixture was washed with water, brine, and then dilute hydrochloric acid, and the DCM layer was dried over magnesium sulphate. The solvent was evaporated to yield an orange solid which was triturated with ether, to give methyl 2-[2,4,6-trifluorophenylacetylamino]-3-pyrazine carboxylate as a yellow solid (1.5 g).
  • 1H NMR (CDCl3) δ ppm: 4.03 (s, 5H), 6.74 (t, 2H), 8.43 (d, 1H), 8.61 (d, 1H) 10.9 (s, 1H).
  • Step 2
  • The product of Step 1 (3.25 g) was dissolved in DMF (10 ml) and added dropwise to a stirred suspension of sodium hydride (0.60 g of an 80% dispersion in mineral oil) in DMF (80 ml). There was an immediate reaction, and the mixture was stirred at room temperature for 2 hours, and at 80° C. for 8 hours. The reaction mixture was cooled and evaporated to give a yellow solid (3 g), which was then acidified with dilute hydrochloric acid. The resultant white suspension was filtered and collected, washed with ether and dried to give 6,8-dihydroxy-7-(2,4,6-trifluorophenyl)pyrido[2,3-b]pyrazine (1.8 g).
  • 1H NMR (d6-DMSO) δ ppm: 7.25 (t, 2H), 8.6 (fd, 1H), 8.7 (fd, 1H), 12.6 (s, 1H).
  • Step 3
  • The product from Step 2 (0.90 g) was added portion-wise to phosphorus oxychloride (10 ml) with stirring. The reaction was exothermic. The mixture became brown with a fine suspension, and was then refluxed for 6 hours. Excess phosphorus oxychloride was evaporated, the mixture was diluted with DCM, and then washed with water to give a black oil, which was purified by flash column chromatography on silica gel (40-60) eluting with diethyl ether, to give 6,8-dichloro-7-(2,4,6-trifluorophenyl)pyrido[2,3-b]pyrazine as a dark oil (0.40 g).
  • 1H NMR (CDCl3) δ ppm: 6.9 (t, 2H), 9.1 (d, 1H), 9.2 (d, 1H).
  • Alternative Procedure for Step 3
  • Phosphorus oxychloride (20.90 g) was added over 15 minutes to a suspension of the product from Step 2 (10.0 g), in 1,2-dichloroethane (80 ml) containing DMF (5.0 g) maintained at a temperature between 79°-81° C. Stirring was continued at this temperature for 3 hours, and the reaction was then cooled. The mixture was poured carefully into saturated sodium bicarbonate solution (500 ml) keeping the temperature below 30° C. After stirring for 20 minutes the product was extracted with ethyl acetate, washed with water and brine and dried over sodium sulphate. The solvent was evaporated to yield a dark red oil, which was purified by flash chromatography eluting with cyclohexane:ethyl acetate, 4:1 to give 6,8-dichloro-7-(2,4,6-trifluorophenyl)pyrido[2,3-b]pyrazine as a light brown solid (7.5 g), m.p. 139-141° C.
  • Step 4
  • The product from Step 3 (0.20 g), isopropylamine (1.0 ml) and N-ethyl-diisopropylamine (0.20 g) were refluxed in a sealed tube at 90° C. for 17 hours. The dark coloured reaction mixture was evaporated to give an oil, which was purified by flash column chromatography on silica gel (40-60) in diethyl ether.
  • A fraction containing a mixture of isomers (0.080 g), was obtained, and a portion of this mixture (0.020 g) was purified by reverse phase HPLC on a Kromasil 100-5C18 column, eluting with methanol:water (65:35) to give [6-chloro-7-(2,4,6-trifluorophenyl)-pyrido[2,3-b]pyrazin-8-yl]-isopropylamine as a frothy solid (0.013 g).
  • 1H NMR (CDCl3) δ ppm: 1.1 (d, 6H), 3.26 (m, 1H), 6.84 (m, 2H), 6.95 (bd, 1H), 8.67 (d, 1H), 9.0 (d, 1H).
  • EXAMPLE 2
  • This Example illustrates the preparation of [6-fluoro-7-(2,4,6-trifluorophenyl)-pyrido[2,3-b]pyrazin-8-yl]-isopropylamine (Compound No. 3, Table 103)
  • Figure US20090069333A1-20090312-C00012
  • Step 1
  • 6,8-Dichloro-7-(2,4,6-trifluorophenyl)-pyrido[2,3-b]pyrazine (1.25 g) and potassium fluoride (0.66 g, spray dried) in dry sulpholane (5 ml) were heated to 130° C. for 16 hours. The reaction mixture was poured into water and extracted with ethyl acetate. The extract was washed with water and brine and dried over sodium sulphate. After evaporation of the solvent, the remaining oil was purified by flash chromatography on silica gel eluting with cyclohexane:ethyl acetate, 3:1 to yield 6,8-difluoro-7-(2,4,6-trifluorophenyl)-pyrido[2,3-b]-pyrazine as a slightly brownish solid (0.79 g), m.p. 120-121° C.
  • Step 2
  • The product from Step 1 (0.30 g) was added to a suspension of isopropylamine (0.090 g), potassium carbonate (0.21 g) and a catalytic amount of DMAP in DMF (3 ml), and the mixture was stirred at room temperature for 19 hours. After addition of ethyl acetate, the mixture was washed with water and brine, dried over sodium sulphate, filtered and the solvent evaporated. The residue was purified by flash chromatography eluting with toluene:ethyl acetate, 9:1 to give [6-fluoro-7-(2,4,6-trifluorophenyl)-pyrido[2,3-b]pyrazin-8-yl]-isopropylamine as a yellow powder (0.20 g), m.p. 127-128° C.
  • EXAMPLE 3
  • This Example illustrates the preparation of [6-chloro-7-(2,4,6-trifluorophenyl)-pyrido[3,2-c]pyridazin-8-yl]-isopropylamine (Compound No. 3, Table 11).
  • Figure US20090069333A1-20090312-C00013
  • Step 1
  • A solution of 4-aminopyridazine-3-carbonitrile (0.248 g, prepared as in J. Het. Chem. (1970), 3, 467-473) in absolute ethanol (30 ml) was saturated with hydrogen chloride gas, the flask being cooled in an ice bath. The ice bath was then removed and the resulting solution was refluxed for 18 hours. It was then cooled, the solvent evaporated, and cold, saturated aqueous sodium bicarbonate was added. The aqueous phase was then extracted with DCM, the organic phases were combined, dried over magnesium sulphate, filtered and evaporated to give 4-aminopyridazine-3-carboxylic acid ethyl ester as a white solid (0.229 g). The aqueous phase was evaporated, DCM was added, the organic phase was isolated, dried over magnesium sulphate, filtered and evaporated under vacuo to give further ester as a white solid (0.010 g), m.p. 149-150° C.
  • 1H NMR (CDCl3) δ ppm: 1.48 (t, 3H), 4.52 (q, 2H), 6.73 (d, 1H), 8.75 (d, 1H).
  • Step 2
  • A mixture of the product from Step 1 (0.239 g) and DMAP (0.175 g) in dry toluene (1 ml) was added to 2,4,6-trifluorophenylacetyl chloride (crude product from reaction of 0.275 g 2,4,6-trifluorophenylacetic acid and oxalyl chloride) and a few drops of DMF in toluene (1 ml) at room temperature, giving a thick yellow precipitate. The stirred suspension was heated for 3 hours at reflux, becoming dark brown/green with a green precipitate. It was left to stand overnight for 18 hours. The solid was collected and washed with diethyl ether. The dark green filtrate was evaporated to give a dark green liquid which was purified by flash column chromatography on silica gel (40-60) eluting with ethyl acetate to give 4-[2-(2,4,6-trifluorophenyl)-acetylamino]-pyridazine-3-carboxylic acid ethyl ester as green/yellow oil that solidified on standing (0.307 g).
  • 1H NMR (CDCl3) δ ppm: 1.50 (t, 3H), 3.87 (s, 2H), 4.55 (q, 2H), 6.77 (t, 2H), 8.78 (d, 1H), 9.15 (d, 1H), 11.20 (bs, 1H).
  • Step 3
  • The product from Step 2 (0.307 g) and potassium carbonate (0.25 g) were stirred in dry DMF (10 ml) at 110° C. for 2 hours and then cooled and stood for 18 hours. The DMF was evaporated and the resulting brown solid was triturated with diethyl ether and the organic phase decanted. The solid was dissolved in water then acidified with dilute hydrochloric acid to neutrality. Most of the aqueous phase was then evaporated, leading to precipitation of a black solid that was filtered, and the yellow/brown aqueous phase was evaporated to dryness, affording a residue that was dissolved in methanol, the insoluble inorganic salts were filtered and the organic phase was evaporated to dryness to give 7-(2,4,6-trifluorophenyl)-5H-pyrido[3,2-c]pyridazine-6,8-dione as a light brown/beige solid (0.258 g).
  • 1H NMR (CD3OD) δ ppm: 6.83 (2d, 2H), 7.44 (d, 1H), 9.00 (d, 1H).
  • Step 4
  • Phosphorus oxychloride (0.048 ml) was added to the product from Step 3 (0.05 g) in 1,2-dichloroethane (2 ml) containing a catalytic amount of DMF. The suspension was stirred and refluxed for 1 hour and then stood for 18 hours, and then refluxed for a further hour and then allowed to cool. The excess phosphorus oxychloride was evaporated to give a brown oil, which was dissolved in DCM and washed with cold water. The organic layer was separated and dried over magnesium sulphate, filtered and evaporated to give a brown oil, which was purified by flash column chromatography on silica gel (40-60) eluting with diethyl ether to give 6,8-dichloro-7-(2,4,6-trifluorophenyl)-pyrido[3,2-c]pyridazine as a yellow oil (0.015 g).
  • 1H NMR (CDCl3) δ ppm: 6.92 (m, 2H), 8.11 (d, 1H), 9.71 (d, 1H).
  • Step 5
  • Isopropylamine (0.5 ml) was added to the product from Step 4 (0.015 g) dissolved in DCM (1 ml) containing dimethylacetamide (0.3 ml) in a sealed tube. The yellow solution became yellow/greenish. The vessel was then sealed and stirred at room temperature. The solvents were evaporated and the crude residue was purified using preparative thin layer chromatography silica gel plates eluting with ethyl acetate:hexane 1:1 to give [6-Chloro-7-(2,4,6-trifluorophenyl)-pyrido[3,2-c]pyridazin-8-yl]-isopropylamine (0.003 g).
  • 1H NMR (CDCl3) δ ppm: 1.16 (d, 6H), 3.41 (m, 1H), 6.85 (dd, 2H), 7.79 (bs, 1H), 7.84 (d, 1H). 9.40 (d, 1H).
  • EXAMPLE 4
  • This Example illustrates the preparation of [2-chloro-3-(2,4,6-trifluorophenyl)-pyrido[2,3-d]pyridazin-4-yl]-isopropylamine (Compound No. 3, Table 21).
  • Figure US20090069333A1-20090312-C00014
  • Step 1
  • 5-Aminopyridazine-4-carboxylic acid ethyl ester (1.26 g, prepared according to J. Het. Chem., (1968), 5, 845) was dissolved in dry toluene (125 ml) at 90° C., and DMAP (0.92 g) was added. 2,4,6-Trifluorophenylacetyl chloride (1.75 g of 95% purity material) was added dropwise with stirring at 70° C., and a white solid precipitated. The reaction was stirred at reflux for 5 hours and then filtered hot. The filtrate was evaporated to give 5-[2-(2,4,6-trifluorophenyl)-acetylamino]-pyridazine-4-carboxylic acid ethyl ester as a white solid (2.6 g), m.p. 143-144° C.
  • 1H NMR (CDCl3) δ ppm: 1.45 (t, 3H), 3.90 (s, 2H), (4.45 (q, 2H), 6.75 (m, 2H), 9.45 (s1H), 10.60 (s, 1H), 11.1 (bs, 1H).
  • Step 2
  • The product from Step 1 (2.5 g) was dissolved in dry THF (50 ml) and the flask purged with nitrogen. Sodium bis-trimethylsilylamide (22.1 ml of a 1M solution in THF) was added dropwise with stirring at 0° C. A yellow precipitate appeared, and the reaction was stirred for 3 hours at 0° C. The reaction was quenched with concentrated hydrochloric acid (5 ml) at 0° C. and then poured onto ice water, extracted with DCM and dried over magnesium sulphate. The solvent was evaporated to give 3-(2,4,6-trifluorophenyl)-1H-pyrido[2,3-d]pyridazine-2,4-dione as a yellow solid. Further product crystallised out of the aqueous solution overnight, to give a total yield of 1.29 g, m.p. >300° C.
  • 1H NMR (d6-DMSO) δ ppm: 7.25 (m, 2H), 9.17 (s, 1H), 9.47 (s, 1H), 12.30 (bs, 1H).
  • Step 3
  • The product from Step 2 (0.10 g) was heated to 90° C. with phosphorus oxychloride (1.6 ml) with stirring. After 1 hour a clear yellow solution was obtained and the excess solvent was evaporated and ice water was added, giving a yellow solid. This was extracted with DCM, and the solution dried over magnesium sulphate and evaporated to give 2,4-dichloro-3-(2,4,6-trifluorophenyl)-pyrido[2,3-d]pyridazine as a yellow foamy glass (0.11 g).
  • 1H NMR (CDCl3) δ ppm: 6.90 (m, 2H), 9.80 (s, 1H), 10.0 (s, H).
  • Step 4
  • Isopropylamine (1.5 ml) was added to the product from Step 3 (0.020 g) in DCM and the tube stoppered and the reaction stirred overnight at room temperature. The DCM was evaporated and water added to the residue, which was then extracted with DCM. The extract was dried over magnesium sulphate and evaporated to give an orange oil, which was purified by HPLC eluting with ethyl acetate:hexane 4:1 to give [2-Chloro-3-(2,4,6-trifluorophenyl)-pyrido[2,3-d]pyridazin-4-yl]-isopropylamine (0.007 g)
  • 1H NMR (CDCl3) δ ppm: 1.27 (d, 6H), 4.05 (m, 1H), 4.90 (bs, 1H), 6.92 (m, 2H), 9.55 (s, 1H), 9.90 (s, 1H).
  • EXAMPLE 5
  • This Example illustrates the preparation of [7-chloro-6-(2,4,6-trifluorophenyl)-pyrido[2,3-c]pyridazin-5-yl]-isopropylamine (Compound No. 3, Table 26).
  • Figure US20090069333A1-20090312-C00015
  • Step 1
  • 3-Aminopyridazine-4-carboxylic acid (1.68 g, prepared as in JOC, (1985), 50, 346) was refluxed in ethanol (170 ml) with concentrated hydrochloric acid (2 ml) and p-toluene-sulphonyl chloride (0.1 g) for 55 hours. The solvent was evaporated and ice water added to the residue, which was then neutralised with solid sodium bicarbonate. The mixture was extracted with chloroform, insoluble material filtered, the organic extract dried over magnesium sulphate and evaporated to give 3-aminopyridazine-4-carboxylic acid ethyl ester (1.02 g) as a white solid.
  • 1H NMR (CDCl3) δ ppm: 1.40 (t, 3H), 4.40 (q, 2H), 6.50 (bs, 2H), 7.74 (d, 1H), 8.72 (d, 1H).
  • Step 2
  • The product from Step 1 (0.36 g) was dissolved in dry toluene (25 ml) and DMAP (0.262 g) was added. A solution of 2,4,6-trifluorophenylacetyl chloride (0.45 g) in dry toluene (1 ml) was added dropwise with stirring, and a white precipitate formed. After stirring at room temperature for 10 minutes the reaction was stirred under reflux for 4.5 hours, and then allowed to stand overnight at room temperature. The white solid was filtered and washed with toluene, and the filtrate evaporated to give a brown oil, which was purified by HPLC eluting with ethyl acetate:hexane 4:1 to give 3-[2-(2,4,6-trifluorophenyl)-acetylamino]-pyridazine-4-carboxylic acid ethyl ester as a pale yellow solid (0.57 g), m.p. 135° C.
  • 1H NMR (CDCl3) δ ppm: 1.40 (t, 3H), 4.22 (s, 2H), 4.41 (q, 2H), 6.70 (m, 2H), 7.94 (d, 1H), 9.15 (d, 1H), 10.30 (bs, 1H).
  • Step 3
  • The product from Step 2 (2.0 g) was dissolved in dry THF (50 ml), and sodium bistrimethylsilylamide (17.7 ml of a 1.0M solution in THF) was added dropwise with stirring under nitrogen at 0° C. The reaction was stirred for 3 hours at 0° C. and a yellow precipitate was formed. The reaction was quenched with concentrated hydrochloric acid and then poured into ice water. The solid was filtered, washed with water and air dried to give 6-(2,4,6-trifluorophenyl)-8H-pyrido[2,3-c]pyridazine-5,7-dione as a yellow solid (1.92 g), m.p. >330° C., still containing some THF, which was used without further purification.
  • 1H NMR (D6-DMSO) δ ppm: 7.30 (m, 2H), 8.10 (d, 1H), 9.20 (d, 1H), 11.90 (bs, 1H), 12.60 (s, 1H).
  • Step 4
  • The product from Step 3 (0.060 g) was heated to 90° C. in phosphorus oxychloride (1 ml) for 1 hour to give a clear black solution. The mixture was cooled and the excess in phosphorus oxychloride evaporated. The residue was quenched with ice and aqueous sodium bicarbonate, extracted with ethyl acetate, the extract dried over magnesium sulphate and evaporated to give 5,7-dichloro-6-(2,4,6-trifluorophenyl)-pyrido[2,3-c]pyridazine as a black solid (0.087 g).
  • 1H NMR (CDCl3) δ ppm: 6.90 (m, 2H), 8.30 (d, 1H), 9.75 (d, 1H).
  • Step 4
  • The product from Step 3 (0.080 g) was stirred with isopropylamine (2 ml) in DCM (5 ml) at room temperature overnight and then heated to 40° C. in a sealed tube for 4 hours. The volatiles were evaporated, water was added and the mixture extracted with DCM. The extracts were dried over magnesium sulphate and evaporated to give a dark brown tar, which was purified by preparative TLC on silica gel plates eluting with ethyl acetate:hexane 3:2 to give [7-Chloro-6-(2,4,6-trifluorophenyl)-pyrido[2,3-c]pyridazin-5-yl]-isopropylamine (0.008 g),
  • 1H NMR (CDCl3) δ ppm: 1.20 (d, 6H), 3.71 (m, 1H), 4.45 (bs, 1H), 6.87-6.92 (m, 2H), 7.97 (d, 1H), 9.37 (d, 1H).
  • TABLE 133
    NMR data (ppm,
    in CDCl3,
    Compound Table Compound unless otherwise
    No. No. Structure stated) or Mpt.
      3  1
    Figure US20090069333A1-20090312-C00016
    1.1 (d, 6 H), 3.26 (m, 1 H), 6.84 (m, 2 H),6.95 (bd, 1 H), 8.67 (d, 1 H), 9.0 (d, 1 H).
      4  1
    Figure US20090069333A1-20090312-C00017
    0.8 (t, 3 H), 1.27 (m, 2 H), 1.55 (m, 2 H),2.87 (m, 2 H), 6.8, 6.85 (ABd, 2 H); 8.66,8.99 (ABd, 2 H).
      14  1
    Figure US20090069333A1-20090312-C00018
    129-131° C.
      15  1
    Figure US20090069333A1-20090312-C00019
    149-150° C.
      16  1
    Figure US20090069333A1-20090312-C00020
    175-177° C.
      17  1
    Figure US20090069333A1-20090312-C00021
    153-155° C.
      22  1
    Figure US20090069333A1-20090312-C00022
    0.92 (m) + 1.22 (m) + 1.55 (m)(total = 8 H), 2.9 (m, 2 H), 6.85 (m, 2 H),8.78, 8.96 (ABd, 2 H).
      23  1
    Figure US20090069333A1-20090312-C00023
    151-153° C.
      58  1
    Figure US20090069333A1-20090312-C00024
    102-104° C.
     108  1
    Figure US20090069333A1-20090312-C00025
    1.12 (d, 3 H), 3.27 (m, 2 H), 3.3 (s, 3 H),3.5 (m, 1 H), 6.8 (m, 2 H), 8.67 (d) + 8.97 (ABd)(total = 2 H)
     161  1
    Figure US20090069333A1-20090312-C00026
    138-140° C.
     162  1
    Figure US20090069333A1-20090312-C00027
    140-141° C.
     219  1
    Figure US20090069333A1-20090312-C00028
    3.0 (s, 6 H), 6.85 (m, 2 H), 8.65,8.87 (ABd, 2 H)
      3  5
    Figure US20090069333A1-20090312-C00029
    157-159° C.
      4  5
    Figure US20090069333A1-20090312-C00030
    0.82 (m, 3 H), 1.22 m + 1.5 m (total = 4 H),2.82 (m, 2 H), 7.1-7.47 (m, 3 H), 8.67 + 9.05(ABd, 2 H).
      17  5
    Figure US20090069333A1-20090312-C00031
    159-160° C.
      20  5
    Figure US20090069333A1-20090312-C00032
    166-168° C.
      22  5
    Figure US20090069333A1-20090312-C00033
    163-165° C.
      23  5
    Figure US20090069333A1-20090312-C00034
    163-165° C.
      28  5
    Figure US20090069333A1-20090312-C00035
     71-73° C.
     108  5
    Figure US20090069333A1-20090312-C00036
    1.05 (d) + 1.12 (d) (total = 3 H), 3.1-3.5(m, 3 H), 3.25 (d) + 3.32 (d) (total = 3 H),7.1 (m) + 7.4 (m) (total = 4 H), 8.67(d, 1 H), 9.06 (d, 1 H)
     161  5
    Figure US20090069333A1-20090312-C00037
    0.82 (m, 4 H), 3.65 (m, 4 H), 7.12-7.35(m, 3 H), 8.66 + 8.87 (ABd, 2 H).
     162  5
    Figure US20090069333A1-20090312-C00038
    1.52 (m, 6 H), 3.3 (m, 4 H), 7.25 (m) + 7.4 (m)(total = 3 H), 8.78 + 8.95 (ABd, 2 H).
     171  5
    Figure US20090069333A1-20090312-C00039
    2.3 (s, 3 H), 2.5 (m, 4 H), 7.15 (m, 1 H),7.37 (m, 2 H), 8.75 (d, 1 H), 8.92 (d, 1 H).
      3  11
    Figure US20090069333A1-20090312-C00040
    1.16 (d, 6 H), 3.41 (m, 1 H), 6.85 (dd, 2 H),7.79 (bs, 1 H), 7.84 (d, 1 H). 9.40 (d, 1 H).
      23  11
    Figure US20090069333A1-20090312-C00041
    0.79 (t, 3 H), 1.11 (d, 3 H), 1.47 (m, 2 H),3.13 (m, 1 H), 6.86 (dd, 2 H), 7.79 (bs,1 H), 7.84 (d, 1 H), 9.40 (d, 1 H).
      3  21
    Figure US20090069333A1-20090312-C00042
    1.27 (d, 6 H), 4.05 (m, 1 H), 4.90 (bs, 1 H),6.92 (m, 2 H), 9.55 (s, 1 H), 9.90 (s, 1 H).
      3  26
    Figure US20090069333A1-20090312-C00043
    1.20 (d, 6 H), 3.71 (m, 1 H), 4.45 (bs, 1 H),6.87-6.92 (m, 2 H), 7.97 (d, 1 H), 9.37 (d, 1 H).
      3  31
    Figure US20090069333A1-20090312-C00044
    1.25 (d, 6 H), 4.5 (bd, 1 H), 4.6 (m, 1 H),7.15 (t, 2 H), 7.6 (m, 1 H), 8.625 (fd, 1 H),8.85 (fd, 1 H).
      3  32
    Figure US20090069333A1-20090312-C00045
    1.10 (d, 6 H), 4.52 (m, 2 H), 7.28 (m, 3 H),7.47 (m, 1 H), 8.52 (d, 1 H), 8.76 (d, 1 H)
      23  32
    Figure US20090069333A1-20090312-C00046
    0.78 (m, 3 H), 1.07 (m, 3 H), 1.45 (m, 2 H),4.48 (m, 2 H), 7.25 (m, 3 H), 7.50 (m, 1 H),8.51 (d, 1 H), 8.71 (d, 1 H)
      3  37
    Figure US20090069333A1-20090312-C00047
    160-161° C.
      16  37
    Figure US20090069333A1-20090312-C00048
    181-183° C.
     171  37
    Figure US20090069333A1-20090312-C00049
    2.3 (s, 3 H), 2.5 (m, 3 H), 3.2-3.5 (m, 4 H),7.27 (m) + 7.4 (m) + 7.62 (m) (total = 3 H), 8.77(d, 1 H), 8.92 (d, 1 H).
      3  43
    Figure US20090069333A1-20090312-C00050
    1.10 (d, 6 H), 4.32 (d, 1 H), 4.57 (m,1 H), 7.22 (m, 1 H), 7.35 (m, 1 H), 7.48(m, 1 H), 7.78 (m, H), 8.53 (d, 1 H), 8.71(d, 1 H)
      23  43
    Figure US20090069333A1-20090312-C00051
    0.81 (m, 3 H), 1.10 (m, 3 H), 1.40 (m,2 H), 4.26 (m, 1 H), 4.45 (m, 1 H), 7.25 (m,1 H), 7.38 (m, 1 H), 7.50 (m, 1 H), 7.76(m, 1 H), 8.52 (d, 1 H), 8.74 (d, 1 H)
      3 103
    Figure US20090069333A1-20090312-C00052
    127-128° C.
      5 103
    Figure US20090069333A1-20090312-C00053
    138-140° C.
      12 103
    Figure US20090069333A1-20090312-C00054
    106-108° C.
      14 103
    Figure US20090069333A1-20090312-C00055
    120-121° C.
      15 103
    Figure US20090069333A1-20090312-C00056
    153-154° C.
      23 103
    Figure US20090069333A1-20090312-C00057
    101-102° C.
      58 103
    Figure US20090069333A1-20090312-C00058
     99-100° C.
      92 103
    Figure US20090069333A1-20090312-C00059
    1.07 (t, 3 H), 1.57 (s, 3 H), 3.52 (s, 2 H), 3.72(q, 2 H), 4.85 (m, 2 H), 6.85 (m, 2 H), 8.8 (d,1 H), 9.0 (d, 1 H).
     161 103
    Figure US20090069333A1-20090312-C00060
    148-150° C.
     171 103
    Figure US20090069333A1-20090312-C00061
    167-160° C.
     2651 103
    Figure US20090069333A1-20090312-C00062
    100-101° C.
     2660 103
    Figure US20090069333A1-20090312-C00063
    1.3 (d, 3 H), 1.4 (d, 3 H), 3.9 (m, 1 H), 6.95-7.6(m, 4 H), 8.75 (m, 1 H), 9.05 (m, 1 H).
     2671 103
    Figure US20090069333A1-20090312-C00064
    123-124° C.
     2706 103
    Figure US20090069333A1-20090312-C00065
    0.8 (m, 6 H), 1.72 (m, 1 H), 2.6 (m, 2 H), 7.02-7.47 (m, 4 H), 8.6 (d, 1 H), 8.92 (d, 1 H).
    43704 103
    Figure US20090069333A1-20090312-C00066
    133-135° C.(diastereoisomer 1)
    43704 103
    Figure US20090069333A1-20090312-C00067
    137-139° C.(diastereoisomer 2)
    43715 103
    Figure US20090069333A1-20090312-C00068
    118-119° C.
    43750 103
    Figure US20090069333A1-20090312-C00069
    0.80 (d) + 0.83 (d) (total = 6 H), 1.72 (m, 1 H),2.65 (m, 2 H), 7.1-7.3 (m) + 7.35, 7.6 (d)(total = 3 H), 8.6 (d, 1 H), 8.92 (d, 1 H).
      1 128
    Figure US20090069333A1-20090312-C00070
    4.03 (s, 5 H), 6.74 (t, 2 H), 8.43 (d, 1 H), 8.61(d, 1 H), 10.9 (s, 1 H).
      6 128
    Figure US20090069333A1-20090312-C00071
    162-163° C.
      12 128
    Figure US20090069333A1-20090312-C00072
    158-159° C.
      13 128
    Figure US20090069333A1-20090312-C00073
    1.48 (t, 3 H), 4.52 (q, 2 H), 6.73 (d, 1 H),8.75 (d, 1 H).
      25 128
    Figure US20090069333A1-20090312-C00074
    1.45 (t, 3 H), 3.90 (s, 2 H), (4.45 (q, 2 H), 6.75(m, 2 H), 9.45 (s1 H), 10.60 (s, 1 H), 11.1 (bs,1 H).
      37 128
    Figure US20090069333A1-20090312-C00075
    1.40 (t, 3 H), 4.22 (s, 2 H), 4.41 (q, 2 H),6.70 (m, 2 H), 7.94 (d, 1 H), 9.15 (d, 1 H), 10.30(bs, 1 H).
      1 129
    Figure US20090069333A1-20090312-C00076
    (d6-DMSO) 7.25(t, 2 H), 8.6(fd, 1 H), 8.7(fd,1 H), 12.6(s, 1 H).
      6 129
    Figure US20090069333A1-20090312-C00077
    >220° C.
      9 129
    Figure US20090069333A1-20090312-C00078
    250-252° C.
      11 129
    Figure US20090069333A1-20090312-C00079
    258° C.
      12 129
    Figure US20090069333A1-20090312-C00080
    >200° C.
      13 129
    Figure US20090069333A1-20090312-C00081
    (CD3OD) 6.83 (2d, 2 H), 7.44 (d, 1 H),9.00 (d, 1 H).
      25 129
    Figure US20090069333A1-20090312-C00082
    (D6-DMSO) 7.25 (m, 2 H), 9.17 (s, 1 H),9.47 (s, 1 H), 12.30 (bs, 1 H).
      37 129
    Figure US20090069333A1-20090312-C00083
    (D6-DMSO) 7.30 (m, 2 H), 8.10 (d, 1 H),9.20 (d, 1 H), 11.90 (bs, 1 H), 12.60 (s, 1 H).
      1 130
    Figure US20090069333A1-20090312-C00084
    139-141° C.
      6 130
    Figure US20090069333A1-20090312-C00085
    154-155° C.
      9 130
    Figure US20090069333A1-20090312-C00086
    7.21 (m, 1 H), 7.28(m, 2 H), 7.48(m, 1 H),8.95(d, 1 H), 9.08(d, 1 H).
      11 130
    Figure US20090069333A1-20090312-C00087
    7.18(d, 1 H), 7.29(m, 1 H), 7.41(t, 1 H),7.69(dd, 1 H), 9.00(d, 1 H), 9.09(d, 1 H).
      12 130
    Figure US20090069333A1-20090312-C00088
    159-160° C.
      13 130
    Figure US20090069333A1-20090312-C00089
    6.92 (m, 2 H), 8.11 (d, 1 H), 9.71 (d, 1 H).
      25 130
    Figure US20090069333A1-20090312-C00090
    6.90 (m, 2 H), 9.80 (s, 1 H), 10.0 (s, 1 H).
      37 130
    Figure US20090069333A1-20090312-C00091
    6.90 (m, 2 H), 8.30 (d, 1 H), 9.75 (d, 1 H).
      1 131
    Figure US20090069333A1-20090312-C00092
    120-121° C.
      6 131
    Figure US20090069333A1-20090312-C00093
    7.27 (m) + 7.55 (m) (total = 3 H), 9.07 (d, 1 H),9.2 (d, 1 H).
      12 131
    Figure US20090069333A1-20090312-C00094
    7.45 (m) + 7.67 (d) (total = 3 H), 9.07 (d, 1 H),9.2 (d, 1 H).
  • EXAMPLE 6
  • This Example illustrates the fungicidal properties of the compounds of the general formula (1).
  • Compounds were tested in a leaf disk assay, with methods described below. Test compounds were dissolved in DMSO, and diluted into water to 200 ppm.
  • Plasmopara viticola (downy mildew of grapevine): grapevine leaf disks were placed on agar in a 24-well plate and sprayed a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed seven days after inoculation as preventive fungicidal activity.
    Phytophthora infestans (late blight of potato on tomato): tomato leaf disks were placed on water agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed four days after inoculation as preventive fungicidal activity.
    Erysiphe graminis f.sp. hordei (barley powdery mildew): barley leaf segments were placed on agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed four days after inoculation as preventive fungicidal activity.
    Erysiphe graminis f.sp. tritici (wheat powdery mildew): wheat leaf segments were placed on agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed four days after inoculation as preventive fungicidal activity.
    Puccinia recondita f.sp. tritici (wheat brown rust): wheat leaf segments were placed on agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed nine days after inoculation as preventive fungicidal activity.
    Septoria nodorum (wheat glume blotch): wheat leaf segments were placed on agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed four days after inoculation as preventive fungicidal activity.
    Pyrenophora teres (barley net blotch): barley leaf segments were placed on agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed four days after inoculation as preventive fungicidal activity.
    Pyricularia oryzae (rice blast): rice leaf segments were placed on agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed four days after inoculation as preventive fungicidal activity.
    Botrytis cinerea (grey mould): bean leaf disks were placed on agar in a 24-well plate and sprayed with a solution of the test compound. After allowing to dry completely, for between 12 and 24 hours, the leaf disks were inoculated with a spore suspension of the fungus. After appropriate incubation the activity of a compound was assessed four days after inoculation as preventive fungicidal activity.
    The following compounds gave greater than 60% control of disease:
    Plasmopara viticola, Compounds 4 (1), 20 (1), 23 (5);
    Phytophthora infestans, Compounds 3 (1), 58 (5), 3 (103);
    Erysiphe graminis f.sp. hordei, Compounds 3 (1), 14 (1), 15 (1), 16 (1), 17 (1), 22 (1), 23 (1), 58 (1), 108 (1), 161 (1), 162 (1), 3 (5), 4 (5), 17 (5), 20 (5), 22 (5), 23 (5), 28 (5), 58 (5), 108 (5), 162 (5), 171 (5), 665 (31), 23 (32), 3 (37), 16 (37), 171 (37), 665 (37), 678 (37), 3 (43), 23 (43), 685 (43), 3 (103), 12 (103), 23 (103), 58 (103), 92 (103), 2651 (103), 2660 (103), 2671 (103), 23844 (103) diastereoisomer 1, 23844 (103) diastereoisomer 2, 23855 (103), 23890 (103;
  • Erysiphe graminis f.sp. tritici, Compounds 3 (1), 4 (1), 15 (1), 16 (1), 2291), 23 (1), 58 (1), 108 (1), 162 (1), 219 (1), δ 95), 161 (5), 3 (31), 16 (37), 665 (37), 3 (103), 12 (103), 23 (103), 58 (103), 92 (103), 2651 (103), 2660 (103), 2671 (103), 23844 (103) diastereoisomer 1, 23844 (103) diastereoisomer 2, 23855 (103), 23890 (103);
  • Puccinia recondita f.sp. tritici, Compounds 3 (1), 14 (1), 15 (1), 16 (1), 17 (1), 23 (1), 58 (1), 108 (1), 161 (1), 162 (1), 4 (5), 17 (5), 23 (5), 28 (5), 58 (5), 108 (5), 3 (31), 16 (37), 665 (37), 678 (37), 3 (103), 12 (103), 23 (103), 58 (103), 92 (103), 2651 (103), 2660 (103), 2671 (103), 23844 (103) diastereoisomer 1, 23855 (103), 23890 (103);
    Septoria nodorum, Compounds 391), 15 (1), 16 (1), 17 (1), 23 (1), 58 (1), 5895), 161 (5), 22 (6), 665 (37), 685 (43), 12 (103), 23 (103), 58 (103), 2660 (103), 2671 (103), 23844 (103) diastereoisomer 1, 23855 (103), 23890 (103);
    Pyrenophora teres, Compounds 3 (1), 14 (1), 15 (1), 16 (1), 17 (1), 23 (1), 58 (1), 161 (1), 3 (5), 20 (5), 16 (37), 665 (37), 3 (103), 12 (103), 23 (103), 58 (103), 2651 (103), 2660 (103), 2671 (103), 23844 (103) diastereoisomer 1, 23855 (103), 23890 (103);
    Pyricularia oryzae, Compounds 3 (1), 4 (1), 14 (1), 15 (1), 16 (1), 17 (1), 20 (1), 23 (1), 58 (1), 108 (1), 161 (1), 3 (5), 4 (5), 20 (5), 23 (5), 58 (5), 108 (5), 3 (32), 3 (37), 16 (37), 678 (37), 3 (43), 3 (103), 12 (103), 23 (103), 58 (103), 92 (103), 171 (103), 2651 (103), 2669 (103), 2671 (103), 23844 (103) diastereoisomer 1, 23844 (103) diastereoisomer 2, 23855 (103), 23890 (103);
    Botrytis cinerea, Compounds 4 (1), 14 (1), 15 (1), 16 (1), 17 (1), 22 (1), 58 (1), 108 (1), 4 (5), 22 (5), 28 (5), 58 (5), 108 (5), 162 (5), 16 (37), 678 (37), 23 (103), 92 (103), 2651 (103), 2660 (103), 23844 (103) diastereoisomer 2, 23855 (103), 23890 (103).

Claims (13)

1. The compound of the general formula (1):
Figure US20090069333A1-20090312-C00095
wherein
W and X, X and Y or Y and Z are N and the other two are CR8;
R8 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
R is halo;
R1 is halo, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, C1-8 alkoxy, C1-8 alkylthio, aryl, aryloxy, arylthio, heteroaryl, heteroaryloxy, heteroarylthio, aryl(C1-4)alkyl, aryl(C1-4)alkoxy, heteroaryl(C1-4)alkyl, heteroaryl(C1-4)alkoxy, aryl(C1-4)alkylthio, heteroaryl(C1-4)alkylthio, morpholino, piperidino or pyrrolidino;
R2 is NR3R4;
R3 and R4 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl, heteroaryl(C1-8)alkyl, NR5R6, provided that not both R3 and R4 are H or NR5R6, or
R3 and R4 together form a C3-7 alkylene or C3-7 alkenylene chain optionally substituted with one or more C1-4 alkyl or C1-4 alkoxy groups, or,
together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl ring; and
R5 and R6 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl (C1-6)alkyl, heteroaryl or heteroaryl(C1-8)alkyl;
any of the foregoing alkyl, alkenyl, alkynyl or cycloalkyl groups or moieties (other than for R8) being optionally substituted with halogen, cyano, C1-6 alkoxy, C1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 haloalkoxy, C1-6 alkylthio, tri(C1-4)alkylsilyl, C1-6 alkylamino or C1-6 dialkylamino,
any of the foregoing morpholine, thiomorpholine, piperidine, piperazine and pyrrolidine rings being optionally substituted with C1-4 alkyl, and
any of the foregoing aryl or heteroaryl groups or moieties being optionally substituted with one or more substituents selected from halo, hydroxy, mercapto, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C2-6 alkenyloxy, C2-6 alkynyloxy, halo(C1-6)alkyl, halo(C1-6)alkoxy, C1-6 alkylthio, halo(C1-6)alkylthio, hydroxy(C1-6)alkyl, C1-4 alkoxy(C1-6)alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenoxy, benzyloxy, benzoyloxy, cyano, isocyano, thiocyanato, isothiocyanato, nitro, —NR′″R″″, —NHCOR′″, —NHCONR′″R″″, —CONR′″R″″, —SO2R′″, —OSO2R′″, —COR′″, —CR′″═NR″″ or —N═CR′″R″″, in which R′″ and R″″ are independently hydrogen, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy, halo(C1-4)alkoxy, C1-4 alkylthio,
C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenyl or benzyl, the phenyl and benzyl groups being optionally substituted with halogen, C1-4 alkyl or C1-4 alkoxy.
2. A compound according to claim 1 wherein
R3 is C1-8 alkyl, halo(C1-8)alkyl, hydroxy(C1-8)alkyl, C1-4 alkoxy(C1-8)alkyl, C1-4 alkoxyhalo-(C1-8)alkyl, tri(C1-4)alkylsilyl(C1-6)alkyl, C1-4 alkylcarbonyl(C1-8)alkyl, C1-4 alkylcarbonyl-halo(C1-8)alkyl, phenyl(1-4)alkyl, C2-8 alkenyl, halo(C2-8)alkenyl, C2-8 alkynyl, C3-8 cycloalkyl optionally substituted with chloro, fluoro or methyl, C3-8 cycloalkyl(C1-4)alkyl, phenylamino, piperidino or morpholino, the phenyl ring of phenylalkyl or phenylamino being optionally substituted with one, two or three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy and halo(C1-4)alkoxy; and
R4 is H, C1-4 alkyl, halo(C1-4)alkyl or amino, or
R3 and R4 together form a C3-7 alkylene or alkenylene chain optionally substituted with methyl, or,
together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl ring, in which the morpholine or piperazine rings are optionally substituted with methyl.
3. A compound according to claim 1 wherein
R1 is phenyl optionally substituted with from one to five halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy or halo(C1-4)alkoxy, pyridyl optionally substituted with from one to four halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy or halo(C1-4)alkoxy, 2- or 3-thienyl optionally substituted with from one to three halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl,
C1-4 alkoxy or halo(C1-4)alkoxy, or piperidino or morpholino both optionally substituted with one or two methyl groups.
4. A compound according to claim 4 wherein R1 is 2,6-difluorophenyl, 2-fluoro-6-chlorophenyl, 2,5,6-trifluorophenyl, 2,4,6-trifluorophenyl, 2,6-difluoro-4-methoxyphenyl or pentafluorophenyl.
5. A compound according to claim 1 wherein
R8 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
R is halo;
R1 is halo, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, C1-8 alkoxy, C1-8 alkylthio, aryl, aryloxy, arylthio, heteroaryl, heteroaryloxy, heteroarylthio, aryl(C1-4)alkyl, aryl(C1-4)alkoxy, heteroaryl(C1-4)alkyl, heteroaryl(C1-4)alkoxy, aryl(C1-4)-alkylthio, heteroaryl(C1-4)alkylthio, morpholino, piperidino or pyrrolidino;
R2 is NR3R4;
R3 and R4 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl, heteroaryl(C1-8)alkyl, NR5R6, provided that not both R3 and R4 are H or NR5R6, or
R3 and R4 together form a C3-7 alkylene or C3-7 alkenylene chain optionally substituted with one or more C1-4 alkyl or C1-4 alkoxy groups, or,
together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-14)alkyl ring; and
R5 and R6 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl or heteroaryl(C1-8)alkyl;
any of the foregoing alkyl, alkenyl, alkynyl or cycloalkyl groups or moieties (other than for R8) being optionally substituted with halogen, cyano, C1-6 alkoxy, C1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 haloalkoxy, C1-6 alkylthio, tri(C1-4)alkylsilyl, C1-6 alkylamino or C1-6 dialkylamino,
any of the foregoing morpholine, thiomorpholine, piperidine, piperazine and pyrrolidine rings being optionally substituted with C1-4 alkyl, and
any of the aryl, heteroaryl, aryloxy or heteroaryl groups being optionally substituted with one or more substituents selected from halo, hydroxy, mercapto, C1-6 alkyl, C2-6 alkenyl,
C2-6 alkynyl, C1-6 alkoxy, C2-6 alkenyloxy, C2-6 alkynyloxy, halo(C1-6)alkyl, halo(C1-6)alkoxy, C1-6 alkylthio, halo(C1-6)alkylthio, hydroxy(C1-6)alkyl, C1-4 alkoxy(C1-6)alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenoxy, benzyloxy, benzoyloxy, cyano, isocyano, thiocyanato, isothiocyanato, nitro, —NR′″R″″, —NHCOR′″, —NHCONR′″R″″, —CONR′″R″″, —SO2R′″, —OSO2R′″, —COR′″, —CR′″═NR″″ or —N═CR′″R″″, in which R′″ and R″″ are independently hydrogen, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy, halo(C1-4)alkoxy, C1-4 alkylthio,
C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenyl or benzyl, the phenyl and benzyl groups being optionally substituted with halogen, C1-4 alkyl or C1-4 alkoxy.
6. A compound according to claim 1 wherein
R8 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
R is halo;
R1 is halo, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, C1-8 alkoxy, C1-8 alkylthio, aryl, aryloxy, arylthio, heteroaryl, heteroaryloxy, heteroarylthio, aryl(C1-4)alkyl, aryl(C1-4)alkoxy, heteroaryl(C1-4)alkyl, heteroaryl(C1-4)alkoxy, aryl(C1-4)alkylthio, heteroaryl(C1-4)alkylthio, morpholino, piperidino or pyrrolidino;
R2 is NR34;
R3 is C1-4 alkyl, halo(C1-4)alkyl, C2-4 alkenyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl or phenylamino in which the phenyl ring is optionally substituted with one, two or three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy and halo(C1-4)alkoxy; and
R4 is H, C1-4 alkyl or amino, or
R3 and R4 together form a C4-6 alkylene chain optionally substituted with C1-4 alkyl or C1-4 alkoxy, or,
together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl ring;
any of the alkyl, alkenyl, alkynyl or cycloalkyl groups or moieties (other than for R8) being optionally substituted with halogen, cyano, C1-6 alkoxy, C1-6 alkylcarbonyl,
C1-6 alkoxycarbonyl, C1-6 haloalkoxy, C1-6 alkylthio, tri(C1-4)alkylsilyl, C1-6 alkylamino or
C1-6 dialkylamino,
any of the foregoing morpholine, thiomorpholine, piperidine, piperazine and pyrrolidine rings being optionally substituted with C1-4 alkyl, and
any of the aryl or heteroaryl groups or moieties being optionally substituted with one or more substituents selected from halo, hydroxy, mercapto, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl,
C1-6 alkoxy, C2-6 alkenyloxy, C2-6 alkynyloxy, halo(C1-6)alkyl, halo(C1-6)alkoxy,
C1-6 alkylthio, halo(C1-6)alkylthio, hydroxy(C1-6)alkyl, C1-4 alkoxy(C1-6)alkyl, C3-6 cycloalkyl,
C3-6 cycloalkyl(C1-4)alkyl, phenoxy, benzyloxy, benzoyloxy, cyano, isocyano, thiocyanato, isothiocyanato, nitro, —NR′″R″″, —NHCOR′″, —NHCONR′″R″″, —CONR′″R″″, —SO2R′″, —OSO2R′″, —COR′″, —CR′″═NR″″ or —N═CR′″R″″, in which R′″ and R″″ are independently hydrogen, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy, halo(C1-4)alkoxy, C1-4 alkylthio,
C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenyl or benzyl, the phenyl and benzyl groups being optionally substituted with halogen, C1-4 alkyl or C1-4 alkoxy.
7. A compound according to claim 1 wherein
R8 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
R is halo;
R1 is optionally substituted phenyl;
R2 is NR3R4;
R3 and R4 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl, heteroaryl(C1-8)alkyl, NR5R6, provided that not both R3 and R4 are H or NR5R6, or
R3 and R4 together form a C3-7 alkylene or C3-7 alkenylene chain optionally substituted with one or more C1-4 alkyl or C1-4 alkoxy groups, or,
together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl ring; and
R5 and R6 are independently H, C1-8 alkyl, C2-8 alkenyl, C2-8 alkynyl, aryl, aryl(C1-8)alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl(C1-6)alkyl, heteroaryl or heteroaryl(C1-8)alkyl;
any of the alkyl, alkenyl, alkynyl or cycloalkyl groups or moieties (other than for R8) being optionally substituted with halogen, cyano, C1-6 alkoxy, C1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 haloalkoxy, C1-6 alkylthio, tri(C1-4)alkylsilyl, C1-6 alkylamino or C1-6 dialkylamino,
any of the foregoing morpholine, thiomorpholine, piperidine, piperazine and pyrrolidine rings being optionally substituted with C1-4 alkyl, and
any of the aryl or heteroaryl groups or moieties, including the phenyl group of R1, being optionally substituted with one or more substituents selected from halo, hydroxy, mercapto, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C2-6 alkenyloxy, C2-6 alkynyloxy, halo(C1-6)alkyl, halo(C1-6)alkoxy, C1-6 alkylthio, halo(C1-6)alkylthio, hydroxy(C1-6)alkyl, C1-4 alkoxy(C1-6)alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-14)alkyl, phenoxy, benzyloxy, benzoyloxy, cyano, isocyano, thiocyanato, isothiocyanato, nitro, —NR′″R″″, —NHCOR′″, —NHCONR′″R″″, —CONR′″R″″, —SO2R′″, —OSO2R′″, —COR′″, —CR′″═NR″″ or —N═CR′″R″″, in which R′″ and R″″ are independently hydrogen, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy, halo(C1-4)alkoxy, C1-4 alkylthio, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl, phenyl or benzyl, the phenyl and benzyl groups being optionally substituted with halogen, C1-4 alkyl or
C1-4 alkoxy.
8. A compound according to claim 1 wherein
R8 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
R is halo;
R1 is phenyl optionally substituted with from one to five halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy or halo(C1-4)alkoxy, pyridyl optionally substituted with from one to four halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy or halo(C1-4)alkoxy, 2- or 3-thienyl optionally substituted with from one to three halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy or halo(C1-4)alkoxy, or piperidino or morpholino both optionally substituted with one or two methyl groups;
R2 is NR3R4;
R3 is C1-8 alkyl, halo(C1-8)alkyl, hydroxy(C1-8)alkyl, C1-4 alkoxy(C1-8)alkyl, C1-4 alkoxyhalo-(C1-8)alkyl, tri(C1-4)alkylsilyl(C1-6)alkyl, C1-4 alkylcarbonyl(C1-8)alkyl, C1-4 alkylcarbonyl-halo(C1-8)alkyl, phenyl(1-4)alkyl, C2-8 alkenyl, halo(C2-8)alkenyl, C2-8 alkynyl, C3-8 cycloalkyl optionally substituted with chloro, fluoro or methyl, C3-8 cycloalkyl(C1-4)alkyl, phenylamino, piperidino or morpholino, the phenyl ring of phenylalkyl or phenylamino being optionally substituted with one, two or three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy and halo(C1-4)alkoxy; and
R4 is H, C1-4 alkyl, halo(C1-4)alkyl or amino, or
R3 and K4 together form a C3-7 alkylene or C3-7 alkenylene chain optionally substituted with methyl, or,
together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine, thiomorpholine, thiomorpholine S-oxide or thiomorpholine S-dioxide ring or a piperazine or piperazine N—(C1-4)alkyl ring, in which the morpholine or piperazine rings are optionally substituted with methyl.
9. A compound according to claim 1 wherein
R8 is H, halo, C1-4 alkyl, C1-4 alkoxy or halo(C1-4)alkyl;
R is halo;
R1 is phenyl optionally substituted with from one to five halogen atoms or with from one to three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy or
halo(C1-4)alkoxy;
R2 is NR3R4;
R3 is C1-4 alkyl, halo(C1-4)alkyl, C2-4 alkenyl, C3-6 cycloalkyl, C3-6 cycloalkyl(C1-4)alkyl or phenylamino in which the phenyl ring is optionally substituted with one, two or three substituents selected from halo, C1-4 alkyl, halo(C1-4)alkyl, C1-4 alkoxy and halo(C1-4)alkoxy; and
R4 is H, C1-4 alkyl or amino, or R3 and R4 together form a C4-6 alkylene chain optionally substituted with methyl, or, together with the nitrogen atom to which they are attached, R3 and R4 form a morpholine ring.
10. A process for preparing a compound of the general formula (1) according to claim 1 wherein R is chloro or fluoro and R2 is NR3R4 and W, X, Y, Z, R1, R3 and R4 are as defined in claim 1, which comprises reacting an amine of the general formula NR3R4 with a compound of the general formula (6) or (13)
Figure US20090069333A1-20090312-C00096
11. The intermediate chemicals having the general formulae (4), (5), (6) and (13):
Figure US20090069333A1-20090312-C00097
wherein W, X, Y, Z and R1 are as defined in claim 1 and R7 is C1-4 alkyl, other than the compound of formula (6) wherein X and Y are N, W and Z are C—Cl and R1 is Cl.
12. A plant fungicidal composition comprising a fungicidally effective amount of a compound as defined in claim 1 and a suitable carrier or diluent therefor.
13. A method of combating or controlling phytopathogenic fungi which comprises applying to a plant, to a seed of a plant, to the locus of the plant or seed or to soil or to any other plant growth medium, a fungicidally effective amount of a compound according to claim 1 or a composition according to claim 13.
US12/187,072 2002-12-23 2008-08-06 Fungicides Abandoned US20090069333A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/187,072 US20090069333A1 (en) 2002-12-23 2008-08-06 Fungicides

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0230020.0 2002-12-23
GBGB0230020.0A GB0230020D0 (en) 2002-12-23 2002-12-23 Fungicides
US10/540,035 US7410967B2 (en) 2002-12-23 2003-12-03 Pyridodiazines as plant fungicides
PCT/GB2003/005250 WO2004056825A1 (en) 2002-12-23 2003-12-03 Pyridodiazines as plant fungicides
US12/187,072 US20090069333A1 (en) 2002-12-23 2008-08-06 Fungicides

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/GB2003/005250 Division WO2004056825A1 (en) 2002-12-23 2003-12-03 Pyridodiazines as plant fungicides
US10/540,035 Division US7410967B2 (en) 2002-12-23 2003-12-03 Pyridodiazines as plant fungicides

Publications (1)

Publication Number Publication Date
US20090069333A1 true US20090069333A1 (en) 2009-03-12

Family

ID=9950323

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/540,035 Expired - Fee Related US7410967B2 (en) 2002-12-23 2003-12-03 Pyridodiazines as plant fungicides
US12/187,072 Abandoned US20090069333A1 (en) 2002-12-23 2008-08-06 Fungicides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/540,035 Expired - Fee Related US7410967B2 (en) 2002-12-23 2003-12-03 Pyridodiazines as plant fungicides

Country Status (24)

Country Link
US (2) US7410967B2 (en)
EP (1) EP1575948B1 (en)
JP (1) JP4847017B2 (en)
KR (1) KR101099434B1 (en)
CN (1) CN100341872C (en)
AR (1) AR042660A1 (en)
AT (1) ATE353897T1 (en)
AU (1) AU2003288410B2 (en)
BR (1) BR0317678A (en)
CA (1) CA2509451C (en)
CR (1) CR7864A (en)
DE (1) DE60311876T2 (en)
DK (1) DK1575948T3 (en)
EC (1) ECSP055863A (en)
ES (1) ES2282702T3 (en)
GB (1) GB0230020D0 (en)
GT (1) GT200300298A (en)
IL (1) IL169186A (en)
MX (1) MXPA05006648A (en)
PT (1) PT1575948E (en)
RU (1) RU2352570C2 (en)
TW (1) TWI326683B (en)
WO (1) WO2004056825A1 (en)
ZA (1) ZA200504296B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0230018D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
GB0230020D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
NZ540612A (en) 2003-01-14 2008-02-29 Arena Pharm Inc 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
BRPI0412704A (en) * 2003-07-18 2006-09-26 Basf Ag bicyclic compounds, their use, process and agent to combat phytopathogenic fungi, and, ketone
GB0413955D0 (en) * 2004-06-22 2004-07-28 Syngenta Participations Ag Chemical compounds
GB0413953D0 (en) * 2004-06-22 2004-07-28 Syngenta Participations Ag Chemical compounds
WO2007088060A1 (en) * 2006-02-03 2007-08-09 Syngenta Participations Ag Tetrahydropyrido [2, 3-b] pyrazine and dihydropyrido [2 , 3-b] pyrazine derivatives as plant fungicides
GB0614471D0 (en) 2006-07-20 2006-08-30 Syngenta Ltd Herbicidal Compounds
EP1920654A1 (en) 2006-09-13 2008-05-14 Syngeta Participations AG Novel pyridopyrazine N-oxides
US20100093738A1 (en) * 2006-10-06 2010-04-15 Basf Se Fungicidal Compounds and Fungicidal Compositions
GB0624760D0 (en) * 2006-12-12 2007-01-17 Syngenta Ltd Herbicidal compounds
GB0800856D0 (en) * 2008-01-17 2008-02-27 Syngenta Ltd Herbicidal compounds
GB0800855D0 (en) 2008-01-17 2008-02-27 Syngenta Ltd Herbicidal compounds
EP3323818A1 (en) 2010-09-22 2018-05-23 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
CN102273442A (en) * 2011-09-13 2011-12-14 广西田园生化股份有限公司 Ultralow volume liquid containing epoxiconazole
CN102273441B (en) * 2011-09-13 2015-01-07 广西田园生化股份有限公司 Ultralow volume liquid containing azoxystronbin
MX2017008925A (en) 2015-01-06 2017-10-11 Arena Pharm Inc Methods of treating conditions related to the s1p1 receptor.
PL3310760T3 (en) 2015-06-22 2023-03-06 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in s1p1 receptor-associated disorders
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984412A (en) * 1974-07-25 1976-10-05 E. R. Squibb & Sons, Inc. Amino derivatives of pyrido[2,3-b]pyrazine carboxylic acids and esters
US4801592A (en) * 1986-12-31 1989-01-31 Basf Aktiengesellschaft Substituted 1,8-naphthyridine derivatives and fungicides containing them
US5258356A (en) * 1989-03-11 1993-11-02 Basf Aktiengesellschaft Substituted 1,8-naphthyridines, their preparation and their use as antidotes
US5597776A (en) * 1991-09-18 1997-01-28 Basf Aktiengesellschaft Substituted pyrido[2, 3-dipyrimidines as antidotes for herbicidal cyclohexenones
US5821244A (en) * 1993-03-13 1998-10-13 Hoechst Schering Agrevo Gmbh Condensed nitrogen heterocycles and their use as pesticides, fungicides and antimycotics
US5852042A (en) * 1994-09-28 1998-12-22 Hoechst Schering Agrevo Gmbh Substituted pyridines, processes for their preparation and their use as pesticides and fungicides
US5955473A (en) * 1995-09-12 1999-09-21 Basf Aktiengesellschaft Fungicidal quinolines
US6117884A (en) * 1997-07-31 2000-09-12 Daeuble; John 4-substituted quinoline derivatives having fungicidal activity
US20060069089A1 (en) * 2002-12-23 2006-03-30 Crowley Patrick J Fungicides

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1004223A (en) * 1972-05-12 1977-01-25 Theodor Denzel Amino derivatives of pyrido(2,3-d)pyridazine carboxylic acids and esters
AU634561B2 (en) 1989-07-27 1993-02-25 Eli Lilly And Company Naphthyridine derivatives
GB2323476B (en) * 1997-03-20 2002-01-16 David Ganeshmoorthy Communication antenna and equipment
PL202547B1 (en) 1999-09-07 2009-07-31 Syngenta Participations Ag Novel herbicides
JP2002249492A (en) 2000-12-22 2002-09-06 Nippon Bayer Agrochem Co Ltd Triazopyrimidines
EP1249452B1 (en) * 2001-04-09 2004-06-30 Basf Aktiengesellschaft Fungicidal 5-Alkylamino-6-phenyl-7-halo-triazolopyrimidines
EP1381610B1 (en) 2001-04-11 2004-08-25 Basf Aktiengesellschaft 6-(2-chloro-6-fluoro-phenyl)-triazolopyrimidines
ES2236509T3 (en) * 2001-04-11 2005-07-16 Basf Aktiengesellschaft 5-HALOGEN-6-FENIL-7-FLUOROALQUILAMINO-TRIAZOLOPIRIMIDINAS USEFUL AS FUNGICIDES.
DE10121101A1 (en) 2001-04-27 2002-10-31 Bayer Ag triazolopyrimidines
DE10121102A1 (en) 2001-04-27 2002-11-07 Bayer Ag triazolopyrimidines
DE10121162A1 (en) 2001-04-30 2002-10-31 Bayer Ag triazolopyrimidines
GB0230021D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
GB0230020D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides
GB0230019D0 (en) 2002-12-23 2003-01-29 Syngenta Ltd Fungicides

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984412A (en) * 1974-07-25 1976-10-05 E. R. Squibb & Sons, Inc. Amino derivatives of pyrido[2,3-b]pyrazine carboxylic acids and esters
US4801592A (en) * 1986-12-31 1989-01-31 Basf Aktiengesellschaft Substituted 1,8-naphthyridine derivatives and fungicides containing them
US5258356A (en) * 1989-03-11 1993-11-02 Basf Aktiengesellschaft Substituted 1,8-naphthyridines, their preparation and their use as antidotes
US5597776A (en) * 1991-09-18 1997-01-28 Basf Aktiengesellschaft Substituted pyrido[2, 3-dipyrimidines as antidotes for herbicidal cyclohexenones
US5821244A (en) * 1993-03-13 1998-10-13 Hoechst Schering Agrevo Gmbh Condensed nitrogen heterocycles and their use as pesticides, fungicides and antimycotics
US5852042A (en) * 1994-09-28 1998-12-22 Hoechst Schering Agrevo Gmbh Substituted pyridines, processes for their preparation and their use as pesticides and fungicides
US5955473A (en) * 1995-09-12 1999-09-21 Basf Aktiengesellschaft Fungicidal quinolines
US6117884A (en) * 1997-07-31 2000-09-12 Daeuble; John 4-substituted quinoline derivatives having fungicidal activity
US20060069089A1 (en) * 2002-12-23 2006-03-30 Crowley Patrick J Fungicides

Also Published As

Publication number Publication date
EP1575948B1 (en) 2007-02-14
CN1732168A (en) 2006-02-08
IL169186A0 (en) 2007-07-04
MXPA05006648A (en) 2005-08-16
RU2005123331A (en) 2006-05-10
CA2509451C (en) 2012-01-24
JP4847017B2 (en) 2011-12-28
CA2509451A1 (en) 2004-07-08
BR0317678A (en) 2005-11-29
GT200300298A (en) 2004-07-27
DK1575948T3 (en) 2007-06-11
KR20050095830A (en) 2005-10-04
EP1575948A1 (en) 2005-09-21
GB0230020D0 (en) 2003-01-29
TWI326683B (en) 2010-07-01
JP2006516129A (en) 2006-06-22
ZA200504296B (en) 2006-02-22
RU2352570C2 (en) 2009-04-20
DE60311876D1 (en) 2007-03-29
WO2004056825A1 (en) 2004-07-08
CR7864A (en) 2007-08-28
AR042660A1 (en) 2005-06-29
TW200510409A (en) 2005-03-16
IL169186A (en) 2010-02-17
AU2003288410A1 (en) 2004-07-14
ECSP055863A (en) 2005-09-20
AU2003288410B2 (en) 2009-12-03
US20060205717A1 (en) 2006-09-14
DE60311876T2 (en) 2007-11-08
ES2282702T3 (en) 2007-10-16
PT1575948E (en) 2007-05-31
KR101099434B1 (en) 2011-12-28
US7410967B2 (en) 2008-08-12
CN100341872C (en) 2007-10-10
ATE353897T1 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
US20090069333A1 (en) Fungicides
EP1638928B1 (en) N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides
US20080280766A1 (en) Pyridopyrazines for Combating Phytopathogenic Fungi
US20080287472A1 (en) Fungicides
US20080318962A1 (en) Fungicides Based on Nitrogen-Containing Heterocycles
US7947679B2 (en) Fungicides
US20060100203A1 (en) Fungicides based on nitrogen-containing heterocycles
WO2003039259A1 (en) Fungicides

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION